<?xml version="1.0" encoding="UTF-8" ?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/">
    <channel>
        <title>ABPI Blogs and News</title>
        <description>ABPI Blogs and News</description>
        <link>https://www.abpi.org.uk/media/</link>  
        <atom:link href="https://www.abpi.org.uk/feed/" rel="self" type="application/rss+xml" />
        <lastBuildDate>Thu, 02 Apr 2026 03:00:11 GMT</lastBuildDate>
        <language>en-gb</language>
                <item>
                    <title>The UK should seek to be a European leader for rare disease medicine, says new report</title>
<link>https://www.abpi.org.uk/media/news/2026/april/the-uk-should-seek-to-be-a-european-leader-for-rare-disease-medicine-says-new-report/</link>                    <pubDate>Thu, 02 Apr 2026 03:00:11 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Rare diseases]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2026/april/the-uk-should-seek-to-be-a-european-leader-for-rare-disease-medicine-says-new-report/</guid>
                    <description><![CDATA[Improving NHS access to innovative rare disease treatments could generate &#xA3;19 billion in productivity gains over 10 years.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/m2zhbrml/fingers-vial-blue-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef6c23a0"/>
                </item>
                <item>
                    <title>UK-US deal is good news for NHS patients and will help to support UK life sciences competitiveness, says ABPI</title>
<link>https://www.abpi.org.uk/media/news/2025/december/uk-us-deal-is-good-news-for-nhs-patients-and-will-help-to-support-uk-life-sciences-competitiveness-says-abpi/</link>                    <pubDate>Tue, 31 Mar 2026 17:06:24 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Commercial]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/december/uk-us-deal-is-good-news-for-nhs-patients-and-will-help-to-support-uk-life-sciences-competitiveness-says-abpi/</guid>
                    <description><![CDATA[Industry hopes the new trade agreement will allow more innovative medicines to reach a greater number of NHS patients and will be a positive step in supporting the UK life sciences industry. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/yheezl41/doctor-consult-bed-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef31b2b0"/>
                </item>
                <item>
                    <title>Unlocking NHS data to increase recruitment into clinical trials will give the UK a competitive edge, says ABPI</title>
<link>https://www.abpi.org.uk/media/news/2026/march/unlocking-nhs-data-to-increase-recruitment-into-clinical-trials-will-give-the-uk-a-competitive-edge-says-abpi/</link>                    <pubDate>Tue, 31 Mar 2026 14:03:09 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Clinical research]]></category>
                            <category><![CDATA[Health data]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2026/march/unlocking-nhs-data-to-increase-recruitment-into-clinical-trials-will-give-the-uk-a-competitive-edge-says-abpi/</guid>
                    <description><![CDATA[The UK has an opportunity to enhance its global competitiveness in the delivery of industry clinical trials by harnessing NHS health data to more efficiently recruit patients, according to a new report from the ABPI.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/chxbqmn1/doctor-examining-patient-2025-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1dc5d1b9c8c1ac0"/>
                </item>
                <item>
                    <title>Life Sciences Sector Policy Delivery</title>
<link>https://www.abpi.org.uk/media/news/2026/march/life-sciences-sector-policy-delivery/</link>                    <pubDate>Tue, 31 Mar 2026 14:03:09 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Medicines pricing]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Access]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2026/march/life-sciences-sector-policy-delivery/</guid>
                    <description><![CDATA[The government and the UK life sciences industry have launched a Joint Taskforce to drive innovation in the UK&#x2019;s commercial environment for medicines. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/zbkfg4k4/sales-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52efd14e10"/>
                </item>
                <item>
                    <title>UK opportunity to accelerate development of new medicines</title>
<link>https://www.abpi.org.uk/media/news/2026/february/uk-opportunity-to-accelerate-development-of-new-medicines/</link>                    <pubDate>Tue, 31 Mar 2026 14:03:09 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2026/february/uk-opportunity-to-accelerate-development-of-new-medicines/</guid>
                    <description><![CDATA[New report shows a coordinated approach needed to so academic discoveries can be taken forward with industry to develop new treatments.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/pq3fnuvz/scientist-pipetting-580x405-webp75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee960ef0"/>
                </item>
                <item>
                    <title>New report underlines the health and economic opportunity from boosting industry clinical trials</title>
<link>https://www.abpi.org.uk/media/news/2026/february/new-report-underlines-the-health-and-economic-opportunity-from-boosting-industry-clinical-trials/</link>                    <pubDate>Tue, 31 Mar 2026 14:03:08 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2026/february/new-report-underlines-the-health-and-economic-opportunity-from-boosting-industry-clinical-trials/</guid>
                    <description><![CDATA[A new EFPIA report highlights the significant health, economic and productivity returns that would result from increasing clinical trial activity across Europe.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/smlloguk/petri-dish-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee483d10"/>
                </item>
                <item>
                    <title>ABPI response to publication of England&#x27;s Rare Diseases Action Plan 2026</title>
<link>https://www.abpi.org.uk/media/news/2026/february/abpi-response-to-publication-of-englands-rare-diseases-action-plan-2026/</link>                    <pubDate>Tue, 31 Mar 2026 14:03:08 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Rare diseases]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2026/february/abpi-response-to-publication-of-englands-rare-diseases-action-plan-2026/</guid>
                    <description><![CDATA[The ABPI has responded to England&#x27;s latest Rare Diseases Action Plan, published in advance of Rare Disease Day. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/dkmh2k31/microscope-laptop-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eec7cd50"/>
                </item>
                <item>
                    <title>ABPI response to National Cancer Plan</title>
<link>https://www.abpi.org.uk/media/news/2026/february/abpi-response-to-national-cancer-plan/</link>                    <pubDate>Tue, 31 Mar 2026 14:03:08 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Cancer]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2026/february/abpi-response-to-national-cancer-plan/</guid>
                    <description><![CDATA[The government has published its National Cancer Plan, outlining how it intends to transform cancer care and outcomes in England by 2035. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/hh4eb3sp/scientists-screen-looking-2025-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1db81ed8db87570"/>
                </item>
                <item>
                    <title>ABPI comment on measles outbreak and childhood vaccination</title>
<link>https://www.abpi.org.uk/media/news/2026/february/abpi-comment-on-measles-outbreak-and-childhood-vaccination/</link>                    <pubDate>Tue, 31 Mar 2026 14:03:07 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Vaccines]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2026/february/abpi-comment-on-measles-outbreak-and-childhood-vaccination/</guid>
                    <description><![CDATA[The ABPI&#x27;s comment on the measles outbreak in North London, highlighting the importance of vaccination. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/aebpbmh5/vials-spin-blue-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef3de7b0"/>
                </item>
                <item>
                    <title>UK tumbles down global rankings for pharma investment and research</title>
<link>https://www.abpi.org.uk/media/news/2025/september/uk-tumbles-down-global-rankings-for-pharma-investment-and-research/</link>                    <pubDate>Tue, 31 Mar 2026 14:03:07 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Budget]]></category>
                            <category><![CDATA[Clinical research]]></category>
                            <category><![CDATA[Commercial]]></category>
                            <category><![CDATA[Economy and Industry]]></category>
                            <category><![CDATA[G7]]></category>
                            <category><![CDATA[Health and Access to Medicines]]></category>
                            <category><![CDATA[Health data]]></category>
                            <category><![CDATA[Intellectual Property]]></category>
                            <category><![CDATA[Innovation]]></category>
                            <category><![CDATA[International]]></category>
                            <category><![CDATA[International research]]></category>
                            <category><![CDATA[Life Sciences]]></category>
                            <category><![CDATA[Manufacturing]]></category>
                            <category><![CDATA[Medicines sales]]></category>
                            <category><![CDATA[Politics]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Reputation]]></category>
                            <category><![CDATA[Research and Development]]></category>
                            <category><![CDATA[Rest of the World]]></category>
                            <category><![CDATA[Science and innovation]]></category>
                            <category><![CDATA[Statistics]]></category>
                            <category><![CDATA[Trade]]></category>
                            <category><![CDATA[UK-EU]]></category>
                            <category><![CDATA[Value]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[VPAG]]></category>
                            <category><![CDATA[VPAG (1)]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/september/uk-tumbles-down-global-rankings-for-pharma-investment-and-research/</guid>
                    <description><![CDATA[A new Pharmaceutical Competitiveness Framework reveals that the UK is losing the race for investment in R&amp;D, clinical trial delivery, and foreign direct investment, due to increasing drags on competitiveness.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/3calxvpd/g7-flags-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eeb99c80"/>
                </item>
                <item>
                    <title>The UK risks undervaluing life sciences manufacturing investment</title>
<link>https://www.abpi.org.uk/media/news/2025/september/the-uk-risks-undervaluing-life-sciences-manufacturing-investment/</link>                    <pubDate>Tue, 31 Mar 2026 14:03:00 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Research and Development]]></category>
                            <category><![CDATA[Manufacturing]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/september/the-uk-risks-undervaluing-life-sciences-manufacturing-investment/</guid>
                    <description><![CDATA[The official methods used by the UK government to assess the value of innovative life sciences manufacturing may lead the UK to miss out on strategic investments and the jobs and productivity growth they can bring to all regions across the UK]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/rcbecr0f/biotherapeutics-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f042d490"/>
                </item>
                <item>
                    <title>Companies granted extension to VPAG 2026 decision deadline</title>
<link>https://www.abpi.org.uk/media/news/2025/september/companies-granted-extension-to-vpag-2026-decision-deadline/</link>                    <pubDate>Tue, 31 Mar 2026 14:03:00 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[VPAG]]></category>
                            <category><![CDATA[VPAG (1)]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/september/companies-granted-extension-to-vpag-2026-decision-deadline/</guid>
                    <description><![CDATA[The ABPI and the government have agreed to a four-week extension to the deadline by which companies must give notice if they intend to leave the 2024 voluntary scheme for branded medicines pricing, access and growth (VPAG). The revised deadline for submitting notice to leave the VPAG scheme is 31 October 2025.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/fweh4rnt/wearables.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f0c30110"/>
                </item>
                <item>
                    <title>ABPI launches manifesto to make Scotland a leader in R&amp;D and cutting-edge medicines</title>
<link>https://www.abpi.org.uk/media/news/2025/september/abpi-launches-manifesto-to-make-scotland-a-leader-in-rd-and-cutting-edge-medicines/</link>                    <pubDate>Tue, 31 Mar 2026 14:03:00 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Scotland]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/september/abpi-launches-manifesto-to-make-scotland-a-leader-in-rd-and-cutting-edge-medicines/</guid>
                    <description><![CDATA[The ABPI has launched its manifesto for the next Scottish Government, calling for urgent action to unlock Scotland&#x2019;s full potential as a partner of choice for life sciences and health innovation.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/jcgofh1n/women-scientist-microscope-871x581-webp75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef19bde0"/>
                </item>
                <item>
                    <title>Companies granted further extension to VPAG 2026 decision deadline</title>
<link>https://www.abpi.org.uk/media/news/2025/october/companies-granted-further-extension-to-vpag-2026-decision-deadline/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:59 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Statutory Scheme]]></category>
                            <category><![CDATA[VPAG]]></category>
                            <category><![CDATA[VPAG (1)]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Access]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/october/companies-granted-further-extension-to-vpag-2026-decision-deadline/</guid>
                    <description><![CDATA[The ABPI and the government have agreed to a further two-week extension to the deadline by which companies must give notice if they intend to leave the 2024 voluntary scheme for branded medicines pricing, access and growth (VPAG). ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/fweh4rnt/wearables.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f0c30110"/>
                </item>
                <item>
                    <title>Scotland&#x27;s life sciences strategy is a welcome vision that must be matched with delivery, says ABPI</title>
<link>https://www.abpi.org.uk/media/news/2025/november/scotlands-life-sciences-strategy-is-a-welcome-vision-that-must-be-matched-with-delivery-says-abpi/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:59 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Scotland]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/november/scotlands-life-sciences-strategy-is-a-welcome-vision-that-must-be-matched-with-delivery-says-abpi/</guid>
                    <description><![CDATA[The Strategy aims to create the most effective environment for developing, testing, manufacturing and commercialising life sciences innovation. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/hmibbi0s/biochemical-research-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eea1a7b0"/>
                </item>
                <item>
                    <title>Companies granted third extension to VPAG 2026 decision deadline &#x2013; now set for 16 December</title>
<link>https://www.abpi.org.uk/media/news/2025/november/companies-granted-third-extension-to-vpag-2026-decision-deadline-now-set-for-16-december/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:59 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[VPAG]]></category>
                            <category><![CDATA[VPAG (1)]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/november/companies-granted-third-extension-to-vpag-2026-decision-deadline-now-set-for-16-december/</guid>
                    <description><![CDATA[The ABPI and the government have agreed to a further extension to the deadline by which companies must give notice if they intend to leave the 2024 voluntary scheme for branded medicines pricing, access and growth (VPAG). The revised deadline for submitting notice to leave the VPAG scheme is now 16 December 2025.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/fweh4rnt/wearables.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f0c30110"/>
                </item>
                <item>
                    <title>ABPI calls for Budget action to revive UK life sciences investment</title>
<link>https://www.abpi.org.uk/media/news/2025/november/abpi-calls-for-budget-action-to-revive-uk-life-sciences-investment/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:58 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Budget]]></category>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Economy and Industry]]></category>
                            <category><![CDATA[Health and Access to Medicines]]></category>
                            <category><![CDATA[Life Sciences]]></category>
                            <category><![CDATA[MHRA]]></category>
                            <category><![CDATA[NICE]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Research and Development]]></category>
                            <category><![CDATA[Science and innovation]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[VPAG]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/november/abpi-calls-for-budget-action-to-revive-uk-life-sciences-investment/</guid>
                    <description><![CDATA[The ABPI has used its pre-Budget submission to urge the government to take urgent steps to reverse a decade-long decline in investment and restore the UK&#x2019;s position as a global leader in life sciences. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/0mgjexoi/mps-2-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d9da41cdf42800"/>
                </item>
                <item>
                    <title>UK-India trade agreement does not support UK life sciences ambitions, says ABPI</title>
<link>https://www.abpi.org.uk/media/news/2025/may/uk-india-trade-agreement-does-not-support-uk-life-sciences-ambitions-says-abpi/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:58 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[International]]></category>
                            <category><![CDATA[Intellectual Property]]></category>
                            <category><![CDATA[Economy and Industry]]></category>
                            <category><![CDATA[Free Trade Agreements]]></category>
                            <category><![CDATA[G7]]></category>
                            <category><![CDATA[Trade]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/may/uk-india-trade-agreement-does-not-support-uk-life-sciences-ambitions-says-abpi/</guid>
                    <description><![CDATA[The ABPI is disappointed that the deal does not appear to address longstanding industry concerns about intellectual property protections for UK life science innovators within the Indian market, particularly the need for regulatory data protection. This will prevent our sector from realising the true potential of this deal. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/dbhj0cp5/pexels-tom-fisk-3063470.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1da27881f8f4710"/>
                </item>
                <item>
                    <title>ABPI comment on UK-US trade agreement</title>
<link>https://www.abpi.org.uk/media/news/2025/may/abpi-comment-on-uk-us-trade-agreement/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:58 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[International]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/may/abpi-comment-on-uk-us-trade-agreement/</guid>
                    <description><![CDATA[The UK government has announced a trade agreement with the US.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/uashznt5/hands-agreement-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eed19150"/>
                </item>
                <item>
                    <title>Novo Nordisk ABPI membership restored</title>
<link>https://www.abpi.org.uk/media/news/2025/march/novo-nordisk-abpi-membership-restored/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:57 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[PMCPA]]></category>
                            <category><![CDATA[Regulatory]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/march/novo-nordisk-abpi-membership-restored/</guid>
                    <description><![CDATA[Novo Nordisk&#x2019;s two-year suspension from the Association of the British Pharmaceutical Industry (ABPI) for serious breaches of the ABPI Code of Practice has come to an end.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/vhxbspk4/vial-pipette-purple-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef5ce160"/>
                </item>
                <item>
                    <title>Medicine levy makes the UK un-investable, say pharma leaders</title>
<link>https://www.abpi.org.uk/media/news/2025/march/medicine-levy-makes-the-uk-un-investable-say-pharma-leaders/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:57 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Medicines sales]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Statutory Scheme]]></category>
                            <category><![CDATA[Value]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/march/medicine-levy-makes-the-uk-un-investable-say-pharma-leaders/</guid>
                    <description><![CDATA[Leaders from across a key growth sector for the government&#x2019;s upcoming industrial strategy say future UK investment is unlikely unless an unsustainable levy on manufacturers is addressed.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/wqxdl050/brown-bottle-fill-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef7af0b0"/>
                </item>
                <item>
                    <title>ABPI welcomes new MHRA Chief Executive Officer</title>
<link>https://www.abpi.org.uk/media/news/2025/march/abpi-welcomes-new-mhra-chief-executive-officer/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:56 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Regulatory]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/march/abpi-welcomes-new-mhra-chief-executive-officer/</guid>
                    <description><![CDATA[Lawrence Tallon has been named as the new Chief Executive Officer of Medicines and Healthcare products Regulatory Agency (MHRA).]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/d3gp0fba/capsules-clear-blister-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef5a4950"/>
                </item>
                <item>
                    <title>UK doubles statutory payment rate on pharmaceutical sales from July</title>
<link>https://www.abpi.org.uk/media/news/2025/june/uk-doubles-statutory-payment-rate-on-pharmaceutical-sales-from-july/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:56 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Statutory Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/june/uk-doubles-statutory-payment-rate-on-pharmaceutical-sales-from-july/</guid>
                    <description><![CDATA[The UK government has doubled the rate that pharmaceutical companies must repay on the sales of newer products to the NHS under the statutory scheme for branded medicines in the second half of 2025, to a record 31.3 per cent.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ujpcz05h/records-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f0369f90"/>
                </item>
                <item>
                    <title>The UK must act to stem &#xA3;11 billion loss to health research</title>
<link>https://www.abpi.org.uk/media/news/2025/june/the-uk-must-act-to-stem-11-billion-loss-to-health-research/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:56 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Health and Access to Medicines]]></category>
                            <category><![CDATA[Medicines sales]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Value]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                            <category><![CDATA[VPAG]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/june/the-uk-must-act-to-stem-11-billion-loss-to-health-research/</guid>
                    <description><![CDATA[The UK could lose out on &#xA3;11bn in pharmaceuticals research and development (R&amp;D) investment by 2033, and see fewer new medicine launches in the NHS, unless very high and unpredictable medicines sales clawbacks are addressed, according to WPI Economics.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/5mxhyzbe/genetics-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f025d6b0"/>
                </item>
                <item>
                    <title>Gen Z are turning to TikTok for career advice and inspiration, finds new report</title>
<link>https://www.abpi.org.uk/media/news/2025/june/gen-z-are-turning-to-tiktok-for-career-advice-and-inspiration-finds-new-report/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:55 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Education]]></category>
                            <category><![CDATA[ABPI Schools]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/june/gen-z-are-turning-to-tiktok-for-career-advice-and-inspiration-finds-new-report/</guid>
                    <description><![CDATA[Employers looking to attract young talent into life sciences careers must embrace authenticity and social media channels, according to a new report.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/fdzf5j0f/gen-z-report-image.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1dbd52f30f05e80"/>
                </item>
                <item>
                    <title>Publication of A Common Understanding 2025</title>
<link>https://www.abpi.org.uk/media/news/2025/july/publication-of-a-common-understanding-2025/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:55 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Partnership]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/july/publication-of-a-common-understanding-2025/</guid>
                    <description><![CDATA[The Common Understanding 2025 publication demonstrates the value of productive relationships between the pharmaceutical industry and other partners in Scotland. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/wzqj5vnu/careers-support-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52efafbc50"/>
                </item>
                <item>
                    <title>Modernising UK homecare will boost neighbourhood health services and save money, says ABPI</title>
<link>https://www.abpi.org.uk/media/news/2025/july/modernising-uk-homecare-will-boost-neighbourhood-health-services-and-save-money-says-abpi/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:55 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Homecare]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/july/modernising-uk-homecare-will-boost-neighbourhood-health-services-and-save-money-says-abpi/</guid>
                    <description><![CDATA[The UK&#x2019;s homecare service potentially saves the NHS &#xA3;1.67 billion a year, and has the potential to save significantly more through shifting care from hospitals and into patients&#x2019; homes.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/pglfbcdf/nurse-patient-hands-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef4c1880"/>
                </item>
                <item>
                    <title>Equitable access to medicines and vaccines essential for patient safety and outcomes, says ABPI</title>
<link>https://www.abpi.org.uk/media/news/2025/july/equitable-access-to-medicines-and-vaccines-essential-for-patient-safety-and-outcomes-says-abpi/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:54 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Safety]]></category>
                            <category><![CDATA[Supply]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/july/equitable-access-to-medicines-and-vaccines-essential-for-patient-safety-and-outcomes-says-abpi/</guid>
                    <description><![CDATA[The Dash Review has warned that poor or inconsistent access to appropriate treatment is a patient safety issue. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/jihl0ma0/wheelchair-professional-871x581-webp75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eeebf720"/>
                </item>
                <item>
                    <title>ABPI response to the Chancellor&#x2019;s Davos speech on attracting talent for UK growth sectors</title>
<link>https://www.abpi.org.uk/media/news/2025/january/abpi-response-to-the-chancellor-s-davos-speech-on-attracting-talent-for-uk-growth-sectors/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:54 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Skills]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/january/abpi-response-to-the-chancellor-s-davos-speech-on-attracting-talent-for-uk-growth-sectors/</guid>
                    <description><![CDATA[The UK will look to secure the world&#x2019;s top talent in key growth sectors.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/1qsnrrpa/international-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52efb8e410"/>
                </item>
                <item>
                    <title>VPAG payment rate for newer medicines will be 14.5% in 2026</title>
<link>https://www.abpi.org.uk/media/news/2025/december/vpag-payment-rate-for-newer-medicines-will-be-145-in-2026/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:54 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[VPAG]]></category>
                            <category><![CDATA[VPAG (1)]]></category>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Life Sciences]]></category>
                            <category><![CDATA[Medicines sales]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Statutory Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/december/vpag-payment-rate-for-newer-medicines-will-be-145-in-2026/</guid>
                    <description><![CDATA[The government has announced that the 2026 payment rate for newer medicines under the Voluntary Scheme for Branded Medicines Pricing and Access (VPAG) will be 14.5 per cent, down from a record 22.5 per cent in 2025. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/qcmp1kqt/statistics-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f01275c0"/>
                </item>
                <item>
                    <title>Decline in commercial clinical trial recruitment selling patients short, says ABPI</title>
<link>https://www.abpi.org.uk/media/news/2025/december/decline-in-commercial-clinical-trial-recruitment-selling-patients-short-says-abpi/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:53 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Clinical research]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/december/decline-in-commercial-clinical-trial-recruitment-selling-patients-short-says-abpi/</guid>
                    <description><![CDATA[The low number of patients recruited, together with slow set-up times, is raising costs and lowering the efficiency of industry clinical trials in the UK. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/pgwagn03/doctor-patient-bedside-871x581-web75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eefc4ad0"/>
                </item>
                <item>
                    <title>ABPI welcomes Chancellor&#x2019;s speech at Labour party conference</title>
<link>https://www.abpi.org.uk/media/news/2024/september/abpi-welcomes-chancellor-s-speech-at-labour-party-conference/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:53 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[ABPI Manifesto]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/september/abpi-welcomes-chancellor-s-speech-at-labour-party-conference/</guid>
                    <description><![CDATA[Chancellor Rachel Reeves addressed the Labour Party Conference, setting out Labour&#x2019;s plans for economic stability and growth. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/hmibbi0s/biochemical-research-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eea1a7b0"/>
                </item>
                <item>
                    <title>2024 ABPI Code of Practice launched, with a new constitution and procedure for the PMCPA</title>
<link>https://www.abpi.org.uk/media/news/2024/september/2024-abpi-code-of-practice-launched-with-a-new-constitution-and-procedure-for-the-pmcpa/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:52 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/september/2024-abpi-code-of-practice-launched-with-a-new-constitution-and-procedure-for-the-pmcpa/</guid>
                    <description><![CDATA[The ABPI and the PMCPA have published an updated Code of Practice for the pharmaceutical industry.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/axgnabjp/code_image_aggregation.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1db81f95fcf69f0"/>
                </item>
                <item>
                    <title>Emerging research points to NHS and industry being a successful partnership for patients</title>
<link>https://www.abpi.org.uk/media/news/2024/october/emerging-research-points-to-nhs-and-industry-being-a-successful-partnership-for-patients/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:52 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Partnership]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/october/emerging-research-points-to-nhs-and-industry-being-a-successful-partnership-for-patients/</guid>
                    <description><![CDATA[Early evidence links NHS-industry partnerships with improved prescribing practices and better health outcomes for patients.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/yheezl41/doctor-consult-bed-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef31b2b0"/>
                </item>
                <item>
                    <title>The King&#x2019;s Fund calls on NHS leaders to help unlock power of industry partnerships</title>
<link>https://www.abpi.org.uk/media/news/2024/november/the-king-s-fund-calls-on-nhs-leaders-to-help-unlock-power-of-industry-partnerships/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:51 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Partnership]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/november/the-king-s-fund-calls-on-nhs-leaders-to-help-unlock-power-of-industry-partnerships/</guid>
                    <description><![CDATA[The ABPI has welcomed a new report from The King&#x2019;s Fund which explores the positive impacts of NHS and industry partnerships.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/pglfbcdf/nurse-patient-hands-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef4c1880"/>
                </item>
                <item>
                    <title>Life sciences sector a vital partner for Labour&#x2019;s plans</title>
<link>https://www.abpi.org.uk/media/news/2024/july/life-sciences-sector-a-vital-partner-for-labour-s-plans/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:51 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[ABPI Manifesto]]></category>
                            <category><![CDATA[ABPI Manifesto (1)]]></category>
                            <category><![CDATA[Economy and Industry]]></category>
                            <category><![CDATA[Health and Access to Medicines]]></category>
                            <category><![CDATA[Politics]]></category>
                            <category><![CDATA[Vaccines]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/july/life-sciences-sector-a-vital-partner-for-labour-s-plans/</guid>
                    <description><![CDATA[Richard Torbett offers his congratulations to Keir Starmer and the Labour Party on winning the 2024 General Election.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/hh4eb3sp/scientists-screen-looking-2025-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1db81ed8db87570"/>
                </item>
                <item>
                    <title>Calls for collaboration on medical research in Wales</title>
<link>https://www.abpi.org.uk/media/news/2024/july/calls-for-collaboration-on-medical-research-in-wales/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:51 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Devolved Nations - Cymru Wales]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/july/calls-for-collaboration-on-medical-research-in-wales/</guid>
                    <description><![CDATA[ABPI Cymru and the British Heart Foundation (BHF) Cymru call for prioritisation of medical research funding in Wales.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/wiuabwgs/sennedd-2522x722-banner.jpg?rxy=0.3629310026155884,0.4863656195462478&amp;width=240&amp;height=135&amp;quality=90&amp;v=1dacd3655fdb7b0"/>
                </item>
                <item>
                    <title>ABPI welcomes RSV national vaccination programme</title>
<link>https://www.abpi.org.uk/media/news/2024/july/abpi-welcomes-rsv-national-vaccination-programme/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:50 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Vaccines]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/july/abpi-welcomes-rsv-national-vaccination-programme/</guid>
                    <description><![CDATA[The government has announced a new national respiratory syncytial virus (RSV) vaccine programme, which will protect infants and older people. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/r5gfhzmm/doctor-vaccine-arm-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eeb38200"/>
                </item>
                <item>
                    <title>UK life science industry sets out priorities for the Budget</title>
<link>https://www.abpi.org.uk/media/news/2024/february/uk-life-science-industry-sets-out-priorities-for-the-budget/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:50 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Budget]]></category>
                            <category><![CDATA[ABPI Manifesto]]></category>
                            <category><![CDATA[ABPI Manifesto (1)]]></category>
                            <category><![CDATA[Health and Access to Medicines]]></category>
                            <category><![CDATA[Life Sciences]]></category>
                            <category><![CDATA[Politics]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/february/uk-life-science-industry-sets-out-priorities-for-the-budget/</guid>
                    <description><![CDATA[The Association of the British Pharmaceutical Industry (ABPI) has set out the measures the UK&#x2019;s life sciences industry wants to see in Chancellor Jeremy Hunt&#x2019;s Budget on Wednesday, 6 March.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/0mgjexoi/mps-2-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d9da41cdf42800"/>
                </item>
                <item>
                    <title>ABPI launches new prescribing support guide for healthcare professionals</title>
<link>https://www.abpi.org.uk/media/news/2024/february/abpi-launches-new-prescribing-support-guide-for-healthcare-professionals/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:50 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[ABPI Code]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/february/abpi-launches-new-prescribing-support-guide-for-healthcare-professionals/</guid>
                    <description><![CDATA[A new guide to how the pharmaceutical industry can help healthcare professionals with complex prescribing decisions has been launched today by the ABPI. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/21zjbgkf/doctor-patient-talk-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d9af1fa473a6b0"/>
                </item>
                <item>
                    <title>ABPI Exam name change to widen professional appeal</title>
<link>https://www.abpi.org.uk/media/news/2024/february/abpi-exam-name-change-to-widen-professional-appeal/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:49 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[ABPI Exam]]></category>
                            <category><![CDATA[ABPI Code]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/february/abpi-exam-name-change-to-widen-professional-appeal/</guid>
                    <description><![CDATA[A key pharmaceutical qualification has been given a new name to reflect its broader relevance to roles across the industry. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/h1jjhrca/pharmacists-medical-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f084e6a0"/>
                </item>
                <item>
                    <title>Regulatory renewal needed for UK life sciences ambitions</title>
<link>https://www.abpi.org.uk/media/news/2024/december/regulatory-renewal-needed-for-uk-life-sciences-ambitions/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:49 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Regulatory]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/december/regulatory-renewal-needed-for-uk-life-sciences-ambitions/</guid>
                    <description><![CDATA[A new report, &#x27;Enhancing the role of UK medicine regulation&#x27; sets out key recommendations to rebuild the UK&#x2019;s world-class reputation in regulatory science, medicines&#x2019; development and licensing.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/nrxnqdto/tablets-pills-capsules-blisters-871x571.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d8c44a900facc0"/>
                </item>
                <item>
                    <title>UK secures &#xA3;400 million investment to boost clinical trials</title>
<link>https://www.abpi.org.uk/media/news/2024/august/uk-secures-400-million-investment-to-boost-clinical-trials/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:48 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Clinical research]]></category>
                            <category><![CDATA[Economy and Industry]]></category>
                            <category><![CDATA[Manufacturing]]></category>
                            <category><![CDATA[NICE]]></category>
                            <category><![CDATA[Research and Development]]></category>
                            <category><![CDATA[Science and innovation]]></category>
                            <category><![CDATA[Scotland]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                            <category><![CDATA[ABPI Cymru Wales Weekly Digest]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/august/uk-secures-400-million-investment-to-boost-clinical-trials/</guid>
                    <description><![CDATA[World-first public-private collaboration launched to kickstart economic growth and build an NHS fit for the future.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/5tyjzxue/female-pipette-bench-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef73c4c0"/>
                </item>
                <item>
                    <title>ABPI welcomes rare diseases research landscape report</title>
<link>https://www.abpi.org.uk/media/news/2023/september/abpi-welcomes-rare-diseases-research-landscape-report/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:48 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Rare diseases]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/september/abpi-welcomes-rare-diseases-research-landscape-report/</guid>
                    <description><![CDATA[The National Institute for Health and Care Research (NIHR) has today published the first Rare Diseases Research Landscape report for the UK. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/dkmh2k31/microscope-laptop-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eec7cd50"/>
                </item>
                <item>
                    <title>UK&#x2019;s grand ambition for life sciences hinges on delivery</title>
<link>https://www.abpi.org.uk/media/news/2023/may/uk-s-grand-ambition-for-life-sciences-hinges-on-delivery/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:48 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Clinical research]]></category>
                            <category><![CDATA[Life Sciences]]></category>
                            <category><![CDATA[Manufacturing]]></category>
                            <category><![CDATA[MHRA]]></category>
                            <category><![CDATA[Regulatory]]></category>
                            <category><![CDATA[Trials]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/may/uk-s-grand-ambition-for-life-sciences-hinges-on-delivery/</guid>
                    <description><![CDATA[The government has moved closer to realising its life sciences vision with an ambitious and broad-ranging set of proposals to improve the clinical trials environment, but delivery and addressing acute commercial challenges remain the key to success.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/at2lhehk/news-3-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d8b1a311387d50"/>
                </item>
                <item>
                    <title>Novo Nordisk is suspended from ABPI membership</title>
<link>https://www.abpi.org.uk/media/news/2023/march/novo-nordisk-is-suspended-from-abpi-membership/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:47 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[ABPI Code]]></category>
                            <category><![CDATA[PMCPA]]></category>
                            <category><![CDATA[Corporate Responsibility]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/march/novo-nordisk-is-suspended-from-abpi-membership/</guid>
                    <description><![CDATA[Novo Nordisk has been suspended as a member of the Association of the British Pharmaceutical Industry (ABPI) for two years due to serious breaches of the ABPI Code of Practice.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ekih3er0/finance-v2-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52efd370f0"/>
                </item>
                <item>
                    <title>ABPI sets out new proposals to support the NHS and economic growth</title>
<link>https://www.abpi.org.uk/media/news/2023/march/abpi-sets-out-new-proposals-to-support-the-nhs-and-economic-growth/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:47 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Statutory Scheme]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Commercial]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/march/abpi-sets-out-new-proposals-to-support-the-nhs-and-economic-growth/</guid>
                    <description><![CDATA[The pharmaceutical industry&#x2019;s offer includes an annual &#xA3;1bn boost to the NHS as well as an additional &#xA3;1bn new investment facility to maximise the potential of the UK&#x2019;s health and life science ecosystem.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ptvdrsdy/data-laptop-patient-580x405-1-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eed40250"/>
                </item>
                <item>
                    <title>UK life sciences in search for AI, digital and data talent</title>
<link>https://www.abpi.org.uk/media/news/2023/june/uk-life-sciences-in-search-for-ai-digital-and-data-talent/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:46 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Industry Academic Link Survey]]></category>
                            <category><![CDATA[Skills]]></category>
                            <category><![CDATA[Apprentices]]></category>
                            <category><![CDATA[Education]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/june/uk-life-sciences-in-search-for-ai-digital-and-data-talent/</guid>
                    <description><![CDATA[The pharmaceutical industry is increasingly adopting new digital tools, such as artificial intelligence (AI) and big data analytics, to support innovative drug discovery and development.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/oxon3vgh/three-scientists-sitting-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef20e9d0"/>
                </item>
                <item>
                    <title>Boost UK manufacturing to attract &#xA3;15 billion new investment, says medicines manufacturing alliance</title>
<link>https://www.abpi.org.uk/media/news/2023/june/boost-uk-manufacturing-to-attract-15-billion-new-investment-says-medicines-manufacturing-alliance/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:46 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Manufacturing]]></category>
                            <category><![CDATA[MMIP]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/june/boost-uk-manufacturing-to-attract-15-billion-new-investment-says-medicines-manufacturing-alliance/</guid>
                    <description><![CDATA[With the right policies in place, the UK can be the best global location for innovative and environmentally sustainable medicines manufacturing, according to a new report from the Medicines Manufacturing Industry Partnership (MMIP). ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/zmienqrm/petri-dish-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d99ddf541a0700"/>
                </item>
                <item>
                    <title>Medicines manufacturing has the potential to drive UK growth over the next 10 years</title>
<link>https://www.abpi.org.uk/media/news/2023/january/medicines-manufacturing-has-the-potential-to-drive-uk-growth-over-the-next-10-years/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:46 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Manufacturing]]></category>
                            <category><![CDATA[MMIP]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/january/medicines-manufacturing-has-the-potential-to-drive-uk-growth-over-the-next-10-years/</guid>
                    <description><![CDATA[Recent successes in supplying high-value medicines and in advanced therapies manufacture must be built on, according to a cross-industry coalition.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/uszcvdfe/scientist-mask-microscope-blue-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef62fbe0"/>
                </item>
                <item>
                    <title>Pharma industry urges halt to further rises in record revenue clawbacks</title>
<link>https://www.abpi.org.uk/media/news/2023/february/pharma-industry-urges-halt-to-further-rises-in-record-revenue-clawbacks/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:45 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Statutory Scheme]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Medicines sales]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/february/pharma-industry-urges-halt-to-further-rises-in-record-revenue-clawbacks/</guid>
                    <description><![CDATA[The pharmaceutical industry is calling on the government to scrap plans to raise the statutory revenue clawback rate from 24.5% to a record 27.5%. Doing so is a fundamental first step to reassuring investors about the UK&#x2019;s ambition to halt the contraction of UK life sciences, and to secure a positive outcome to critical upcoming negotiations with the industry.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/gzkduqfi/chemical-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f00d6cb0"/>
                </item>
                <item>
                    <title>ABPI response to England&#x27;s 2023 Rare Disease Action Plan</title>
<link>https://www.abpi.org.uk/media/news/2023/february/abpi-response-to-englands-2023-rare-disease-action-plan/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:45 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Rare diseases]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/february/abpi-response-to-englands-2023-rare-disease-action-plan/</guid>
                    <description><![CDATA[The Department of Health and Social Care has published the 2023 England Rare Diseases Action Plan, setting out the actions that will be delivered this year to support people with rare diseases in England.&#xA0;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/pnafsqgg/doctor-patient-detail-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eee25a30"/>
                </item>
                <item>
                    <title>ABPI respond to the new Northern Ireland Brexit deal</title>
<link>https://www.abpi.org.uk/media/news/2023/february/abpi-respond-to-the-new-northern-ireland-brexit-deal/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:45 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Northern Ireland]]></category>
                            <category><![CDATA[Devolved Nations - Northern Ireland]]></category>
                            <category><![CDATA[Brexit]]></category>
                            <category><![CDATA[Supply]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/february/abpi-respond-to-the-new-northern-ireland-brexit-deal/</guid>
                    <description><![CDATA[The Prime Minister confirmed today that the new Windsor Framework would ensure medicines approved for use by the UK regulator will automatically become available in Northern Ireland.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/d3gp0fba/capsules-clear-blister-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef5a4950"/>
                </item>
                <item>
                    <title>ABPI and PMCPA consult on changes to the pharmaceutical industry code of practice</title>
<link>https://www.abpi.org.uk/media/news/2023/december/abpi-and-pmcpa-consult-on-changes-to-the-pharmaceutical-industry-code-of-practice/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:44 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Partnership]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/december/abpi-and-pmcpa-consult-on-changes-to-the-pharmaceutical-industry-code-of-practice/</guid>
                    <description><![CDATA[Proposals to update the 2021 ABPI Code of Practice for the pharmaceutical industry are being consulted on from today. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/5l2beqty/event-930x930-doctor-older-patient-webp75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee8ee300"/>
                </item>
                <item>
                    <title>New survey shows collaboration between pharmaceutical industry and UK academia is growing</title>
<link>https://www.abpi.org.uk/media/news/2022/september/new-survey-shows-collaboration-between-pharmaceutical-industry-and-uk-academia-is-growing/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:44 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Education]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/september/new-survey-shows-collaboration-between-pharmaceutical-industry-and-uk-academia-is-growing/</guid>
                    <description><![CDATA[The ABPI has published its latest survey on the links between industry and academia. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/45apvnua/clinical-research-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f06af600"/>
                </item>
                <item>
                    <title>NHS patients losing access to innovative treatments as UK industry clinical trials face collapse</title>
<link>https://www.abpi.org.uk/media/news/2022/october/nhs-patients-losing-access-to-innovative-treatments-as-uk-industry-clinical-trials-face-collapse/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:44 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Clinical research]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/october/nhs-patients-losing-access-to-innovative-treatments-as-uk-industry-clinical-trials-face-collapse/</guid>
                    <description><![CDATA[The ABPI&#x27;s latest report shows a collapse in the number of UK industry clinical trials. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/hmibbi0s/biochemical-research-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eea1a7b0"/>
                </item>
                <item>
                    <title>Northern Ireland life sciences sector continues strong economic output</title>
<link>https://www.abpi.org.uk/media/news/2022/may/northern-ireland-life-sciences-sector-continues-strong-economic-output/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:43 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Northern Ireland]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/may/northern-ireland-life-sciences-sector-continues-strong-economic-output/</guid>
                    <description><![CDATA[A new report shows how life and health sciences can play an important role in Northern Ireland&#x27;s economic recovery from COVID-19 while driving longer-term economic growth.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/hmibbi0s/biochemical-research-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eea1a7b0"/>
                </item>
                <item>
                    <title>ABPI response to meeting between industry and Government on HRT supply</title>
<link>https://www.abpi.org.uk/media/news/2022/may/abpi-response-to-meeting-between-industry-and-government-on-hrt-supply/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:43 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Supply]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/may/abpi-response-to-meeting-between-industry-and-government-on-hrt-supply/</guid>
                    <description><![CDATA[The ABPI welcomed today&#x2019;s meeting between industry and Government on HRT supply.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/dyiddnmm/pharmacy-handover-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef8725b0"/>
                </item>
                <item>
                    <title>Health and social care leaders unite to improve public involvement in research</title>
<link>https://www.abpi.org.uk/media/news/2022/march/health-and-social-care-leaders-unite-to-improve-public-involvement-in-research/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:42 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Clinical research]]></category>
                            <category><![CDATA[Science and innovation]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/march/health-and-social-care-leaders-unite-to-improve-public-involvement-in-research/</guid>
                    <description><![CDATA[Funders, regulators and research organisations sign up to a bold new shared commitment to improve public involvement in research.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/3gzbzk5p/event-1-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee62a2e0"/>
                </item>
                <item>
                    <title>ABPI welcomes Northern Ireland Cancer Strategy</title>
<link>https://www.abpi.org.uk/media/news/2022/march/abpi-welcomes-northern-ireland-cancer-strategy/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:35 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Cancer]]></category>
                            <category><![CDATA[Northern Ireland]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/march/abpi-welcomes-northern-ireland-cancer-strategy/</guid>
                    <description><![CDATA[A 10-year cancer strategy for Northern Ireland is published, looking at prevention, diagnosis and treatment, and supporting people to live and die well.&#xA0;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/pnafsqgg/doctor-patient-detail-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eee25a30"/>
                </item>
                <item>
                    <title>Latest Disclosure UK data: Highest ever rate of health professionals agreeing to be named</title>
<link>https://www.abpi.org.uk/media/news/2022/june/latest-disclosure-uk-data-highest-ever-rate-of-health-professionals-agreeing-to-be-named/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:34 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Disclosure UK Publication]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/june/latest-disclosure-uk-data-highest-ever-rate-of-health-professionals-agreeing-to-be-named/</guid>
                    <description><![CDATA[The latest information on &#x2018;transfers of value&#x2019; made to healthcare organisations and health professionals in 2021 by pharmaceutical companies is published today on Disclosure UK. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/5l2beqty/event-930x930-doctor-older-patient-webp75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee8ee300"/>
                </item>
                <item>
                    <title>ABPI response to appointment of new Patient Safety Commissioner</title>
<link>https://www.abpi.org.uk/media/news/2022/july/abpi-response-to-appointment-of-new-patient-safety-commissioner/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:34 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Safety]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/july/abpi-response-to-appointment-of-new-patient-safety-commissioner/</guid>
                    <description><![CDATA[The Government has announced the appointment of Dr Henrietta Hughes OBE as the first ever Patient Safety Commissioner for England.&#xA0;&#xA0;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/pnafsqgg/doctor-patient-detail-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eee25a30"/>
                </item>
                <item>
                    <title>ABPI awarded PIF TICK trusted healthcare information creator status</title>
<link>https://www.abpi.org.uk/media/news/2022/july/abpi-awarded-pif-tick-trusted-healthcare-information-creator-status/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:34 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/july/abpi-awarded-pif-tick-trusted-healthcare-information-creator-status/</guid>
                    <description><![CDATA[The ABPI has been awarded &#x2018;trusted health care information creator&#x2019; status by the Patient Information Forum, an accreditation known as the PIF TICK.&#xA0; ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/pgwagn03/doctor-patient-bedside-871x581-web75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eefc4ad0"/>
                </item>
                <item>
                    <title>Pfizer&#x2019;s Brian Henry appointed head of UK medicines manufacturing partnership</title>
<link>https://www.abpi.org.uk/media/news/2022/february/pfizer-s-brian-henry-appointed-head-of-uk-medicines-manufacturing-partnership/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:33 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Manufacturing]]></category>
                            <category><![CDATA[MMIP]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/february/pfizer-s-brian-henry-appointed-head-of-uk-medicines-manufacturing-partnership/</guid>
                    <description><![CDATA[The Medicines Manufacturing Industry Partnership (MMIP) represents the voice of medicines manufacturing in the UK.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/x4dkindr/brian-henry-agreggation.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d829a69bce5410"/>
                </item>
                <item>
                    <title>UK medicines revenue clawback rockets to 26.5% putting Life Sciences Vision at risk, says ABPI</title>
<link>https://www.abpi.org.uk/media/news/2022/december/uk-medicines-revenue-clawback-rockets-to-265-putting-life-sciences-vision-at-risk-says-abpi/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:33 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Health and Access to Medicines]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/december/uk-medicines-revenue-clawback-rockets-to-265-putting-life-sciences-vision-at-risk-says-abpi/</guid>
                    <description><![CDATA[Next year manufacturers of branded medicines will be required to return almost &#xA3;3.3bn in sales revenue to the government (26.5% of sales), up from around &#xA3;0.6bn in 2021 and &#xA3;1.8bn in 2022.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/jgrn2v23/data-woman-explain-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef712cb0"/>
                </item>
                <item>
                    <title>ABPI science resources for schools gets Green Tick of approval</title>
<link>https://www.abpi.org.uk/media/news/2022/december/abpi-science-resources-for-schools-gets-green-tick-of-approval/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:33 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Skills]]></category>
                            <category><![CDATA[Education]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/december/abpi-science-resources-for-schools-gets-green-tick-of-approval/</guid>
                    <description><![CDATA[The ABPI interactive schools resources website has been awarded a Green Tick from the Association for Science Education.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/t4ifrbfk/students-teacher.png?width=240&amp;height=135&amp;quality=90&amp;v=1d7cccaa406fb20"/>
                </item>
                <item>
                    <title>ABPI statement on biomarker testing</title>
<link>https://www.abpi.org.uk/media/news/2022/august/abpi-statement-on-biomarker-testing/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:32 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Cancer]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/august/abpi-statement-on-biomarker-testing/</guid>
                    <description><![CDATA[The ABPI commented in support of a call led by the Institute of Cancer Research (ICR) for all cancer patients to be offered genetic testing so they can get the best treatments available for them.&#xA0;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/prhbezxo/event-930x930-man-with-vial-webp50.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee7603d0"/>
                </item>
                <item>
                    <title>ABPI response to Commons cancer services report</title>
<link>https://www.abpi.org.uk/media/news/2022/april/abpi-response-to-commons-cancer-services-report/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:32 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Cancer]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/april/abpi-response-to-commons-cancer-services-report/</guid>
                    <description><![CDATA[The Health and Social Care Committee has published its report on cancer services in England.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/5l2beqty/event-930x930-doctor-older-patient-webp75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee8ee300"/>
                </item>
                <item>
                    <title>Understanding medicine shortages and how we&#x2019;re working to avoid them</title>
<link>https://www.abpi.org.uk/media/blogs/2026/march/understanding-medicine-shortages-and-how-we-re-working-to-avoid-them/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:32 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2026/march/understanding-medicine-shortages-and-how-we-re-working-to-avoid-them/</guid>
                    <description><![CDATA[When it comes to medicines shortages, close working between the pharmaceutical industry, healthcare professionals, government and regulators is essential to ensure patients receive their medication on time and in full.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/q55n4rdk/patient-information-leaflet-2025-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1dc0d3a98c3b820"/>
                </item>
                <item>
                    <title>Innovation with integrity: Why NHS-industry partnerships matter, and how conflicts of interest are managed</title>
<link>https://www.abpi.org.uk/media/blogs/2026/march/innovation-with-integrity-why-nhs-industry-partnerships-matter-and-how-conflicts-of-interest-are-managed/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:31 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[ABPI Code]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2026/march/innovation-with-integrity-why-nhs-industry-partnerships-matter-and-how-conflicts-of-interest-are-managed/</guid>
                    <description><![CDATA[Dr Amit Aggarwal discusses the importance of NHS-industry relationships, and the safeguards in place to ensure they always put patients and the NHS first. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/xziohiwe/review-871-581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee51da00"/>
                </item>
                <item>
                    <title>Improving diversity in clinical trials is both an equity issue and a scientific necessity</title>
<link>https://www.abpi.org.uk/media/blogs/2026/march/improving-diversity-in-clinical-trials-is-both-an-equity-issue-and-a-scientific-necessity/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:31 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Clinical research]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2026/march/improving-diversity-in-clinical-trials-is-both-an-equity-issue-and-a-scientific-necessity/</guid>
                    <description><![CDATA[Brian Duggan reflects on the need for more inclusive research]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/34lnw2yz/two-scientists-vial-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c978d897e40"/>
                </item>
                <item>
                    <title>What drives company decisions on new medicine launches and UK investment?</title>
<link>https://www.abpi.org.uk/media/blogs/2026/january/what-drives-company-decisions-on-new-medicine-launches-and-uk-investment/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:31 GMT</pubDate>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Health and Access to Medicines]]></category>
                            <category><![CDATA[Medicines sales]]></category>
                            <category><![CDATA[NICE]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Statutory Scheme]]></category>
                            <category><![CDATA[Value]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                            <category><![CDATA[VPAG]]></category>
                            <category><![CDATA[VPAG (1)]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2026/january/what-drives-company-decisions-on-new-medicine-launches-and-uk-investment/</guid>
                    <description><![CDATA[In this piece, David Watson, ABPI Executive Director of Patient Access, discusses the findings of ABPI&#x27;s 2025 Medicines Impact and Investment Survey, which aims to supplement existing data to understand and track how UK policy conditions influence company decisions, particularly on investment, workforce plans, and prioritisation of medicines launches. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/34lnw2yz/two-scientists-vial-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c978d897e40"/>
                </item>
                <item>
                    <title>Time to emphasise the economics in health economics</title>
<link>https://www.abpi.org.uk/media/blogs/2026/january/time-to-emphasise-the-economics-in-health-economics/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:30 GMT</pubDate>
                            <dc:creator><![CDATA[Victoria Jordan]]></dc:creator>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Economy and Industry]]></category>
                            <category><![CDATA[NICE]]></category>
                            <category><![CDATA[NICE Methods Review]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Value]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[VPAG]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2026/january/time-to-emphasise-the-economics-in-health-economics/</guid>
                    <description><![CDATA[Victoria Jordan, ABPI Value and Access Policy Director, discusses the Health Economics of the UK-US Economic Prosperity Deal and the commitment to increase NICE&#x27;s baseline threshold use, the first change since its introduction in the early 2000s.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/zbkfg4k4/sales-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52efd14e10"/>
                </item>
                <item>
                    <title>Rare Disease Day: Prevention can be the most powerful treatment of all</title>
<link>https://www.abpi.org.uk/media/blogs/2026/february/rare-disease-day-prevention-can-be-the-most-powerful-treatment-of-all/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:30 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Rare diseases]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2026/february/rare-disease-day-prevention-can-be-the-most-powerful-treatment-of-all/</guid>
                    <description><![CDATA[Dan O&#x2019;Connor reflects on the need for greater investment in prevention, as well as the need for equity, for this year&#x2019;s Rare Disease Day. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/jcgofh1n/women-scientist-microscope-871x581-webp75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef19bde0"/>
                </item>
                <item>
                    <title>Equity in the age of advanced therapies: insights from haemophilia</title>
<link>https://www.abpi.org.uk/media/blogs/2026/february/equity-in-the-age-of-advanced-therapies-insights-from-haemophilia/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:30 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2026/february/equity-in-the-age-of-advanced-therapies-insights-from-haemophilia/</guid>
                    <description><![CDATA[In Laurence Woollard&#x27;s latest blog for Rare Disease Day, he reflects on how advanced therapies are being introduced within the NHS &#x2013; highlighting the need for a Patient Charter. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/oqsek0un/laurence-woollard.png?width=240&amp;height=135&amp;quality=90&amp;v=1dca67f1e14a880"/>
                </item>
                <item>
                    <title>Building momentum through the VPAG review</title>
<link>https://www.abpi.org.uk/media/blogs/2026/february/building-momentum-through-the-vpag-review/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:29 GMT</pubDate>
                            <dc:creator><![CDATA[Pinchas Kahtan]]></dc:creator>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Medicines sales]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                            <category><![CDATA[VPAG]]></category>
                            <category><![CDATA[VPAG (1)]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2026/february/building-momentum-through-the-vpag-review/</guid>
                    <description><![CDATA[The latest Operational Review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access and Growth (VPAG) took place in late December. In this piece, Pinchas Kahtan, ABPI&#x27;s Head of Commercial Policy, shares the key points discussed and agreed at the meeting, and looks ahead to what&#x27;s next for 2026.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/rszec1xe/compensation-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52efe74710"/>
                </item>
                <item>
                    <title>UK medicines investment: the case for improving the UK commercial environment</title>
<link>https://www.abpi.org.uk/media/blogs/2025/september/uk-medicines-investment-the-case-for-improving-the-uk-commercial-environment/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:29 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Commercial]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2025/september/uk-medicines-investment-the-case-for-improving-the-uk-commercial-environment/</guid>
                    <description><![CDATA[David Watson builds on The King&#x27;s Fund&#x27;s explainer on medicines pricing to make the case for policymakers to protect the UK&#x2019;s position in life sciences and ensure long-term patient access to new medicines. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/riwf5xcq/quality-control-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eff577e0"/>
                </item>
                <item>
                    <title>Making Wales a destination for industry clinical trials and medical research</title>
<link>https://www.abpi.org.uk/media/blogs/2025/september/making-wales-a-destination-for-industry-clinical-trials-and-medical-research/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:28 GMT</pubDate>
                            <category><![CDATA[Wales]]></category>
                            <category><![CDATA[Devolved Nations - Cymru Wales]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2025/september/making-wales-a-destination-for-industry-clinical-trials-and-medical-research/</guid>
                    <description><![CDATA[Clinical trials are at the heart of developing new medicines and vaccines. They offer the opportunity for patients to receive early access to potentially lifesaving treatments and deliver huge benefits to both the NHS and the wider economy. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/wwfhwapd/senedd-968x457-banner.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1dacb90127a1210"/>
                </item>
                <item>
                    <title>ABPI Regulatory Science symposium 2025</title>
<link>https://www.abpi.org.uk/media/blogs/2025/october/abpi-regulatory-science-symposium-2025/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:28 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Regulatory]]></category>
                            <category><![CDATA[MHRA]]></category>
                            <category><![CDATA[NICE]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2025/october/abpi-regulatory-science-symposium-2025/</guid>
                    <description><![CDATA[The ABPI was pleased to host our second Regulatory Science Symposium which brought together leaders from across the life sciences ecosystem.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ncdhwokx/events-audience-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee69ced0"/>
                </item>
                <item>
                    <title>What does the latest data tell us about NHS patients&#x27; access to medicines?</title>
<link>https://www.abpi.org.uk/media/blogs/2025/may/what-does-the-latest-data-tell-us-about-nhs-patients-access-to-medicines/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:28 GMT</pubDate>
                            <dc:creator><![CDATA[Victoria Jordan]]></dc:creator>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Devolved Nations - Scotland]]></category>
                            <category><![CDATA[England]]></category>
                            <category><![CDATA[Health and Access to Medicines]]></category>
                            <category><![CDATA[NICE]]></category>
                            <category><![CDATA[Supply]]></category>
                            <category><![CDATA[Value]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2025/may/what-does-the-latest-data-tell-us-about-nhs-patients-access-to-medicines/</guid>
                    <description><![CDATA[Understanding how well the system performs in meeting the NHS&#x2019;s ambition for patients to have rapid access to effective new medicines is not easy. There are several sources of data, and like any reporting of metrics, it isn&#x2019;t always immediately obvious what the data includes/excludes.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/yubpvozw/pharmacists-regulatory-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1dbbe87c06f1790"/>
                </item>
                <item>
                    <title>Why the pharmaceutical industry needs NHS data to develop new medicines</title>
<link>https://www.abpi.org.uk/media/blogs/2025/june/why-the-pharmaceutical-industry-needs-nhs-data-to-develop-new-medicines/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:27 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Health data]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2025/june/why-the-pharmaceutical-industry-needs-nhs-data-to-develop-new-medicines/</guid>
                    <description><![CDATA[To help understand why NHS data is crucial for research, developing innovative, safe, and effective medicines, we have created a publicly accessible case study library.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/yheezl41/doctor-consult-bed-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef31b2b0"/>
                </item>
                <item>
                    <title>Disclosure UK 2024: new record for transparency, with nine in ten healthcare professionals named in database</title>
<link>https://www.abpi.org.uk/media/blogs/2025/june/disclosure-uk-2024-new-record-for-transparency-with-nine-in-ten-healthcare-professionals-named-in-database/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:27 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Disclosure UK]]></category>
                            <category><![CDATA[Disclosure UK Publication]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2025/june/disclosure-uk-2024-new-record-for-transparency-with-nine-in-ten-healthcare-professionals-named-in-database/</guid>
                    <description><![CDATA[Dr Amit Aggarwal, ABPI Director of Medical Affairs, and Alex Fell, PMCPA Chief Executive, discuss the latest data published on Disclosure UK.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/3wnlijqi/plans3-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d9da41cda851f0"/>
                </item>
                <item>
                    <title>Speedy Anna is now award-winning</title>
<link>https://www.abpi.org.uk/media/blogs/2025/february/speedy-anna-is-now-award-winning/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:27 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Rare diseases]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2025/february/speedy-anna-is-now-award-winning/</guid>
                    <description><![CDATA[In 2020, we spoke to Anna Turner and her Mum Jenna from Waringstown, Northern Ireland, to get their perspective on living with hypophosphatasia (HPP). In 2024 we caught up with Jenna again to see how Anna, now 12, is doing.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/3rqfugom/anna-turner-2025-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1db82c4f3c35fb0"/>
                </item>
                <item>
                    <title>Getting ready for the Windsor Framework: ensuring continuity of UK medicines supply beyond 1 January 2025</title>
<link>https://www.abpi.org.uk/media/blogs/2024/october/getting-ready-for-the-windsor-framework-ensuring-continuity-of-uk-medicines-supply-beyond-1-january-2025/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:26 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Regulatory]]></category>
                            <category><![CDATA[Supply]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2024/october/getting-ready-for-the-windsor-framework-ensuring-continuity-of-uk-medicines-supply-beyond-1-january-2025/</guid>
                    <description><![CDATA[The Windsor Framework, agreed between the UK and the EU in February 2023, is expected to be fully implemented on 1 January 2025. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/1vmpcc04/abpi-blister-pack-carbon-footprint-tool-930x930.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d81f3a6157ae10"/>
                </item>
                <item>
                    <title>Comparing new medicine availability across Europe</title>
<link>https://www.abpi.org.uk/media/blogs/2024/june/comparing-new-medicine-availability-across-europe/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:26 GMT</pubDate>
                            <dc:creator><![CDATA[Orban Holdgate]]></dc:creator>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[England]]></category>
                            <category><![CDATA[Health and Access to Medicines]]></category>
                            <category><![CDATA[Regulatory]]></category>
                            <category><![CDATA[Scotland]]></category>
                            <category><![CDATA[Value]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2024/june/comparing-new-medicine-availability-across-europe/</guid>
                    <description><![CDATA[Each year, the European Pharmaceutical Industry Association (EFPIA) publishes data comparing the availability of new medicines across 36 European countries, as well as the average time it takes to make these new medicines accessible to patients. This article explains what the data shows and what it means for the UK.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/pnafsqgg/doctor-patient-detail-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eee25a30"/>
                </item>
                <item>
                    <title>Latest Disclosure UK data: higher R&amp;D spend, greater transparency and more partnership with the NHS</title>
<link>https://www.abpi.org.uk/media/blogs/2024/july/latest-disclosure-uk-data-higher-rd-spend-greater-transparency-and-more-partnership-with-the-nhs/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:26 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Disclosure UK]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2024/july/latest-disclosure-uk-data-higher-rd-spend-greater-transparency-and-more-partnership-with-the-nhs/</guid>
                    <description><![CDATA[The 2023 Disclosure UK data continues to show positive trends, says the ABPI&#x2019;s Medical Director Dr Amit Aggarwal. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/00kl03qg/nursesl-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d9da41cdfdc4f0"/>
                </item>
                <item>
                    <title>How regulation can help to unlock the potential of preventative medicines</title>
<link>https://www.abpi.org.uk/media/blogs/2024/july/how-regulation-can-help-to-unlock-the-potential-of-preventative-medicines/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:25 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Regulatory]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2024/july/how-regulation-can-help-to-unlock-the-potential-of-preventative-medicines/</guid>
                    <description><![CDATA[A blog post on the potential of preventative medicines from Sarah Montagne, Bayer Senior Regulatory &amp; Policy Advisor (UKI), ABPI Regulatory Science Board Sponsored Group, Dr Dan O&#x2019;Connor, ABPI Director of Regulatory Policy and Early Access and Andy Collier, Regulatory Policy Manager]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/uashznt5/hands-agreement-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eed19150"/>
                </item>
                <item>
                    <title>Why we need the new Rare Therapies Launch Pad</title>
<link>https://www.abpi.org.uk/media/blogs/2024/february/why-we-need-the-new-rare-therapies-launch-pad/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:25 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Rare diseases]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2024/february/why-we-need-the-new-rare-therapies-launch-pad/</guid>
                    <description><![CDATA[The ABPI&#x2019;s Director of Regulatory and Early Access Policy Dr Dan O&#x2019;Connor looks forward to an innovative initiative to improve access to personalised treatments for rare diseases.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/gpgpu4qr/dan-oconnor-871x581.jpg?rxy=0.513524741506647,0.09872213559786888&amp;width=240&amp;height=135&amp;quality=90&amp;v=1dac19a21f3c880"/>
                </item>
                <item>
                    <title>mRNA technology: navigating preclinical research for rare diseases</title>
<link>https://www.abpi.org.uk/media/blogs/2024/february/mrna-technology-navigating-preclinical-research-for-rare-diseases/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:25 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Rare diseases]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2024/february/mrna-technology-navigating-preclinical-research-for-rare-diseases/</guid>
                    <description><![CDATA[Philip Cruz, Country Medical Director at Moderna UK talks about the potential of mRNA technology for rare diseases in a blog for Rare Disease Day 2024. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/u3lnwxcd/philip-cruz-moderna-871x571.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1da9c876ebbcb50"/>
                </item>
                <item>
                    <title>June&#x2019;s story of sickle cell</title>
<link>https://www.abpi.org.uk/media/blogs/2024/february/june-s-story-of-sickle-cell/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:24 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Rare diseases]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2024/february/june-s-story-of-sickle-cell/</guid>
                    <description><![CDATA[June has sickle cell, a genetic blood disorder that affects the red blood cells. She is one of the 1 in 17 people with a rare disease in the UK. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/mb2jntfx/june_rdd24_abpi.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1da6b30cf430890"/>
                </item>
                <item>
                    <title>Principles for analysis and use of health data by ABPI members</title>
<link>https://www.abpi.org.uk/media/blogs/2023/september/principles-for-analysis-and-use-of-health-data-by-abpi-members/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:24 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Health data]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2023/september/principles-for-analysis-and-use-of-health-data-by-abpi-members/</guid>
                    <description><![CDATA[Blog post from Dr Janet Valentine, ABPI Executive Director, Innovation and Research Policy on the principles for responsible health data analysis]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/4ynexl2a/clinical-data-management-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f061ce40"/>
                </item>
                <item>
                    <title>MHRA&#x2019;s new International Recognition Procedure (IRP): how does it shape up?</title>
<link>https://www.abpi.org.uk/media/blogs/2023/september/mhra-s-new-international-recognition-procedure-irp-how-does-it-shape-up/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:24 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Regulatory]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2023/september/mhra-s-new-international-recognition-procedure-irp-how-does-it-shape-up/</guid>
                    <description><![CDATA[The MHRA has introduced a number of regulatory flexibilities for companies to consider when applying for their products to enter the UK market.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/jlzjcnyb/regulation-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f01a16e0"/>
                </item>
                <item>
                    <title>My sons have taught me more than I could ever teach them</title>
<link>https://www.abpi.org.uk/media/blogs/2023/february/my-sons-have-taught-me-more-than-i-could-ever-teach-them/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:23 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Rare diseases]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2023/february/my-sons-have-taught-me-more-than-i-could-ever-teach-them/</guid>
                    <description><![CDATA[Bob Stevens is group CEO of the MPS Society and Rare Disease Research Partners. His sons Oliver and Samuel both have MPS II &#x2013; known as Hunter Syndrome.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/jlkjcozh/bob_family_holiday.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d9484421eb1210"/>
                </item>
                <item>
                    <title>Medics 4 Rare Diseases: We need services to diagnose people earlier so they can have access to treatments</title>
<link>https://www.abpi.org.uk/media/blogs/2023/february/medics-4-rare-diseases-we-need-services-to-diagnose-people-earlier-so-they-can-have-access-to-treatments/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:23 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Rare diseases]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2023/february/medics-4-rare-diseases-we-need-services-to-diagnose-people-earlier-so-they-can-have-access-to-treatments/</guid>
                    <description><![CDATA[Dr Lucy McKay is the Chief Executive of Medics 4 Rare Diseases. She explains how training for healthcare professionals can help to unlock the potential of the Rare Disease Framework, while also stressing the importance of screening and access to treatments.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/t4sp1wn5/lucy-detail-for_web.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d94b67a68a3390"/>
                </item>
                <item>
                    <title>A Breath of Fresh Air: A Welsh project to improve management of Cystic Fibrosis</title>
<link>https://www.abpi.org.uk/media/blogs/2023/february/a-breath-of-fresh-air-a-welsh-project-to-improve-management-of-cystic-fibrosis/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:23 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Rare diseases]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2023/february/a-breath-of-fresh-air-a-welsh-project-to-improve-management-of-cystic-fibrosis/</guid>
                    <description><![CDATA[Cendl Xanthe talks about her remote health monitoring study for people with Cystic Fibrosis (CF), and the importance of people with rare diseases taking part in clinical trials.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/sprb5pn4/ceni-2-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d94868e295b140"/>
                </item>
                <item>
                    <title>Paving the way to sustainability: transforming pharmaceutical industry practices</title>
<link>https://www.abpi.org.uk/media/blogs/2023/december/paving-the-way-to-sustainability-transforming-pharmaceutical-industry-practices/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:22 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Sustainability]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2023/december/paving-the-way-to-sustainability-transforming-pharmaceutical-industry-practices/</guid>
                    <description><![CDATA[Blog post by Roz Bekker, Managing Director Janssen UK &amp; Ireland, ABPI Sustainability Board Sponsor ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ntgefz2d/cop28-tree-wind-farm.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1da21212386dfd0"/>
                </item>
                <item>
                    <title>Could more medicines be recommended for routine commissioning rather than spending time in the Cancer Drugs Fund?</title>
<link>https://www.abpi.org.uk/media/blogs/2022/october/could-more-medicines-be-recommended-for-routine-commissioning-rather-than-spending-time-in-the-cancer-drugs-fund/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:22 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2022/october/could-more-medicines-be-recommended-for-routine-commissioning-rather-than-spending-time-in-the-cancer-drugs-fund/</guid>
                    <description><![CDATA[A new analysis commissioned by the ABPI suggests they could.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/b5dkqqxg/victoria-jordan-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d8e341b78e5f10"/>
                </item>
                <item>
                    <title>Reflections from NICON22</title>
<link>https://www.abpi.org.uk/media/blogs/2022/november/reflections-from-nicon22/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:21 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Clinical research]]></category>
                            <category><![CDATA[Trials]]></category>
                            <category><![CDATA[Northern Ireland]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2022/november/reflections-from-nicon22/</guid>
                    <description><![CDATA[Commentary on this year&#x27;s Northern Ireland Annual Conference and Exhibition 2022.&#xA;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/jmbn45nr/event-930x930-hands-laptop.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee7fa0c0"/>
                </item>
                <item>
                    <title>Working together, we are all determined to create more medicines for pregnant women</title>
<link>https://www.abpi.org.uk/media/blogs/2022/may/working-together-we-are-all-determined-to-create-more-medicines-for-pregnant-women/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:21 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Clinical research]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2022/may/working-together-we-are-all-determined-to-create-more-medicines-for-pregnant-women/</guid>
                    <description><![CDATA[Steve Hoare, the ABPI&#x27;s Head of Safety and Quality, talks about how industry is trying to address the lack of medicines approved for pregnant women. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/pq3fnuvz/scientist-pipetting-580x405-webp75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee960ef0"/>
                </item>
                <item>
                    <title>ABPI analysis on NICE&#x2019;s changes for evaluating new medicines: Next steps</title>
<link>https://www.abpi.org.uk/media/blogs/2022/january/abpi-analysis-on-nice-s-changes-for-evaluating-new-medicines-next-steps/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:21 GMT</pubDate>
                            <dc:creator><![CDATA[Paul Catchpole]]></dc:creator>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Health and Access to Medicines]]></category>
                            <category><![CDATA[NICE Methods Review]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2022/january/abpi-analysis-on-nice-s-changes-for-evaluating-new-medicines-next-steps/</guid>
                    <description><![CDATA[Commentary on the publication of NICE&#x27;s Manual which sets out how the latest medicines and health technologies will be evaluated. &#xA;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/5l2beqty/event-930x930-doctor-older-patient-webp75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee8ee300"/>
                </item>
                <item>
                    <title>Shanali &#x2013; I am not the illness, I am a person first</title>
<link>https://www.abpi.org.uk/media/blogs/2022/february/shanali-i-am-not-the-illness-i-am-a-person-first/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:20 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Rare diseases]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2022/february/shanali-i-am-not-the-illness-i-am-a-person-first/</guid>
                    <description><![CDATA[Shanali Perera lives with vasculitis, a rare autoimmune condition. She is an artist, educator and writer, having retired from her first career as a rheumatologist. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/qvvfog1y/shanali-perera-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d824e7cf5fb170"/>
                </item>
                <item>
                    <title>Moving beyond box-ticking and lip service &#x2013; why patient involvement matters in a new era of ATMPs for rare diseases</title>
<link>https://www.abpi.org.uk/media/blogs/2022/february/moving-beyond-box-ticking-and-lip-service-why-patient-involvement-matters-in-a-new-era-of-atmps-for-rare-diseases/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:20 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Rare diseases]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2022/february/moving-beyond-box-ticking-and-lip-service-why-patient-involvement-matters-in-a-new-era-of-atmps-for-rare-diseases/</guid>
                    <description><![CDATA[Laurence Woollard is a patient advocate for rare diseases and a Patient and Public Voice (PPV) Partner on NHS England&#x2019;s ATMP working group. For Rare Disease Day, his message is that meaningful patient involvement is essential to achieve greater access to potentially life-changing therapies for rare diseases.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/hhqpg4pw/laurence-woollard-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d82a1fbc7708a0"/>
                </item>
                <item>
                    <title>Diane walks to beat Primary Biliary Cholangitis (PBC)</title>
<link>https://www.abpi.org.uk/media/blogs/2022/february/diane-walks-to-beat-primary-biliary-cholangitis-pbc/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:20 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Rare diseases]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2022/february/diane-walks-to-beat-primary-biliary-cholangitis-pbc/</guid>
                    <description><![CDATA[Diane Reeves is a teacher in Solihull. She has Primary Biliary Cholangitis (PBC). It&#x2019;s a rare, chronic and progressive autoimmune disease where the body attacks the bile ducts, causing damage to the liver. This is her story.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/2ljpdysy/diane-reeves-468x251.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d82a1fbc80a590"/>
                </item>
                <item>
                    <title>By working together we can improve the lives of people with rare diseases</title>
<link>https://www.abpi.org.uk/media/blogs/2022/february/by-working-together-we-can-improve-the-lives-of-people-with-rare-diseases/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:19 GMT</pubDate>
                            <dc:creator><![CDATA[Christian Wieszner]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2022/february/by-working-together-we-can-improve-the-lives-of-people-with-rare-diseases/</guid>
                    <description><![CDATA[Many people are surprised to learn that rare diseases are actually comparatively common. A rare disease is defined as one that affects fewer than one in 2,000 people and it is reckoned that 300 million people worldwide have one. More than 6,000 rare diseases have been identified and about 72% of those have a genetic origin. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/jcsjc0qj/christian-wieszner-csl-bering-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d8224f7cdc4200"/>
                </item>
                <item>
                    <title>Alan and Ataxia: Explaining the lived experience of a rare disease</title>
<link>https://www.abpi.org.uk/media/blogs/2022/february/alan-and-ataxia-explaining-the-lived-experience-of-a-rare-disease/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:19 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Rare diseases]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2022/february/alan-and-ataxia-explaining-the-lived-experience-of-a-rare-disease/</guid>
                    <description><![CDATA[Alan Thomas from Wales is a patient advocate for rare diseases and Ataxia in particular. Known as &#x2018;the rare disease warrior&#x2019;; he founded the charity Ataxia and Me, which now has a global following. He campaigns around the world to raise awareness of the lived experience of having a rare condition. This is his story. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/uxdjinay/alan-thomas-v2-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d82a28aecc1b60"/>
                </item>
                <item>
                    <title>Worth the wait &#x2013; The Goldacre review</title>
<link>https://www.abpi.org.uk/media/blogs/2022/april/worth-the-wait-the-goldacre-review/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:19 GMT</pubDate>
                            <dc:creator><![CDATA[Colette Goldrick]]></dc:creator>
                            <category><![CDATA[Health data]]></category>
                            <category><![CDATA[Clinical research]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2022/april/worth-the-wait-the-goldacre-review/</guid>
                    <description><![CDATA[Our thoughts on Professor Ben Goldacre&#x2019;s &#x201C;Better, broader, safer&#x201D; report into health data.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/l5yb0obc/patenting-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f01eaac0"/>
                </item>
                <item>
                    <title>There&#x2019;s nothing we can&#x2019;t do or achieve, but people with thalassaemia need understanding and support</title>
<link>https://www.abpi.org.uk/media/blogs/2021/february/there-s-nothing-we-can-t-do-or-achieve-but-people-with-thalassaemia-need-understanding-and-support/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:18 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Rare diseases]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2021/february/there-s-nothing-we-can-t-do-or-achieve-but-people-with-thalassaemia-need-understanding-and-support/</guid>
                    <description><![CDATA[Thalassaemia major is a serious, genetic blood disorder.&#xA0;Roanna Maharaj was diagnosed with a severe form of the disease as a baby in the Caribbean. This is her story.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/tj4a1eoo/thalassaemia-rohanna-maharaj-580x405.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d7cce6b36b0a40"/>
                </item>
                <item>
                    <title>Taking control: Inspiring others to beat rare diseases</title>
<link>https://www.abpi.org.uk/media/blogs/2020/february/taking-control-inspiring-others-to-beat-rare-diseases/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:18 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Rare diseases]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2020/february/taking-control-inspiring-others-to-beat-rare-diseases/</guid>
                    <description><![CDATA[Karen Owen lives with a condition called hereditary angioedema (HAE). She has learned to take control of HAE through self-management techniques and peer support.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/0weaqfae/karen-owen-580x405.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d7cce6b2111f90"/>
                </item>
                <item>
                    <title>Rare Disease 101 - the first cross-rare disease course for healthcare professionals</title>
<link>https://www.abpi.org.uk/media/blogs/2020/february/rare-disease-101-the-first-cross-rare-disease-course-for-healthcare-professionals/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:17 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Rare diseases]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2020/february/rare-disease-101-the-first-cross-rare-disease-course-for-healthcare-professionals/</guid>
                    <description><![CDATA[Dr Lucy McKay, CEO of the charity Medics4Rare Diseases tells us why their new educational module &#x2013; Rare Disease 101 - should be essential for all healthcare professionals.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ea2lhrvg/lucy-mckay-580x405.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d7cce6b3e199d0"/>
                </item>
                <item>
                    <title>Rare bone disease can&#x2019;t stop speedy Anna</title>
<link>https://www.abpi.org.uk/media/blogs/2020/february/rare-bone-disease-can-t-stop-speedy-anna/</link>                    <pubDate>Tue, 31 Mar 2026 14:00:16 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Rare diseases]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2020/february/rare-bone-disease-can-t-stop-speedy-anna/</guid>
                    <description><![CDATA[Anna Turner from Waringstown, Northern Ireland, recently celebrated her 8th birthday with family and friends. She lives with a rare condition called hypophosphatasia (HPP).]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/reifpwxn/anna-rare-580x405.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d7cce6b4115c60"/>
                </item>
                <item>
                    <title>One thing I have learned while living with a rare disease is to never give up</title>
<link>https://www.abpi.org.uk/media/blogs/2020/february/one-thing-i-have-learned-while-living-with-a-rare-disease-is-to-never-give-up/</link>                    <pubDate>Tue, 31 Mar 2026 14:00:16 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Rare diseases]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2020/february/one-thing-i-have-learned-while-living-with-a-rare-disease-is-to-never-give-up/</guid>
                    <description><![CDATA[Prabhjot is a is a university lecturer in living in London. She describes her experience of living with polymyositis.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/divnwc5d/prabhjot-rare-580x405.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d7cce6b20782a0"/>
                </item>
                <item>
                    <title>More than just cold hands</title>
<link>https://www.abpi.org.uk/media/blogs/2020/february/more-than-just-cold-hands/</link>                    <pubDate>Tue, 31 Mar 2026 14:00:16 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Rare diseases]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2020/february/more-than-just-cold-hands/</guid>
                    <description><![CDATA[February is Raynaud&#x2019;s awareness month. Physiotherapist and Parkinson&#x2019;s dance teacher Liz Hooks has the condition and for her, a little kindness and the offer of some hot water would go a long way to help manage it.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/srakuwj2/liz-hooks-rare-580x405.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d7cce6b2e2c770"/>
                </item>
                <item>
                    <title>&#x2018;I don&#x2019;t let Fabry disease stop me from doing what I want to do&#x27;</title>
<link>https://www.abpi.org.uk/media/blogs/2020/february/i-don-t-let-fabry-disease-stop-me-from-doing-what-i-want-to-do/</link>                    <pubDate>Tue, 31 Mar 2026 14:00:15 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Rare diseases]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2020/february/i-don-t-let-fabry-disease-stop-me-from-doing-what-i-want-to-do/</guid>
                    <description><![CDATA[Fabry disease is a rare disorder caused by an enzyme deficiency in the body. University of Southampton student Sebastiaan Van Dyck from Belgium describes his journey with Fabry disease and how he copes with the condition.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/clnn31ua/seb-rare-580x405.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d7cce6b437f730"/>
                </item>
                <item>
                    <title>Early diagnosis is key to improve outcomes for patients</title>
<link>https://www.abpi.org.uk/media/blogs/2020/february/early-diagnosis-is-key-to-improve-outcomes-for-patients/</link>                    <pubDate>Tue, 31 Mar 2026 14:00:14 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Rare diseases]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2020/february/early-diagnosis-is-key-to-improve-outcomes-for-patients/</guid>
                    <description><![CDATA[Professor Derralynn Hughes is Professor of experimental haematology based at the Royal Free London NHS Foundation Trust and University College London, and an expert on a group of rare diseases called lysosomal disorders.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/kqja3axa/female-tubes-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eea8d3a0"/>
                </item>
                <item>
                    <title>Boost for transparency as highest ever rate of healthcare professionals named on Disclosure UK</title>
<link>https://www.abpi.org.uk/media/news/2023/june/boost-for-transparency-as-highest-ever-rate-of-healthcare-professionals-named-on-disclosure-uk/</link>                    <pubDate>Wed, 14 Jan 2026 10:40:29 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/june/boost-for-transparency-as-highest-ever-rate-of-healthcare-professionals-named-on-disclosure-uk/</guid>
                    <description><![CDATA[The proportion of named healthcare professionals (HCPs) in transparency data published on Disclosure UK has risen for the third year in a row.  ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/5l2beqty/event-930x930-doctor-older-patient-webp75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee8ee300"/>
                </item>
                <item>
                    <title>Reflections from the British Neuroscience Association Scholars Day</title>
<link>https://www.abpi.org.uk/media/blogs/2023/october/reflections-from-the-british-neuroscience-association-scholars-day/</link>                    <pubDate>Thu, 20 Nov 2025 16:22:51 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Reputation]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2023/october/reflections-from-the-british-neuroscience-association-scholars-day/</guid>
                    <description><![CDATA[The pharmaceutical industry is a vast and dynamic sector. It offers countless career opportunities for scientists, as well as other important non-science roles, and welcomes people from diverse backgrounds and career stages.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/skkad031/bna-scholars-1-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d9f791dc4a8490"/>
                </item>
                <item>
                    <title>Attracting global talent is key to UK Life Sciences success</title>
<link>https://www.abpi.org.uk/media/news/2025/october/attracting-global-talent-is-key-to-uk-life-sciences-success/</link>                    <pubDate>Thu, 13 Nov 2025 17:57:15 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/october/attracting-global-talent-is-key-to-uk-life-sciences-success/</guid>
                    <description><![CDATA[If the UK is to become Europe&#x2019;s leading life sciences economy by 2030, it must sharpen its global appeal and do more to attract and keep world-class talent.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/2dkbtonm/chemist-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f01c12b0"/>
                </item>
                <item>
                    <title>International comparisons in medicines spending and the link to competitiveness</title>
<link>https://www.abpi.org.uk/media/blogs/2025/october/international-comparisons-in-medicines-spending-and-the-link-to-competitiveness/</link>                    <pubDate>Wed, 29 Oct 2025 12:00:29 GMT</pubDate>
                            <dc:creator><![CDATA[]]></dc:creator>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[VPAG]]></category>
                            <category><![CDATA[VPAG (1)]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                            <category><![CDATA[Statutory Scheme]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2025/october/international-comparisons-in-medicines-spending-and-the-link-to-competitiveness/</guid>
                    <description><![CDATA[Kim Assender, Director of Commercial Policy and Analysis at the ABPI, discusses a new report from IQVIA and what it says about the right strategic level of spending on medicines to deliver the best outcomes for patients while supporting cash-strapped health systems and delivering wider economic growth.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ilxj4h3y/glove-vial-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef087fd0"/>
                </item>
                <item>
                    <title>Public attitudes on the pharmaceutical industry: will increasing familiarity build confidence?</title>
<link>https://www.abpi.org.uk/media/blogs/2025/october/public-attitudes-on-the-pharmaceutical-industry-will-increasing-familiarity-build-confidence/</link>                    <pubDate>Thu, 16 Oct 2025 18:06:59 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Reputation]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2025/october/public-attitudes-on-the-pharmaceutical-industry-will-increasing-familiarity-build-confidence/</guid>
                    <description><![CDATA[Each year, the Association of the British Pharmaceutical Industry (ABPI) and Ipsos carry out quantitative and qualitative research with members of the public and healthcare professionals to understand how the pharmaceutical industry is viewed in the UK.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/g41ibnes/public-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d9da41ce1851d0"/>
                </item>
                <item>
                    <title>Why the government must urgently raise the NICE cost-effectiveness threshold</title>
<link>https://www.abpi.org.uk/media/blogs/2025/october/why-the-government-must-urgently-raise-the-nice-cost-effectiveness-threshold/</link>                    <pubDate>Tue, 07 Oct 2025 08:06:44 GMT</pubDate>
                            <dc:creator><![CDATA[Victoria Jordan]]></dc:creator>
                            <category><![CDATA[NICE]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Access]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2025/october/why-the-government-must-urgently-raise-the-nice-cost-effectiveness-threshold/</guid>
                    <description><![CDATA[In this piece, Victoria Jordan, ABPI&#x27;s Director, Value and Access Policy, explains why the government must increase NICE&#x2019;s baseline threshold to ensure that NHS patients benefit from timely access to the latest treatments.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/00kl03qg/nursesl-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d9da41cdfdc4f0"/>
                </item>
                <item>
                    <title>The UK must act to secure the future of UK life sciences and deliver for patients</title>
<link>https://www.abpi.org.uk/media/blogs/2025/september/the-uk-must-act-to-secure-the-future-of-uk-life-sciences-and-deliver-for-patients/</link>                    <pubDate>Mon, 29 Sep 2025 13:04:05 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Economy and Industry]]></category>
                            <category><![CDATA[Health and Access to Medicines]]></category>
                            <category><![CDATA[Life Sciences]]></category>
                            <category><![CDATA[Medicines sales]]></category>
                            <category><![CDATA[NICE]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Politics]]></category>
                            <category><![CDATA[Research and Development]]></category>
                            <category><![CDATA[Science and innovation]]></category>
                            <category><![CDATA[Value]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                            <category><![CDATA[VPAG]]></category>
                            <category><![CDATA[VPAG (1)]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2025/september/the-uk-must-act-to-secure-the-future-of-uk-life-sciences-and-deliver-for-patients/</guid>
                    <description><![CDATA[Richard Torbett, ABPI Chief Executive, sets out the stark choice facing the UK. Will uncertainty and short-term thinking erode the UK&#x27;s position as a life sciences centre, or can the UK take the decisive steps needed to restore confidence, attract investment, and ensure that patients in the UK benefit from the very best in modern medicine?]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/avgjryyt/mma-vaccine-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1da6e42002d0be0"/>
                </item>
                <item>
                    <title>Making vaccination an essential service is a step in the right direction</title>
<link>https://www.abpi.org.uk/media/blogs/2020/february/making-vaccination-an-essential-service-is-a-step-in-the-right-direction/</link>                    <pubDate>Fri, 19 Sep 2025 15:52:26 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Vaccines]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2020/february/making-vaccination-an-essential-service-is-a-step-in-the-right-direction/</guid>
                    <description><![CDATA[The new GP contract will change how vaccines are delivered and paid for in primary care. It&#x2019;s the most significant overhaul in decades and is a step in the right direction to improving vaccination coverage across England.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/r5gfhzmm/doctor-vaccine-arm-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eeb38200"/>
                </item>
                <item>
                    <title>Three steps to boost patient access to clinical trials in the UK</title>
<link>https://www.abpi.org.uk/media/blogs/2023/may/three-steps-to-boost-patient-access-to-clinical-trials-in-the-uk/</link>                    <pubDate>Fri, 19 Sep 2025 14:59:22 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2023/may/three-steps-to-boost-patient-access-to-clinical-trials-in-the-uk/</guid>
                    <description><![CDATA[Oliver Buckley-Mellor, ABPI Research Policy Manager, sets out the key actions needed to get clinical trials back to full strength.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/iredl2q2/lab-working-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c98ef455ef0"/>
                </item>
                <item>
                    <title>NHS England is taking welcome new steps to encourage clinical leaders to champion proven innovation in the NHS</title>
<link>https://www.abpi.org.uk/media/blogs/2024/december/nhs-england-is-taking-welcome-new-steps-to-encourage-clinical-leaders-to-champion-proven-innovation-in-the-nhs/</link>                    <pubDate>Thu, 18 Sep 2025 16:43:35 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2024/december/nhs-england-is-taking-welcome-new-steps-to-encourage-clinical-leaders-to-champion-proven-innovation-in-the-nhs/</guid>
                    <description><![CDATA[Dr Amit Aggarwal, Director of Medical Affairs at the Association of the British Pharmaceutical Industry (ABPI), welcomes the steps NHS England has taken to tackle inequalities in patient access to new medicines.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/dsdjc5k2/nurses-corridor-white-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef7858a0"/>
                </item>
                <item>
                    <title>Industry calls on government to boost investment in commercial clinical trial capacity to drive &#xA3;3 billion extra economic growth, 26,000 new jobs</title>
<link>https://www.abpi.org.uk/media/news/2024/september/industry-calls-on-government-to-boost-investment-in-commercial-clinical-trial-capacity-to-drive-3-billion-extra-economic-growth-26-000-new-jobs/</link>                    <pubDate>Thu, 18 Sep 2025 15:38:59 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/september/industry-calls-on-government-to-boost-investment-in-commercial-clinical-trial-capacity-to-drive-3-billion-extra-economic-growth-26-000-new-jobs/</guid>
                    <description><![CDATA[New data shows that industry clinical trials contributed &#xA3;7.4 billion GVA to the UK economy in 2022]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/gv3pzmvi/eyes-microscope-close-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef364690"/>
                </item>
                <item>
                    <title>ABPI joins the Sustainable Medicines Partnership</title>
<link>https://www.abpi.org.uk/media/news/2022/september/abpi-joins-the-sustainable-medicines-partnership/</link>                    <pubDate>Thu, 18 Sep 2025 15:26:26 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Sustainability]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/september/abpi-joins-the-sustainable-medicines-partnership/</guid>
                    <description><![CDATA[YewMaker, the executive lead of the Sustainable Medicines Partnership (SMP), has announced that the ABPI has joined the partnership as a founding collaborator.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/hmibbi0s/biochemical-research-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eea1a7b0"/>
                </item>
                <item>
                    <title>Accelerated review of VPAG concludes without agreement</title>
<link>https://www.abpi.org.uk/media/news/2025/august/accelerated-review-of-vpag-concludes-without-agreement/</link>                    <pubDate>Tue, 26 Aug 2025 10:31:31 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/august/accelerated-review-of-vpag-concludes-without-agreement/</guid>
                    <description><![CDATA[The ABPI can confirm that industry and government have been unable to reach an agreement on changes to a controversial medicines payment scheme which is undermining UK patient access to innovative medicines and the competitiveness of the UK life sciences industry.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/wqxdl050/brown-bottle-fill-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef7af0b0"/>
                </item>
                <item>
                    <title>Laura McMullin of Daiichi Sankyo named as new ABPI Vice-President</title>
<link>https://www.abpi.org.uk/media/news/2025/july/laura-mcmullin-of-daiichi-sankyo-named-as-new-abpi-vice-president/</link>                    <pubDate>Tue, 26 Aug 2025 10:26:50 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/july/laura-mcmullin-of-daiichi-sankyo-named-as-new-abpi-vice-president/</guid>
                    <description><![CDATA[The ABPI has appointed Laura McMullin as Vice-President of the ABPI. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/zd4nk3hm/laura_mcmullin.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1dc168b111caf30"/>
                </item>
                <item>
                    <title>UK life sciences plan falls short, says ABPI</title>
<link>https://www.abpi.org.uk/media/news/2025/july/uk-life-sciences-plan-falls-short-says-abpi/</link>                    <pubDate>Wed, 16 Jul 2025 08:25:29 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/july/uk-life-sciences-plan-falls-short-says-abpi/</guid>
                    <description><![CDATA[The ABPI is warning that the core ambition of the government&#x27;s new life sciences strategy will not be realised unless it makes a real commitment to invest more in new medicines. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/dkmh2k31/microscope-laptop-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eec7cd50"/>
                </item>
                <item>
                    <title>Rare diseases and clinical research: How can we maximise the chances of success?</title>
<link>https://www.abpi.org.uk/media/blogs/2020/february/rare-diseases-and-clinical-research-how-can-we-maximise-the-chances-of-success/</link>                    <pubDate>Mon, 14 Jul 2025 16:49:55 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Rare diseases]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2020/february/rare-diseases-and-clinical-research-how-can-we-maximise-the-chances-of-success/</guid>
                    <description><![CDATA[Our President Haseeb Ahmad sets out how industry is working to find treatments and cures for some of the world&#x2019;s most complex diseases. Nowhere is the need to find new medicines more acute than in rare diseases, many of which are genetic and affect the youngest patients.&#xA0;&#xA0;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/c0yjegmq/abpi-president-haseeb-ahmad-580x405.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d8b1a72bc846b0"/>
                </item>
                <item>
                    <title>Break down barriers to partnerships to change the lives of millions, say NHS Confederation and the ABPI</title>
<link>https://www.abpi.org.uk/media/news/2023/november/break-down-barriers-to-partnerships-to-change-the-lives-of-millions-say-nhs-confederation-and-the-abpi/</link>                    <pubDate>Wed, 09 Jul 2025 16:38:27 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Partnership]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/november/break-down-barriers-to-partnerships-to-change-the-lives-of-millions-say-nhs-confederation-and-the-abpi/</guid>
                    <description><![CDATA[Partnerships between the NHS and the pharmaceutical industry can change the lives of millions of people across the country, according to a new report. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/5l2beqty/event-930x930-doctor-older-patient-webp75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee8ee300"/>
                </item>
                <item>
                    <title>ABPI response to NHS 10-Year Health Plan</title>
<link>https://www.abpi.org.uk/media/news/2025/july/abpi-response-to-nhs-10-year-health-plan/</link>                    <pubDate>Thu, 03 Jul 2025 12:45:18 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[NHS]]></category>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Genomics]]></category>
                            <category><![CDATA[Innovation]]></category>
                            <category><![CDATA[NICE]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/july/abpi-response-to-nhs-10-year-health-plan/</guid>
                    <description><![CDATA[The NHS 10-Year Health Plan gets it right on genomics and advanced therapies, as well as accelerated clinical trials and supporting participation in research. However, innovative medicines could play a far greater role in revolutionising healthcare. The plan also sends a worrying signal about limiting patient and doctor choices around the best treatment for them.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/pnafsqgg/doctor-patient-detail-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eee25a30"/>
                </item>
                <item>
                    <title>ABPI refreshes its commitment to improve public involvement in research</title>
<link>https://www.abpi.org.uk/media/news/2023/march/abpi-refreshes-its-commitment-to-improve-public-involvement-in-research/</link>                    <pubDate>Thu, 26 Jun 2025 14:48:31 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/march/abpi-refreshes-its-commitment-to-improve-public-involvement-in-research/</guid>
                    <description><![CDATA[1 year anniversary of shared commitment to improve public involvement in research.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/lxfbose0/careers-871x581-webp75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef17c210"/>
                </item>
                <item>
                    <title>Understanding NHS medicines spending in England</title>
<link>https://www.abpi.org.uk/media/blogs/2025/march/understanding-nhs-medicines-spending-in-england/</link>                    <pubDate>Mon, 23 Jun 2025 10:23:52 GMT</pubDate>
                            <dc:creator><![CDATA[Pinchas Kahtan]]></dc:creator>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Medicines sales]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Value]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2025/march/understanding-nhs-medicines-spending-in-england/</guid>
                    <description><![CDATA[This article discusses what the NHS Business Services Authority (BSA) data can tell us about NHS medicine spending and how industry payments shape the true level of NHS spending on medicines. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/jgrn2v23/data-woman-explain-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef712cb0"/>
                </item>
                <item>
                    <title>ABPI response to the new Industrial Strategy</title>
<link>https://www.abpi.org.uk/media/news/2025/june/abpi-response-to-the-new-industrial-strategy/</link>                    <pubDate>Mon, 23 Jun 2025 09:50:40 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/june/abpi-response-to-the-new-industrial-strategy/</guid>
                    <description><![CDATA[The government&#x2019;s new Industrial Strategy reaffirms its commitment to growing the economy. The key test for life sciences will be whether it can return the UK to international competitiveness.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/2mzleyni/white-tablet-factory-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef7d61b0"/>
                </item>
                <item>
                    <title>Coalition calls for roadmap to improve inclusivity in clinical research</title>
<link>https://www.abpi.org.uk/media/news/2025/june/coalition-calls-for-roadmap-to-improve-inclusivity-in-clinical-research/</link>                    <pubDate>Wed, 11 Jun 2025 23:08:38 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/june/coalition-calls-for-roadmap-to-improve-inclusivity-in-clinical-research/</guid>
                    <description><![CDATA[Encouraging participation of a wide range of diverse communities in clinical research is essential to make sure that innovative medicines meet the needs of the people they are intended for, says a new report from ABPI and AMRC. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/21zjbgkf/doctor-patient-talk-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d9af1fa473a6b0"/>
                </item>
                <item>
                    <title>Spending Review &#x2013; NHS must invest more in proven innovations, says ABPI</title>
<link>https://www.abpi.org.uk/media/news/2025/june/spending-review-nhs-must-invest-more-in-proven-innovations-says-abpi/</link>                    <pubDate>Wed, 11 Jun 2025 13:19:16 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Budget]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/june/spending-review-nhs-must-invest-more-in-proven-innovations-says-abpi/</guid>
                    <description><![CDATA[The government spending review has concluded with a 3% per year increase for health and the NHS. As part of fixing the broken NHS, the innovative pharmaceutical industry is calling for greater focus to be put on investing in those areas of health spending that have the strongest evidence for both value for money and for directly improving patient outcomes.&#xA;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/l5lb4t5p/mps-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d9da41cdd52e50"/>
                </item>
                <item>
                    <title>BioNTech&#x2019;s investment provides a template for UK growth, say ABPI</title>
<link>https://www.abpi.org.uk/media/news/2025/may/biontech-s-investment-provides-a-template-for-uk-growth-say-abpi/</link>                    <pubDate>Tue, 20 May 2025 15:26:35 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Clinical research]]></category>
                            <category><![CDATA[Economy and Industry]]></category>
                            <category><![CDATA[Life Sciences]]></category>
                            <category><![CDATA[Science and innovation]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/may/biontech-s-investment-provides-a-template-for-uk-growth-say-abpi/</guid>
                    <description><![CDATA[The innovative biopharmaceutical company BioNTech has announced a major investment of up to &#xA3;1bn over 10 years in the UK, potentially creating more than 400 new jobs in London and Cambridge.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ra2leyup/scientists-lab-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c9812ef1ef0"/>
                </item>
                <item>
                    <title>ABPI welcomes announcement of ten-year budgets for R&amp;D funding</title>
<link>https://www.abpi.org.uk/media/news/2025/may/abpi-welcomes-announcement-of-ten-year-budgets-for-rd-funding/</link>                    <pubDate>Mon, 19 May 2025 13:24:52 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Research and Development]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/may/abpi-welcomes-announcement-of-ten-year-budgets-for-rd-funding/</guid>
                    <description><![CDATA[The Department for Science, Innovation and Technology (DSIT) today announced new ten-year budgets for science funding. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/hmibbi0s/biochemical-research-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eea1a7b0"/>
                </item>
                <item>
                    <title>Trust, transparency and purpose &#x2013; managing reputation in a challenging environment</title>
<link>https://www.abpi.org.uk/media/blogs/2025/may/trust-transparency-and-purpose-managing-reputation-in-a-challenging-environment/</link>                    <pubDate>Tue, 13 May 2025 09:06:29 GMT</pubDate>
                            <category><![CDATA[Reputation]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2025/may/trust-transparency-and-purpose-managing-reputation-in-a-challenging-environment/</guid>
                    <description><![CDATA[Blog post by Seyda Atadan Memis, Takeda General Manager UK &amp; Ireland and ABPI Board Member]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ziqjay0f/257_cm406077_abpi_industry-summit.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1dbc3e637375870"/>
                </item>
                <item>
                    <title>Life sciences growth requires payment rates to return to internationally comparable levels</title>
<link>https://www.abpi.org.uk/media/news/2025/may/life-sciences-growth-requires-payment-rates-to-return-to-internationally-comparable-levels/</link>                    <pubDate>Wed, 07 May 2025 23:01:43 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Medicines sales]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Statutory Scheme]]></category>
                            <category><![CDATA[Value]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/may/life-sciences-growth-requires-payment-rates-to-return-to-internationally-comparable-levels/</guid>
                    <description><![CDATA[Existing and proposed medicine payment rates of a quarter to a third of UK pharmaceutical company revenue are incompatible with government ambitions to grow the sector.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/v31prhfs/doctor-woman-watch-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef1c55f0"/>
                </item>
                <item>
                    <title>No room for complacency &#x2013; the UK must do more on access to rare disease medicines</title>
<link>https://www.abpi.org.uk/media/blogs/2025/february/no-room-for-complacency-the-uk-must-do-more-on-access-to-rare-disease-medicines/</link>                    <pubDate>Tue, 06 May 2025 16:07:02 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2025/february/no-room-for-complacency-the-uk-must-do-more-on-access-to-rare-disease-medicines/</guid>
                    <description><![CDATA[Blog post by Richard Torbett, ABPI Chief Executive for Rare Disease Day 2025 ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/1f0lkzvd/sterile-capsules-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eecef940"/>
                </item>
                <item>
                    <title>Celebrating our shared commitment to patient and public involvement in research</title>
<link>https://www.abpi.org.uk/media/blogs/2025/march/celebrating-our-shared-commitment-to-patient-and-public-involvement-in-research/</link>                    <pubDate>Tue, 06 May 2025 16:02:44 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2025/march/celebrating-our-shared-commitment-to-patient-and-public-involvement-in-research/</guid>
                    <description><![CDATA[Celebrating the three-year anniversary of our shared commitment to increasing the involvement of patients and members of the public in research. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/5l2beqty/event-930x930-doctor-older-patient-webp75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee8ee300"/>
                </item>
                <item>
                    <title>ABPI comment on 2025 VPAG rates of 22.9%</title>
<link>https://www.abpi.org.uk/media/news/2025/january/abpi-comment-on-2025-vpag-rates-of-229/</link>                    <pubDate>Tue, 06 May 2025 16:01:49 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/january/abpi-comment-on-2025-vpag-rates-of-229/</guid>
                    <description><![CDATA[The Voluntary Scheme for Branded Medicines Pricing and Access (VPAG) payment rate for newer medicines has been set at 22.9% in 2025, well above expectations, putting UK industry growth and investment at risk. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/nncpaw0e/pharmacist-medicines-shelves-580x405-1-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eec13da0"/>
                </item>
                <item>
                    <title>UK must do more on access to rare disease medicines, says ABPI</title>
<link>https://www.abpi.org.uk/media/news/2025/february/uk-must-do-more-on-access-to-rare-disease-medicines-says-abpi/</link>                    <pubDate>Tue, 06 May 2025 15:59:51 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/february/uk-must-do-more-on-access-to-rare-disease-medicines-says-abpi/</guid>
                    <description><![CDATA[The latest England action plan on rare diseases (published 28 February 2025) does not do enough to ensure NHS patients get access to potentially life-changing new medicines, according to the Association of the British Pharmaceutical Industry (ABPI).]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/j55bfqs1/working-nhs-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1db2c390c438070"/>
                </item>
                <item>
                    <title>Industry/academia links fuel UK medical innovation</title>
<link>https://www.abpi.org.uk/media/news/2025/february/industryacademia-links-fuel-uk-medical-innovation/</link>                    <pubDate>Tue, 06 May 2025 15:58:17 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/february/industryacademia-links-fuel-uk-medical-innovation/</guid>
                    <description><![CDATA[As National Apprenticeship Week (10 - 14 February) begins, new figures highlight the growing importance of industry-academic partnerships in filling skills gaps, advancing research, and keeping the UK ahead in global life sciences innovation.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/zvpilozj/adobestock_536708880.jpeg?width=240&amp;height=135&amp;quality=90&amp;v=1daef1669a41190"/>
                </item>
                <item>
                    <title>UK set to demand a third of pharmaceutical company revenue in second half of 2025</title>
<link>https://www.abpi.org.uk/media/news/2025/march/uk-set-to-demand-a-third-of-pharmaceutical-company-revenue-in-second-half-of-2025/</link>                    <pubDate>Tue, 06 May 2025 15:53:27 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Medicines sales]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Statutory Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/march/uk-set-to-demand-a-third-of-pharmaceutical-company-revenue-in-second-half-of-2025/</guid>
                    <description><![CDATA[The government is proposing to raise the Statutory Scheme payment rate for newer branded medicines from 15.5% to 32.2% of subject companies&#x27; NHS sales in the second half of 2025.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ujpcz05h/records-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f0369f90"/>
                </item>
                <item>
                    <title>Delivering the NHS 10-Year Plan will require a fourth &#x2018;shift&#x2019; says ABPI</title>
<link>https://www.abpi.org.uk/media/news/2025/march/delivering-the-nhs-10-year-plan-will-require-a-fourth-shift-says-abpi/</link>                    <pubDate>Tue, 06 May 2025 15:51:41 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[NHS]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/march/delivering-the-nhs-10-year-plan-will-require-a-fourth-shift-says-abpi/</guid>
                    <description><![CDATA[Creating an NHS fit for the future will mean investing in innovative medicines and vaccines to transform people&#x2019;s lives. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/pgwagn03/doctor-patient-bedside-871x581-web75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eefc4ad0"/>
                </item>
                <item>
                    <title>ABPI response to DSIT spending allocations</title>
<link>https://www.abpi.org.uk/media/news/2025/april/abpi-response-to-dsit-spending-allocations/</link>                    <pubDate>Tue, 06 May 2025 15:46:29 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/april/abpi-response-to-dsit-spending-allocations/</guid>
                    <description><![CDATA[The Department for Science, Innovation and Technology (DSIT) has today announced funding for research and development, including in life sciences. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/25rae34u/two-scientists-tube-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef584d80"/>
                </item>
                <item>
                    <title>Russell Abberley confirmed as ABPI President-elect</title>
<link>https://www.abpi.org.uk/media/news/2025/april/russell-abberley-confirmed-as-abpi-president-elect/</link>                    <pubDate>Tue, 06 May 2025 14:45:18 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/april/russell-abberley-confirmed-as-abpi-president-elect/</guid>
                    <description><![CDATA[Russell Abberley, Vice President and General Manager of Amgen UK and Ireland, has been confirmed as ABPI President-elect]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/3wil3jtu/russell_abberley_actingabpi_president.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1dbaa455d524660"/>
                </item>
                <item>
                    <title>ABPI response to the Budget</title>
<link>https://www.abpi.org.uk/media/news/2024/march/abpi-response-to-the-budget/</link>                    <pubDate>Tue, 06 May 2025 10:08:00 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Budget]]></category>
                            <category><![CDATA[Manufacturing]]></category>
                            <category><![CDATA[Economy and Industry]]></category>
                            <category><![CDATA[Life Sciences]]></category>
                            <category><![CDATA[Politics]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/march/abpi-response-to-the-budget/</guid>
                    <description><![CDATA[The Association of the British Pharmaceutical Industry (ABPI) has welcomed measures in Chancellor Jeremy Hunt&#x2019;s Budget to unlock investment in medical research and medicines manufacturing, and improve NHS productivity. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/4ynexl2a/clinical-data-management-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f061ce40"/>
                </item>
                <item>
                    <title>ABPI response to the Conservative 2024 election manifesto</title>
<link>https://www.abpi.org.uk/media/news/2024/june/abpi-response-to-the-conservative-2024-election-manifesto/</link>                    <pubDate>Tue, 06 May 2025 10:06:17 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Politics]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/june/abpi-response-to-the-conservative-2024-election-manifesto/</guid>
                    <description><![CDATA[The Conservative and Unionist Party has published its Manifesto for the 2024 general election, which includes plans for policies to support the UK&#x2019;s life sciences sector. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/k33aj2pn/two-men-glass-window-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1db2c390c52c2b0"/>
                </item>
                <item>
                    <title>ABPI response to the Labour 2024 election manifesto</title>
<link>https://www.abpi.org.uk/media/news/2024/june/abpi-response-to-the-labour-2024-election-manifesto/</link>                    <pubDate>Tue, 06 May 2025 10:04:32 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Politics]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/june/abpi-response-to-the-labour-2024-election-manifesto/</guid>
                    <description><![CDATA[The Labour Party published its Manifesto for the 2024 general election, which includes plans for policies to support the UK&#x2019;s life sciences sector, alongside other growth sectors. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/hoxk0in2/interview-871x571.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f0d3c9f0"/>
                </item>
                <item>
                    <title>Labour budget can unlock UK life science opportunities</title>
<link>https://www.abpi.org.uk/media/news/2024/october/labour-budget-can-unlock-uk-life-science-opportunities/</link>                    <pubDate>Tue, 06 May 2025 09:57:14 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Budget]]></category>
                            <category><![CDATA[Economy and Industry]]></category>
                            <category><![CDATA[Politics]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/october/labour-budget-can-unlock-uk-life-science-opportunities/</guid>
                    <description><![CDATA[Ahead of the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) has outlined the key measures needed to improve UK life science competitiveness, boost UK R&amp;D, and fully realise the benefits of innovative medicines and vaccines for NHS patients.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/qyofdl1v/computational-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f044d060"/>
                </item>
                <item>
                    <title>ABPI welcomes the Chancellor&#x2019;s backing of life sciences in the Budget</title>
<link>https://www.abpi.org.uk/media/news/2024/october/abpi-welcomes-the-chancellor-s-backing-of-life-sciences-in-the-budget/</link>                    <pubDate>Tue, 06 May 2025 09:55:13 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Budget]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/october/abpi-welcomes-the-chancellor-s-backing-of-life-sciences-in-the-budget/</guid>
                    <description><![CDATA[The Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves&#x2019; measures to improve UK life sciences competitiveness.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/x1alyovv/quality-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eff2dfd0"/>
                </item>
                <item>
                    <title>ABPI response to the Budget</title>
<link>https://www.abpi.org.uk/media/news/2023/march/abpi-response-to-the-budget/</link>                    <pubDate>Tue, 06 May 2025 09:51:56 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Budget]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/march/abpi-response-to-the-budget/</guid>
                    <description><![CDATA[The Chancellor of the Exchequer has delivered his Spring Budget to Parliament.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/jmbn45nr/event-930x930-hands-laptop.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee7fa0c0"/>
                </item>
                <item>
                    <title>ABPI response to Prime Minister&#x27;s announcement on support for medical research</title>
<link>https://www.abpi.org.uk/media/news/2025/april/abpi-response-to-prime-ministers-announcement-on-support-for-medical-research/</link>                    <pubDate>Tue, 08 Apr 2025 10:23:41 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Health data]]></category>
                            <category><![CDATA[Clinical research]]></category>
                            <category><![CDATA[Research and Development]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/april/abpi-response-to-prime-ministers-announcement-on-support-for-medical-research/</guid>
                    <description><![CDATA[The Prime Minister has announced new funding and ambitious targets for UK&#xA0;medical research today (7 April).&#xA0;&#xA0;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/qyofdl1v/computational-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f044d060"/>
                </item>
                <item>
                    <title>The government and ABPI agree to accelerate a planned review of VPAG</title>
<link>https://www.abpi.org.uk/media/news/2025/april/the-government-and-abpi-agree-to-accelerate-a-planned-review-of-vpag/</link>                    <pubDate>Fri, 04 Apr 2025 16:00:53 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Statutory Scheme]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/april/the-government-and-abpi-agree-to-accelerate-a-planned-review-of-vpag/</guid>
                    <description><![CDATA[A planned autumn review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG) will be brought forward to report back in June.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ptvdrsdy/data-laptop-patient-580x405-1-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eed40250"/>
                </item>
                <item>
                    <title>NHS data infrastructure must support the research needs of the life sciences sector</title>
<link>https://www.abpi.org.uk/media/news/2025/february/nhs-data-infrastructure-must-support-the-research-needs-of-the-life-sciences-sector/</link>                    <pubDate>Wed, 02 Apr 2025 12:42:47 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Health data]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/february/nhs-data-infrastructure-must-support-the-research-needs-of-the-life-sciences-sector/</guid>
                    <description><![CDATA[Co-designing new networks with research users is critical to delivering the full scientific and commercial value of NHS health data.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/l0xf1lgz/scientist-pink-background-2025-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1db81eb91909170"/>
                </item>
                <item>
                    <title>Patients missing out on world leading UK genomic capabilities</title>
<link>https://www.abpi.org.uk/media/news/2022/november/patients-missing-out-on-world-leading-uk-genomic-capabilities/</link>                    <pubDate>Fri, 28 Mar 2025 11:16:47 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Genomics]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/november/patients-missing-out-on-world-leading-uk-genomic-capabilities/</guid>
                    <description><![CDATA[ABPI report, &#x2018;Harnessing the UK&#x2019;s genomics expertise to improve patient outcomes,&#x2019; outlines how the NHS and Pharmaceutical sector can work together to bring patients the latest genomic treatments and provide the best care possible.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/pq3fnuvz/scientist-pipetting-580x405-webp75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee960ef0"/>
                </item>
                <item>
                    <title>Growth and skills levy: A catalyst for the UK pharmaceutical industry?</title>
<link>https://www.abpi.org.uk/media/blogs/2025/february/growth-and-skills-levy-a-catalyst-for-the-uk-pharmaceutical-industry/</link>                    <pubDate>Mon, 03 Mar 2025 17:14:49 GMT</pubDate>
                            <dc:creator><![CDATA[Oliver Buckley-Mellor]]></dc:creator>
                            <category><![CDATA[Apprentices]]></category>
                            <category><![CDATA[Skills]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2025/february/growth-and-skills-levy-a-catalyst-for-the-uk-pharmaceutical-industry/</guid>
                    <description><![CDATA[This blog explores how the government&#x2019;s Growth and Skills Levy can help to achieve this ambition by making education and training more accessible while building on the success of apprenticeships in the life sciences sector]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/i3qllhte/biology-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f0316f70"/>
                </item>
                <item>
                    <title>Is investing in medicines harming the health of the UK population?</title>
<link>https://www.abpi.org.uk/media/blogs/2025/january/is-investing-in-medicines-harming-the-health-of-the-uk-population/</link>                    <pubDate>Fri, 28 Feb 2025 11:29:34 GMT</pubDate>
                            <dc:creator><![CDATA[Victoria Jordan]]></dc:creator>
                            <category><![CDATA[NHS Commercial Framework for New Medicines]]></category>
                            <category><![CDATA[NICE]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Value]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2025/january/is-investing-in-medicines-harming-the-health-of-the-uk-population/</guid>
                    <description><![CDATA[A recent study published in the Lancet has disputed the existing decision-making threshold used by NICE. The authors argue that allowing NHS patients access to new NICE-recommended medicines has, counterintuitively, harmed wider population health by displacing other more cost-effective areas of spending.&#xA;&#xA;In this blog, Victoria Jordan explains why the ABPI disagrees with this conclusion and examines some of the assumptions that underpin it.&#xA;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/jihl0ma0/wheelchair-professional-871x581-webp75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eeebf720"/>
                </item>
                <item>
                    <title>Achieving life sciences sector growth requires falling medicine payment rates</title>
<link>https://www.abpi.org.uk/media/blogs/2025/january/achieving-life-sciences-sector-growth-requires-falling-medicine-payment-rates/</link>                    <pubDate>Fri, 28 Feb 2025 11:26:35 GMT</pubDate>
                            <dc:creator><![CDATA[Dr Richard Torbett]]></dc:creator>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2025/january/achieving-life-sciences-sector-growth-requires-falling-medicine-payment-rates/</guid>
                    <description><![CDATA[To tackle the economic stagnation of the last 15 years, the UK needs a strategy that aligns policy across government departments and avoids perverse incentives. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/2mzleyni/white-tablet-factory-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef7d61b0"/>
                </item>
                <item>
                    <title>Updates to the NHS Commercial Framework must deliver more flexibility to support timely access to medicines</title>
<link>https://www.abpi.org.uk/media/blogs/2025/february/updates-to-the-nhs-commercial-framework-must-deliver-more-flexibility-to-support-timely-access-to-medicines/</link>                    <pubDate>Fri, 28 Feb 2025 10:59:49 GMT</pubDate>
                            <dc:creator><![CDATA[Victoria Jordan]]></dc:creator>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Advanced Therapy Medicinal Products (ATMPs)]]></category>
                            <category><![CDATA[ATMP]]></category>
                            <category><![CDATA[Health and Access to Medicines]]></category>
                            <category><![CDATA[NHS Commercial Framework for New Medicines]]></category>
                            <category><![CDATA[NICE]]></category>
                            <category><![CDATA[NICE Methods Review]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Value]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2025/february/updates-to-the-nhs-commercial-framework-must-deliver-more-flexibility-to-support-timely-access-to-medicines/</guid>
                    <description><![CDATA[NHS England (NHSE) has published an update to the commercial framework for new medicines. In this article, Victoria Jordan, ABPI&#x2019;s Director of Value and Access Policy, reflects on what has been achieved and what must be prioritised as phase two of the consultation approaches.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/pgwagn03/doctor-patient-bedside-871x581-web75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eefc4ad0"/>
                </item>
                <item>
                    <title>Fixing NHS needs greater investment in medicines, says ABPI</title>
<link>https://www.abpi.org.uk/media/news/2024/october/fixing-nhs-needs-greater-investment-in-medicines-says-abpi/</link>                    <pubDate>Fri, 24 Jan 2025 10:35:12 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[#ValuingVaccines]]></category>
                            <category><![CDATA[NHS]]></category>
                            <category><![CDATA[NHS Commercial Framework for New Medicines]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/october/fixing-nhs-needs-greater-investment-in-medicines-says-abpi/</guid>
                    <description><![CDATA[As the Health Secretary kicks off a national conversation to shape the government&#x2019;s 10 plan to overhaul the NHS, the ABPI points to the vital role medicines and vaccines can play.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/jzhf4iso/clinical-medicine-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f0559940"/>
                </item>
                <item>
                    <title>Celebrating UK progress in tackling the global threat of antimicrobial resistance (AMR)</title>
<link>https://www.abpi.org.uk/media/blogs/2024/november/celebrating-uk-progress-in-tackling-the-global-threat-of-antimicrobial-resistance-amr/</link>                    <pubDate>Mon, 16 Dec 2024 11:27:11 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[AMR]]></category>
                            <category><![CDATA[Anti Microbial Resistance]]></category>
                            <category><![CDATA[Antibiotic resistance]]></category>
                            <category><![CDATA[Antibiotics]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2024/november/celebrating-uk-progress-in-tackling-the-global-threat-of-antimicrobial-resistance-amr/</guid>
                    <description><![CDATA[World Antimicrobial Awareness Week blog by Amit Aggarwal, ABPI Executive Director, Medical Affairs and Strategic Partnerships. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/brcd3tef/pexels-katarzyna-modrzejewska-6203349-small.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1da0cab8fd590d0"/>
                </item>
                <item>
                    <title>UK clinical trials performance improves but remains in intensive care</title>
<link>https://www.abpi.org.uk/media/news/2024/december/uk-clinical-trials-performance-improves-but-remains-in-intensive-care/</link>                    <pubDate>Tue, 10 Dec 2024 09:05:54 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/december/uk-clinical-trials-performance-improves-but-remains-in-intensive-care/</guid>
                    <description><![CDATA[A new report finds the UK&#x2019;s global rankings for industry clinical trial delivery are improving but further challenges must be overcome. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/at2lhehk/news-3-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d8b1a311387d50"/>
                </item>
                <item>
                    <title>Greater ambition is needed to improve patient access to innovative medicines</title>
<link>https://www.abpi.org.uk/media/blogs/2024/december/greater-ambition-is-needed-to-improve-patient-access-to-innovative-medicines/</link>                    <pubDate>Thu, 05 Dec 2024 10:30:26 GMT</pubDate>
                            <dc:creator><![CDATA[Paul Catchpole]]></dc:creator>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Advanced Therapy Medicinal Products (ATMPs)]]></category>
                            <category><![CDATA[ATMP]]></category>
                            <category><![CDATA[Health and Access to Medicines]]></category>
                            <category><![CDATA[NHS Commercial Framework for New Medicines]]></category>
                            <category><![CDATA[NICE]]></category>
                            <category><![CDATA[Value]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2024/december/greater-ambition-is-needed-to-improve-patient-access-to-innovative-medicines/</guid>
                    <description><![CDATA[The government is consulting on changes to the Commercial Framework for New Medicines and the Budget Impact Test threshold. In this article, Paul Catchpole, ABPI&#x2019;s Director of Value and Access Policy, sets out why this is important and what needs to change.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/00kl03qg/nursesl-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d9da41cdfdc4f0"/>
                </item>
                <item>
                    <title>Better health system partnerships can improve equality of access to innovative medicines</title>
<link>https://www.abpi.org.uk/media/news/2023/january/better-health-system-partnerships-can-improve-equality-of-access-to-innovative-medicines/</link>                    <pubDate>Mon, 02 Dec 2024 13:05:05 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Innovation]]></category>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Health and Access to Medicines]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/january/better-health-system-partnerships-can-improve-equality-of-access-to-innovative-medicines/</guid>
                    <description><![CDATA[ABPI NHS Confederation joint report: &#x2018;Transforming Lives, Improving Health Outcomes&#x2019;.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/5dwdgzm1/three-nurses-corridor-871x581.jpg?rxy=0.498014716843061,0.51805313599910607&amp;width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef81f590"/>
                </item>
                <item>
                    <title>ABPI welcomes the Innovation Ecosystem Programme Review</title>
<link>https://www.abpi.org.uk/media/news/2024/november/abpi-welcomes-the-innovation-ecosystem-programme-review/</link>                    <pubDate>Thu, 28 Nov 2024 10:02:53 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Innovation]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/november/abpi-welcomes-the-innovation-ecosystem-programme-review/</guid>
                    <description><![CDATA[NHS England has published the Innovation Ecosystem Programme Review, recommending a package of measures to help the UK lead the way in health innovation.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/tmebfpef/technicians-operators-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f001ace0"/>
                </item>
                <item>
                    <title>GSK&#x2019;s Bill Dawson appointed head of UK medicines manufacturing alliance</title>
<link>https://www.abpi.org.uk/media/news/2024/march/gsk-s-bill-dawson-appointed-head-of-uk-medicines-manufacturing-alliance/</link>                    <pubDate>Mon, 25 Nov 2024 10:35:29 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Manufacturing]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/march/gsk-s-bill-dawson-appointed-head-of-uk-medicines-manufacturing-alliance/</guid>
                    <description><![CDATA[Bill Dawson, Head of Biologics and Devices Manufacturing at GSK, has been appointed the new Chair of the MMIP, a body representing the voice of medicines manufacturing in the UK.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/nynmdbm5/bill_dawson_x_landscape.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1db81f80d134200"/>
                </item>
                <item>
                    <title>ABPI welcomes the appointment of new MHRA Chair</title>
<link>https://www.abpi.org.uk/media/news/2024/november/abpi-welcomes-the-appointment-of-new-mhra-chair/</link>                    <pubDate>Tue, 19 Nov 2024 17:20:43 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/november/abpi-welcomes-the-appointment-of-new-mhra-chair/</guid>
                    <description><![CDATA[Anthony Harnden has been appointed the new chair of the Medicine and Healthcare products Regulatory Agency. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/2jbpqqht/pharma-lab-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1db2c390bff4b80"/>
                </item>
                <item>
                    <title>NHS-industry partnerships can support the NHS to make the government&#x2019;s three big shifts</title>
<link>https://www.abpi.org.uk/media/blogs/2024/november/nhs-industry-partnerships-can-support-the-nhs-to-make-the-government-s-three-big-shifts/</link>                    <pubDate>Mon, 18 Nov 2024 11:55:28 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Partnership]]></category>
                            <category><![CDATA[NHS]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2024/november/nhs-industry-partnerships-can-support-the-nhs-to-make-the-government-s-three-big-shifts/</guid>
                    <description><![CDATA[the case for partnerships is stronger than ever, and sharing what works must be a crucial part of delivering the NHS 10-Year Plan. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/cm3l5qjx/pfizer-de-link.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d7dcb088651640"/>
                </item>
                <item>
                    <title>UK missing opportunity to unlock medicines for severe conditions</title>
<link>https://www.abpi.org.uk/media/news/2024/november/uk-missing-opportunity-to-unlock-medicines-for-severe-conditions/</link>                    <pubDate>Thu, 14 Nov 2024 13:51:39 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/november/uk-missing-opportunity-to-unlock-medicines-for-severe-conditions/</guid>
                    <description><![CDATA[A new report shows the public wants more support for patients with severe conditions and is prepared to value associated medicines more highly than the current levels used by NICE.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/pgwagn03/doctor-patient-bedside-871x581-web75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eefc4ad0"/>
                </item>
                <item>
                    <title>ABPI response to Sudlow review on the use of health data</title>
<link>https://www.abpi.org.uk/media/news/2024/october/abpi-response-to-sudlow-review-on-the-use-of-health-data/</link>                    <pubDate>Fri, 08 Nov 2024 15:37:37 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Health data]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/october/abpi-response-to-sudlow-review-on-the-use-of-health-data/</guid>
                    <description><![CDATA[An independent review has revealed that complexities and inefficiencies within the UK&#x2019;s health data infrastructure are hindering the effective use of health data resources critical for improving people&#x2019;s health]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/jgrn2v23/data-woman-explain-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef712cb0"/>
                </item>
                <item>
                    <title>Partnerships build trust between industry and healthcare professionals</title>
<link>https://www.abpi.org.uk/media/news/2024/october/partnerships-build-trust-between-industry-and-healthcare-professionals/</link>                    <pubDate>Mon, 21 Oct 2024 10:46:28 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/october/partnerships-build-trust-between-industry-and-healthcare-professionals/</guid>
                    <description><![CDATA[New polling data shows that healthcare professionals&#x27; trust in the pharmaceutical industry increases the more familiar they are with it.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/5ugnkl24/medical-information-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52efcedd10"/>
                </item>
                <item>
                    <title>MPs and peers urge Chancellor to support the life sciences in Budget</title>
<link>https://www.abpi.org.uk/media/news/2024/october/mps-and-peers-urge-chancellor-to-support-the-life-sciences-in-budget/</link>                    <pubDate>Fri, 18 Oct 2024 10:17:26 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/october/mps-and-peers-urge-chancellor-to-support-the-life-sciences-in-budget/</guid>
                    <description><![CDATA[A new group of MPs and peers have written to the Chancellor urging her to protect and promote the UK&#x2019;s world-leading life sciences sector in the government&#x27;s first Budget.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/l5lb4t5p/mps-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d9da41cdd52e50"/>
                </item>
                <item>
                    <title>World Teachers Day: Celebrating the heart of education</title>
<link>https://www.abpi.org.uk/media/blogs/2024/october/world-teachers-day-celebrating-the-heart-of-education/</link>                    <pubDate>Fri, 04 Oct 2024 23:01:48 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2024/october/world-teachers-day-celebrating-the-heart-of-education/</guid>
                    <description><![CDATA[Blog post by Andrew Croydon, ABPI Director, Education and Examination Policy]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/sh2bfzpz/teacher.png?width=240&amp;height=135&amp;quality=90&amp;v=1d7e2243b77dc90"/>
                </item>
                <item>
                    <title>The first six months of the 2024 Voluntary Scheme</title>
<link>https://www.abpi.org.uk/media/blogs/2024/october/the-first-six-months-of-the-2024-voluntary-scheme/</link>                    <pubDate>Fri, 04 Oct 2024 13:24:35 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2024/october/the-first-six-months-of-the-2024-voluntary-scheme/</guid>
                    <description><![CDATA[The newly agreed 2024 voluntary scheme for branded medicines pricing, access, and growth (VPAG) came into force at the beginning of January this year. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/jgrn2v23/data-woman-explain-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef712cb0"/>
                </item>
                <item>
                    <title>ABPI response to United Nations General Assembly political declaration on&#xA0;antimicrobial resistance</title>
<link>https://www.abpi.org.uk/media/news/2024/september/abpi-response-to-united-nations-general-assembly-political-declaration-on-antimicrobial-resistance/</link>                    <pubDate>Fri, 27 Sep 2024 15:22:03 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/september/abpi-response-to-united-nations-general-assembly-political-declaration-on-antimicrobial-resistance/</guid>
                    <description><![CDATA[World leaders came together for the High-level Meeting on antimicrobial resistance (AMR) during the 79th session of the United Nations General Assembly. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/wkjiyyde/msd-rd_web-460.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1daa83670908230"/>
                </item>
                <item>
                    <title>Understanding medicines access: a look at the severity modifier and its impact</title>
<link>https://www.abpi.org.uk/media/blogs/2024/august/understanding-medicines-access-a-look-at-the-severity-modifier-and-its-impact/</link>                    <pubDate>Wed, 25 Sep 2024 17:06:13 GMT</pubDate>
                            <dc:creator><![CDATA[Orban Holdgate]]></dc:creator>
                            <category><![CDATA[NICE]]></category>
                            <category><![CDATA[NICE Methods Review]]></category>
                            <category><![CDATA[Severity modifier]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2024/august/understanding-medicines-access-a-look-at-the-severity-modifier-and-its-impact/</guid>
                    <description><![CDATA[In recent years, NICE has introduced a new way of deciding how much value to assign to some treatments, which is called the severity modifier. But what exactly is the severity modifier, and why is it important?]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/pgwagn03/doctor-patient-bedside-871x581-web75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eefc4ad0"/>
                </item>
                <item>
                    <title>Government must free NICE to unlock access to medicines for severe conditions</title>
<link>https://www.abpi.org.uk/media/news/2024/september/government-must-free-nice-to-unlock-access-to-medicines-for-severe-conditions/</link>                    <pubDate>Wed, 25 Sep 2024 17:05:27 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                            <category><![CDATA[NICE]]></category>
                            <category><![CDATA[NICE Methods Review]]></category>
                            <category><![CDATA[Health and Access to Medicines]]></category>
                            <category><![CDATA[NHS Commercial Framework for New Medicines]]></category>
                            <category><![CDATA[Severity modifier]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/september/government-must-free-nice-to-unlock-access-to-medicines-for-severe-conditions/</guid>
                    <description><![CDATA[The board of NICE has today decided not to change how it values medicines for those with severe health conditions, meaning some patients will continue to miss out on treatments that would have been approved under a previous system.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/awfgfsmy/doctor-lung-580x405-web60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee9aa2d0"/>
                </item>
                <item>
                    <title>PM says life sciences is a key partner to fixing the NHS</title>
<link>https://www.abpi.org.uk/media/news/2024/september/pm-says-life-sciences-is-a-key-partner-to-fixing-the-nhs/</link>                    <pubDate>Thu, 12 Sep 2024 11:55:08 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[NHS]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/september/pm-says-life-sciences-is-a-key-partner-to-fixing-the-nhs/</guid>
                    <description><![CDATA[The Prime Minister has committed to putting the full weight of the British government behind life sciences as part of his plan to fix the NHS.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/dkmh2k31/microscope-laptop-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eec7cd50"/>
                </item>
                <item>
                    <title>ABPI response to the Darzi Review: innovation must be at the heart of improvement</title>
<link>https://www.abpi.org.uk/media/news/2024/september/abpi-response-to-the-darzi-review-innovation-must-be-at-the-heart-of-improvement/</link>                    <pubDate>Wed, 11 Sep 2024 21:55:22 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[NHS]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/september/abpi-response-to-the-darzi-review-innovation-must-be-at-the-heart-of-improvement/</guid>
                    <description><![CDATA[The innovative pharmaceutical industry is ready to be an active partner in helping to fix the broken NHS. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/pnafsqgg/doctor-patient-detail-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eee25a30"/>
                </item>
                <item>
                    <title>Russell Abberley, Amgen UK &amp; Ireland, steps up as Acting ABPI President</title>
<link>https://www.abpi.org.uk/media/news/2024/september/russell-abberley-amgen-uk-ireland-steps-up-as-acting-abpi-president/</link>                    <pubDate>Thu, 05 Sep 2024 08:37:10 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/september/russell-abberley-amgen-uk-ireland-steps-up-as-acting-abpi-president/</guid>
                    <description><![CDATA[Former ABPI Vice-President takes up President role on an interim basis ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/a4aovsx3/russell_abberley_actingabpi_president.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1db81eee3a3e450"/>
                </item>
                <item>
                    <title>UK must get ready for new cell and gene therapies, says ABPI</title>
<link>https://www.abpi.org.uk/media/news/2024/august/uk-must-get-ready-for-new-cell-and-gene-therapies-says-abpi/</link>                    <pubDate>Sun, 18 Aug 2024 23:07:49 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[ATMP]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/august/uk-must-get-ready-for-new-cell-and-gene-therapies-says-abpi/</guid>
                    <description><![CDATA[The NHS got off to a good start with the introduction of cell and gene therapies but must do more to prepare for future advanced therapies.  ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/jcgofh1n/women-scientist-microscope-871x581-webp75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef19bde0"/>
                </item>
                <item>
                    <title>A-Level students urged to consider pharmaceutical careers</title>
<link>https://www.abpi.org.uk/media/news/2024/august/a-level-students-urged-to-consider-pharmaceutical-careers/</link>                    <pubDate>Thu, 15 Aug 2024 13:42:40 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/august/a-level-students-urged-to-consider-pharmaceutical-careers/</guid>
                    <description><![CDATA[]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/zvpilozj/adobestock_536708880.jpeg?width=240&amp;height=135&amp;quality=90&amp;v=1daef1669a41190"/>
                </item>
                <item>
                    <title>ABPI response to the government&#x27;s commitment to boost research by improving access to NHS data</title>
<link>https://www.abpi.org.uk/media/news/2024/july/abpi-response-to-the-governments-commitment-to-boost-research-by-improving-access-to-nhs-data/</link>                    <pubDate>Mon, 29 Jul 2024 12:46:34 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/july/abpi-response-to-the-governments-commitment-to-boost-research-by-improving-access-to-nhs-data/</guid>
                    <description><![CDATA[Government Ministers want to boost research by making it easier for companies to access NHS data.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/5l2beqty/event-930x930-doctor-older-patient-webp75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee8ee300"/>
                </item>
                <item>
                    <title>ABPI respond to the government&#x27;s Skills England announcement</title>
<link>https://www.abpi.org.uk/media/news/2024/july/abpi-respond-to-the-governments-skills-england-announcement/</link>                    <pubDate>Mon, 22 Jul 2024 16:33:17 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/july/abpi-respond-to-the-governments-skills-england-announcement/</guid>
                    <description><![CDATA[The Prime Minister and Education Secretary have announced the launch of Skills England to bring together the fractured skills landscape and create a shared national ambition to boost the nation&#x2019;s skills.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ra2leyup/scientists-lab-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c9812ef1ef0"/>
                </item>
                <item>
                    <title>New research shows why Gen-Z is choosing to work in pharma</title>
<link>https://www.abpi.org.uk/media/news/2024/july/new-research-shows-why-gen-z-is-choosing-to-work-in-pharma/</link>                    <pubDate>Mon, 15 Jul 2024 21:30:02 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/july/new-research-shows-why-gen-z-is-choosing-to-work-in-pharma/</guid>
                    <description><![CDATA[Younger workers are increasingly choosing careers in pharmaceuticals over other leading industries like technology or finance due to perceptions of better work life balance and social purpose in the sector.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/qzjezulo/adobestock_462197775.jpeg?rxy=0.4968108190187081,0.32150126834211973&amp;width=240&amp;height=135&amp;quality=90&amp;v=1db68c283dd63b0"/>
                </item>
                <item>
                    <title>New data shows UK life sciences failing to reach its potential</title>
<link>https://www.abpi.org.uk/media/news/2024/july/new-data-shows-uk-life-sciences-failing-to-reach-its-potential/</link>                    <pubDate>Thu, 11 Jul 2024 12:09:52 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/july/new-data-shows-uk-life-sciences-failing-to-reach-its-potential/</guid>
                    <description><![CDATA[New data on the &#x2018;Life sciences competitiveness indicators 2024&#x2019;, published by the government&#x2019;s Office for Life Sciences.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/riwf5xcq/quality-control-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eff577e0"/>
                </item>
                <item>
                    <title>ABPI respond to Wes Streeting&#x2019;s commitment to boosting the economy through the life sciences sector</title>
<link>https://www.abpi.org.uk/media/news/2024/july/abpi-respond-to-wes-streeting-s-commitment-to-boosting-the-economy-through-the-life-sciences-sector/</link>                    <pubDate>Tue, 09 Jul 2024 14:02:09 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/july/abpi-respond-to-wes-streeting-s-commitment-to-boosting-the-economy-through-the-life-sciences-sector/</guid>
                    <description><![CDATA[Wes Streeting commits to boosting the economy through the life sciences sector]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/iogneyoy/image-12.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1dad20842a8a1d0"/>
                </item>
                <item>
                    <title>Election must deliver a win for UK life science, say ABPI</title>
<link>https://www.abpi.org.uk/media/news/2024/june/election-must-deliver-a-win-for-uk-life-science-say-abpi/</link>                    <pubDate>Fri, 05 Jul 2024 14:58:46 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Politics]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/june/election-must-deliver-a-win-for-uk-life-science-say-abpi/</guid>
                    <description><![CDATA[The ABPI has issued a challenge to all political parties to set out in detail how they will unlock the industry&#x2019;s potential to drive UK heath and economic growth.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/l5lb4t5p/mps-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d9da41cdd52e50"/>
                </item>
                <item>
                    <title>ABPI cheers new gene therapy for IMF and innovative payment first</title>
<link>https://www.abpi.org.uk/media/news/2024/june/abpi-cheers-new-gene-therapy-for-imf-and-innovative-payment-first/</link>                    <pubDate>Thu, 27 Jun 2024 16:03:04 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Health and Access to Medicines]]></category>
                            <category><![CDATA[NHS Commercial Framework for New Medicines]]></category>
                            <category><![CDATA[NICE]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Value]]></category>
                            <category><![CDATA[Innovative Medicines Fund (IMF)]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/june/abpi-cheers-new-gene-therapy-for-imf-and-innovative-payment-first/</guid>
                    <description><![CDATA[The ABPI has welcomed the first gene therapy to be granted managed access through the Innovative Medicines Fund (IMF), alongside an agreement for an innovative payment model.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/m2zhbrml/fingers-vial-blue-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef6c23a0"/>
                </item>
                <item>
                    <title>UK life science inward investment in freefall</title>
<link>https://www.abpi.org.uk/media/news/2023/july/uk-life-science-inward-investment-in-freefall/</link>                    <pubDate>Thu, 06 Jun 2024 16:48:22 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Economy and Industry]]></category>
                            <category><![CDATA[Life Sciences]]></category>
                            <category><![CDATA[Statistics]]></category>
                            <category><![CDATA[Trade]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/july/uk-life-science-inward-investment-in-freefall/</guid>
                    <description><![CDATA[International investors are abandoning UK life sciences as excessive revenue clawback rates start to bite, according to the latest Life Sciences Competitiveness Indicators published by the government. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/gzkduqfi/chemical-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f00d6cb0"/>
                </item>
                <item>
                    <title>Landmark medicines deal to boost nation&#x2019;s health, save NHS &#xA3;14 billion, and support research investment</title>
<link>https://www.abpi.org.uk/media/news/2023/november/landmark-medicines-deal-to-boost-nation-s-health-save-nhs-14-billion-and-support-research-investment/</link>                    <pubDate>Thu, 23 May 2024 14:22:35 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                            <category><![CDATA[Statutory Scheme]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Access]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/november/landmark-medicines-deal-to-boost-nation-s-health-save-nhs-14-billion-and-support-research-investment/</guid>
                    <description><![CDATA[A landmark deal has been agreed that is set to save the NHS &#xA3;14 billion over five years in medicines costs, enable patients to access the latest lifesaving treatments more consistently, and boost the UK&#x2019;s position as a global superpower in advanced healthcare, technology, and clinical research.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/nncpaw0e/pharmacist-medicines-shelves-580x405-1-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eec13da0"/>
                </item>
                <item>
                    <title>Familiarity and trust: Why it matters to industry reputation and what we can we do about it</title>
<link>https://www.abpi.org.uk/media/blogs/2024/march/familiarity-and-trust-why-it-matters-to-industry-reputation-and-what-we-can-we-do-about-it/</link>                    <pubDate>Thu, 23 May 2024 14:03:10 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Reputation]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2024/march/familiarity-and-trust-why-it-matters-to-industry-reputation-and-what-we-can-we-do-about-it/</guid>
                    <description><![CDATA[Jill Pearcy, the ABPI&#x27;s Director of reputation at the ABPI, talks about why familiarity and trust matters to the pharmaceutical industry. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ra2leyup/scientists-lab-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c9812ef1ef0"/>
                </item>
                <item>
                    <title>AMR: the silent undercurrent of modern medicine</title>
<link>https://www.abpi.org.uk/media/blogs/2024/may/amr-the-silent-undercurrent-of-modern-medicine/</link>                    <pubDate>Thu, 23 May 2024 11:22:21 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[AMR]]></category>
                            <category><![CDATA[Antibiotic resistance]]></category>
                            <category><![CDATA[Anti Microbial Resistance]]></category>
                            <category><![CDATA[Antibiotics]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2024/may/amr-the-silent-undercurrent-of-modern-medicine/</guid>
                    <description><![CDATA[A blog post from Dr Ron Daniels BEM, Executive Director, UK Sepsis Trust ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/wkjiyyde/msd-rd_web-460.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1daa83670908230"/>
                </item>
                <item>
                    <title>How to make sure patients get faster and fairer access to new medicines</title>
<link>https://www.abpi.org.uk/media/news/2024/february/how-to-make-sure-patients-get-faster-and-fairer-access-to-new-medicines/</link>                    <pubDate>Thu, 23 May 2024 11:19:09 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/february/how-to-make-sure-patients-get-faster-and-fairer-access-to-new-medicines/</guid>
                    <description><![CDATA[In a new report, the ABPI&#x27;s Patient Advisory Council says that UK governments and NHS leaders need to start with a holistic view of patient need and improve fair access to the latest medical advances. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/00kl03qg/nursesl-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d9da41cdfdc4f0"/>
                </item>
                <item>
                    <title>Russell Abberley, Amgen UK &amp; Ireland, named as new ABPI Vice President</title>
<link>https://www.abpi.org.uk/media/news/2024/may/russell-abberley-amgen-uk-ireland-named-as-new-abpi-vice-president/</link>                    <pubDate>Thu, 23 May 2024 10:47:07 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/may/russell-abberley-amgen-uk-ireland-named-as-new-abpi-vice-president/</guid>
                    <description><![CDATA[The Association of the British Pharmaceutical Industry (ABPI) has appointed Russell Abberley as Vice-President of the ABPI.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ii3hmig4/russell-abberley-871x571.jpg?rxy=0.6185482532218503,0.042853660146984884&amp;width=240&amp;height=135&amp;quality=90&amp;v=1dac19a6ea03b50"/>
                </item>
                <item>
                    <title>ABPI response to Labour pledges</title>
<link>https://www.abpi.org.uk/media/news/2024/may/abpi-response-to-labour-pledges/</link>                    <pubDate>Wed, 22 May 2024 21:46:11 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Partnership]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/may/abpi-response-to-labour-pledges/</guid>
                    <description><![CDATA[This morning Sir Keir Starmer made a speech setting out his pledges if Labour wins the next election, including on health and the economy.  ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/klidc23t/women-eye-chart-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef27eeb0"/>
                </item>
                <item>
                    <title>Embracing innovation can improve care and ease NHS pressures</title>
<link>https://www.abpi.org.uk/media/news/2024/april/embracing-innovation-can-improve-care-and-ease-nhs-pressures/</link>                    <pubDate>Wed, 22 May 2024 21:37:14 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Partnership]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/april/embracing-innovation-can-improve-care-and-ease-nhs-pressures/</guid>
                    <description><![CDATA[Creating a culture of innovation can improve care and tackle some of the pressures faced by healthcare professionals, according to a new joint report from NHS leaders, charity CEOs and the pharmaceutical industry.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/awfgfsmy/doctor-lung-580x405-web60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee9aa2d0"/>
                </item>
                <item>
                    <title>2024 Voluntary Scheme agreement published</title>
<link>https://www.abpi.org.uk/media/news/2023/december/2024-voluntary-scheme-agreement-published/</link>                    <pubDate>Wed, 22 May 2024 17:45:10 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                            <category><![CDATA[Statutory Scheme]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Access]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/december/2024-voluntary-scheme-agreement-published/</guid>
                    <description><![CDATA[The full text of the 2024 voluntary scheme for branded medicines pricing, access and growth (VPAG) has been published by the Department of Health and Social Care (DHSC).]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/xeom40nk/event-930x930-hands-planning-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee7a97b0"/>
                </item>
                <item>
                    <title>ABPI respond to proposals to change the Statutory Scheme</title>
<link>https://www.abpi.org.uk/media/news/2024/may/abpi-respond-to-proposals-to-change-the-statutory-scheme/</link>                    <pubDate>Wed, 22 May 2024 17:37:04 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Statutory Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Access]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/may/abpi-respond-to-proposals-to-change-the-statutory-scheme/</guid>
                    <description><![CDATA[The Association of the British Pharmaceutical Industry (ABPI) has published an executive summary of its consultation response to the government&#x27;s proposed changes to the Statutory Scheme for branded medicines.&#xA;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/xeom40nk/event-930x930-hands-planning-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee7a97b0"/>
                </item>
                <item>
                    <title>Pharmaceutical companies commit to new principles on using NHS data for research</title>
<link>https://www.abpi.org.uk/media/news/2022/july/pharmaceutical-companies-commit-to-new-principles-on-using-nhs-data-for-research/</link>                    <pubDate>Tue, 21 May 2024 11:07:10 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Health data]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/july/pharmaceutical-companies-commit-to-new-principles-on-using-nhs-data-for-research/</guid>
                    <description><![CDATA[Pharmaceutical companies today committed to following a new set of principles for use of NHS data which pledge the highest levels of transparency and sharing of insights to improve care.  ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/oxon3vgh/three-scientists-sitting-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef20e9d0"/>
                </item>
                <item>
                    <title>By coming together, we can overcome antimicrobial resistance</title>
<link>https://www.abpi.org.uk/media/blogs/2022/november/by-coming-together-we-can-overcome-antimicrobial-resistance/</link>                    <pubDate>Mon, 20 May 2024 15:56:42 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[AMR]]></category>
                            <category><![CDATA[Antibiotics]]></category>
                            <category><![CDATA[Antibiotic resistance]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2022/november/by-coming-together-we-can-overcome-antimicrobial-resistance/</guid>
                    <description><![CDATA[Reflections on World Antimicrobial Awareness Week 2022 from Dr Amit Aggarwal, ABPI Executive Director, Medical Affairs.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/e5pdepux/events-930x930-mug-laptop.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee893db0"/>
                </item>
                <item>
                    <title>ABPI welcomes appointment of Madelaine McTernan as Head of HRT Taskforce</title>
<link>https://www.abpi.org.uk/media/news/2022/april/abpi-welcomes-appointment-of-madelaine-mcternan-as-head-of-hrt-taskforce/</link>                    <pubDate>Tue, 07 May 2024 15:04:02 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Supply]]></category>
                            <category><![CDATA[ABPI news]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/april/abpi-welcomes-appointment-of-madelaine-mcternan-as-head-of-hrt-taskforce/</guid>
                    <description><![CDATA[It&#x27;s important that women who need HRT can get the medicines they need]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/nncpaw0e/pharmacist-medicines-shelves-580x405-1-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eec13da0"/>
                </item>
                <item>
                    <title>WTO Ministerial Conference in Abu Dhabi an opportunity to strengthen trade and health agenda</title>
<link>https://www.abpi.org.uk/media/news/2024/february/wto-ministerial-conference-in-abu-dhabi-an-opportunity-to-strengthen-trade-and-health-agenda/</link>                    <pubDate>Thu, 02 May 2024 14:56:58 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[International]]></category>
                            <category><![CDATA[Intellectual Property]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/february/wto-ministerial-conference-in-abu-dhabi-an-opportunity-to-strengthen-trade-and-health-agenda/</guid>
                    <description><![CDATA[Joint industry associations statement on the meeting of global trade ministers at the World Trade Organization&#x2019;s 13th Ministerial Conference in Abu Dhabi (MC13).]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/r5gpft2r/wto-hq.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1da6640f2b0e3f0"/>
                </item>
                <item>
                    <title>Reinventing Reputation: one of pharma&#x27;s biggest challenges</title>
<link>https://www.abpi.org.uk/media/blogs/2024/january/reinventing-reputation-one-of-pharmas-biggest-challenges/</link>                    <pubDate>Thu, 02 May 2024 11:42:19 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Reputation]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2024/january/reinventing-reputation-one-of-pharmas-biggest-challenges/</guid>
                    <description><![CDATA[Blog post by Seyda Atadan Memis, Takeda General Manager UK &amp; Ireland and ABPI Reputation Board Sponsor]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/fllbhtqp/239_cm307191_abpi-reputation-event.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1da4d4bb5121cc0"/>
                </item>
                <item>
                    <title>ABPI Conference 2023: Chief Executive speech</title>
<link>https://www.abpi.org.uk/media/news/2023/april/abpi-conference-2023-chief-executive-speech/</link>                    <pubDate>Fri, 26 Apr 2024 09:55:15 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/april/abpi-conference-2023-chief-executive-speech/</guid>
                    <description><![CDATA[ABPI Chief Executive Richard Torbett opened the ABPI&#x27;s Annual Conference 2023.&#xA0;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/w2fdbqus/richard_lectern.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d979c93bcfc5c0"/>
                </item>
                <item>
                    <title>Reflections from the Patient Advisory Council</title>
<link>https://www.abpi.org.uk/media/blogs/2023/may/reflections-from-the-patient-advisory-council/</link>                    <pubDate>Fri, 26 Apr 2024 09:54:02 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2023/may/reflections-from-the-patient-advisory-council/</guid>
                    <description><![CDATA[Emily Reuben, CEO and co-founder of Duchenne UK and member of the ABPI&#x2019;s Patient Advisory Council from September 2021 to March 2023, reflects on her time as part of the Council.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/qwcbfmc1/956309985a8d5799ce6624a1b23c8b117910b4b3.jpg?rxy=0.52055136800899515,0.18743282754157467&amp;width=240&amp;height=135&amp;quality=90&amp;v=1d97dad56e56a30"/>
                </item>
                <item>
                    <title>Susan Rienow of Pfizer confirmed as President of the ABPI</title>
<link>https://www.abpi.org.uk/media/news/2023/march/susan-rienow-of-pfizer-confirmed-as-president-of-the-abpi/</link>                    <pubDate>Fri, 26 Apr 2024 09:48:45 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/march/susan-rienow-of-pfizer-confirmed-as-president-of-the-abpi/</guid>
                    <description><![CDATA[The ABPI Board has confirmed that Susan Rienow, UK Country President of Pfizer, will be the next President of the Association of the British Pharmaceutical Industry (ABPI). ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/5prlue4c/sr_twitter.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d8c8ec06b32370"/>
                </item>
                <item>
                    <title>ABPI welcomes Labour&#x27;s life sciences plan</title>
<link>https://www.abpi.org.uk/media/news/2024/january/abpi-welcomes-labours-life-sciences-plan/</link>                    <pubDate>Mon, 22 Apr 2024 10:15:37 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Research and Development]]></category>
                            <category><![CDATA[Clinical research]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/january/abpi-welcomes-labours-life-sciences-plan/</guid>
                    <description><![CDATA[The Labour party has today published its plan for life sciences, aimed at transforming how medical treatments are discovered and delivered.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/fh4edk5k/events-930x930-production-worker-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee9376e0"/>
                </item>
                <item>
                    <title>ABPI welcomes ambitious NHS vaccination strategy</title>
<link>https://www.abpi.org.uk/media/news/2023/december/abpi-welcomes-ambitious-nhs-vaccination-strategy/</link>                    <pubDate>Sun, 03 Mar 2024 22:41:36 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Vaccines]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/december/abpi-welcomes-ambitious-nhs-vaccination-strategy/</guid>
                    <description><![CDATA[NHS England has today published its vaccination strategy, setting out how it will increase national uptake of vaccinations to protect people against a range of diseases. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/r5gfhzmm/doctor-vaccine-arm-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eeb38200"/>
                </item>
                <item>
                    <title>ABPI statement on brain tumour research</title>
<link>https://www.abpi.org.uk/media/news/2024/february/abpi-statement-on-brain-tumour-research/</link>                    <pubDate>Mon, 19 Feb 2024 18:48:56 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Clinical research]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/february/abpi-statement-on-brain-tumour-research/</guid>
                    <description><![CDATA[The ABPI has responded to recent concerns from a charity that pharmaceutical companies are holding up brain tumour research. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/dkmh2k31/microscope-laptop-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eec7cd50"/>
                </item>
                <item>
                    <title>The ABPI sets out its plan for investment, health and growth</title>
<link>https://www.abpi.org.uk/media/news/2024/february/the-abpi-sets-out-its-plan-for-investment-health-and-growth/</link>                    <pubDate>Thu, 01 Feb 2024 10:12:12 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[ABPI Manifesto]]></category>
                            <category><![CDATA[ABPI Manifesto (1)]]></category>
                            <category><![CDATA[ABPI news]]></category>
                            <category><![CDATA[Economy and Industry]]></category>
                            <category><![CDATA[Life Sciences]]></category>
                            <category><![CDATA[Manufacturing]]></category>
                            <category><![CDATA[Politics]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/february/the-abpi-sets-out-its-plan-for-investment-health-and-growth/</guid>
                    <description><![CDATA[The Association of the British Pharmaceutical Industry (ABPI) has published a manifesto outlining what a new government must do to make the UK the best place in the world to research, develop and use the medicines and vaccines of the future.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/fwnbt4ua/lab-working-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c98f516a0f0"/>
                </item>
                <item>
                    <title>Leaving no one behind: The current measles outbreak demonstrates the importance of the NHS vaccination strategy</title>
<link>https://www.abpi.org.uk/media/blogs/2024/january/leaving-no-one-behind-the-current-measles-outbreak-demonstrates-the-importance-of-the-nhs-vaccination-strategy/</link>                    <pubDate>Mon, 29 Jan 2024 10:04:52 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Vaccines]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2024/january/leaving-no-one-behind-the-current-measles-outbreak-demonstrates-the-importance-of-the-nhs-vaccination-strategy/</guid>
                    <description><![CDATA[Vaccination is the best line of defence against disease outbreaks. The NHS vaccination strategy will make it easier for people to be protected in the future, says ABPI Medical Director Dr Amit Aggarwal.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/zlzjua4o/injection-arm-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef05e7c0"/>
                </item>
                <item>
                    <title>Latest economic data underlines risk of disincentivising UK life sciences growth</title>
<link>https://www.abpi.org.uk/media/news/2023/december/latest-economic-data-underlines-risk-of-disincentivising-uk-life-sciences-growth/</link>                    <pubDate>Thu, 07 Dec 2023 14:15:51 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Economy and Industry]]></category>
                            <category><![CDATA[Innovation]]></category>
                            <category><![CDATA[Life Sciences]]></category>
                            <category><![CDATA[Manufacturing]]></category>
                            <category><![CDATA[Research and Development]]></category>
                            <category><![CDATA[Science and innovation]]></category>
                            <category><![CDATA[Statistics]]></category>
                            <category><![CDATA[Statutory Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/december/latest-economic-data-underlines-risk-of-disincentivising-uk-life-sciences-growth/</guid>
                    <description><![CDATA[The government has published the latest economic data for UK&#x2019;s life sciences sector for the year 2021/22 showing strong growth in both jobs and sector turnover across the years of the Covid-19 pandemic. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/kqja3axa/female-tubes-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eea8d3a0"/>
                </item>
                <item>
                    <title>Government sends mixed message to global life science investors</title>
<link>https://www.abpi.org.uk/media/news/2023/december/government-sends-mixed-message-to-global-life-science-investors/</link>                    <pubDate>Thu, 07 Dec 2023 10:17:51 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Statutory Scheme]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/december/government-sends-mixed-message-to-global-life-science-investors/</guid>
                    <description><![CDATA[The government has published new terms for the Statutory Scheme for branded medicines, maintaining sales rebates at levels which have damaged the UK&#x2019;s international standing with global life science companies.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ujpcz05h/records-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f0369f90"/>
                </item>
                <item>
                    <title>What the pandemic taught us about international trade rules for health - and how we can make them better for the future</title>
<link>https://www.abpi.org.uk/media/blogs/2023/december/what-the-pandemic-taught-us-about-international-trade-rules-for-health-and-how-we-can-make-them-better-for-the-future/</link>                    <pubDate>Wed, 06 Dec 2023 12:13:59 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Intellectual Property]]></category>
                            <category><![CDATA[Trade]]></category>
                            <category><![CDATA[International]]></category>
                            <category><![CDATA[WTO]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2023/december/what-the-pandemic-taught-us-about-international-trade-rules-for-health-and-how-we-can-make-them-better-for-the-future/</guid>
                    <description><![CDATA[Blog post by Ben Lucas, Managing Director, MSD UK &amp; Ireland and ABPI Board Sponsor, International and Intellectual Property Policy&#xA;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/dbhj0cp5/pexels-tom-fisk-3063470.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1da27881f8f4710"/>
                </item>
                <item>
                    <title>What a new UK-Swiss trade deal would mean for life sciences</title>
<link>https://www.abpi.org.uk/media/blogs/2023/may/what-a-new-uk-swiss-trade-deal-would-mean-for-life-sciences/</link>                    <pubDate>Wed, 06 Dec 2023 12:02:00 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[WTO]]></category>
                            <category><![CDATA[International]]></category>
                            <category><![CDATA[Free Trade Agreements]]></category>
                            <category><![CDATA[Trade]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2023/may/what-a-new-uk-swiss-trade-deal-would-mean-for-life-sciences/</guid>
                    <description><![CDATA[Blog post from Claire Machin, Executive Director, International Policy at the ABPI ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/uashznt5/hands-agreement-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eed19150"/>
                </item>
                <item>
                    <title>ABPI response to UK Biobank whole genome sequencing dataset</title>
<link>https://www.abpi.org.uk/media/news/2023/november/abpi-response-to-uk-biobank-whole-genome-sequencing-dataset/</link>                    <pubDate>Thu, 30 Nov 2023 11:56:30 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Genomics]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/november/abpi-response-to-uk-biobank-whole-genome-sequencing-dataset/</guid>
                    <description><![CDATA[The UK Biobank has revealed a new data from whole genome sequencing from half a million participants. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/0rgly2lq/dna-structure-and-sequence.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d7e2a298145e50"/>
                </item>
                <item>
                    <title>Life sciences leaders unite to condemn radical plans to rewrite medicines scheme</title>
<link>https://www.abpi.org.uk/media/news/2023/october/life-sciences-leaders-unite-to-condemn-radical-plans-to-rewrite-medicines-scheme/</link>                    <pubDate>Wed, 29 Nov 2023 10:09:22 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                            <category><![CDATA[Statutory Scheme]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Access]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/october/life-sciences-leaders-unite-to-condemn-radical-plans-to-rewrite-medicines-scheme/</guid>
                    <description><![CDATA[Over twenty industry leaders from companies supplying the NHS with essential medicines warn that radical plans to change the Statutory Scheme for branded medicines are unworkable. If implemented, the industry believes the measures will be highly damaging to UK life sciences and NHS patients&#x2019; access to medicines.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/h1jjhrca/pharmacists-medical-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f084e6a0"/>
                </item>
                <item>
                    <title>At risk: NHS access to new medicines, investment and research</title>
<link>https://www.abpi.org.uk/media/news/2023/september/at-risk-nhs-access-to-new-medicines-investment-and-research/</link>                    <pubDate>Wed, 29 Nov 2023 09:30:29 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                            <category><![CDATA[Statutory Scheme]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Access]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/september/at-risk-nhs-access-to-new-medicines-investment-and-research/</guid>
                    <description><![CDATA[Proposed changes to the Statutory Scheme for branded medicines will likely deter investment in developing, researching and launching new medicines in the UK, limiting patients&#x2019; access to treatment and clinical trials, according to new analysis.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ksbmf5m1/plans2-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d9da41ce298fe0"/>
                </item>
                <item>
                    <title>ABPI comment on Government&#x27;s full response to the O&#x27;Shaughnessy Review</title>
<link>https://www.abpi.org.uk/media/news/2023/november/abpi-comment-on-governments-full-response-to-the-oshaughnessy-review/</link>                    <pubDate>Wed, 22 Nov 2023 16:14:21 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Clinical research]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/november/abpi-comment-on-governments-full-response-to-the-oshaughnessy-review/</guid>
                    <description><![CDATA[The ABPI has commented on the Government&#x27;s full response to the O&#x27;Shaughnessy Review.&#xA0;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ogojni0v/research-team-580x405.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eea6d7d0"/>
                </item>
                <item>
                    <title>ABPI response to Autumn Statement 2023</title>
<link>https://www.abpi.org.uk/media/news/2023/november/abpi-response-to-autumn-statement-2023/</link>                    <pubDate>Wed, 22 Nov 2023 14:44:36 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Research and Development]]></category>
                            <category><![CDATA[Manufacturing]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/november/abpi-response-to-autumn-statement-2023/</guid>
                    <description><![CDATA[The ABPI has welcomed measures in Chancellor Jeremy Hunt&#x2019;s Autumn Statement to boost life sciences, including on manufacturing, clinical research and the fiscal environment.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/0c5mrene/autumn-statement_pic.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1db81f85f3457e0"/>
                </item>
                <item>
                    <title>UK competition authority unlocks the door to more transformative combination therapies</title>
<link>https://www.abpi.org.uk/media/news/2023/november/uk-competition-authority-unlocks-the-door-to-more-transformative-combination-therapies/</link>                    <pubDate>Fri, 17 Nov 2023 10:06:24 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Value]]></category>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Health and Access to Medicines]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/november/uk-competition-authority-unlocks-the-door-to-more-transformative-combination-therapies/</guid>
                    <description><![CDATA[In a world first, the UK Competition and Markets Authority (CMA) has released a statement which will support pharmaceutical companies working together on access to clinically important combination therapies.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/1vmpcc04/abpi-blister-pack-carbon-footprint-tool-930x930.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d81f3a6157ae10"/>
                </item>
                <item>
                    <title>UK industry clinical trial performance shows signs of improvement, says ABPI report</title>
<link>https://www.abpi.org.uk/media/news/2023/november/uk-industry-clinical-trial-performance-shows-signs-of-improvement-says-abpi-report/</link>                    <pubDate>Fri, 17 Nov 2023 00:01:24 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Clinical research]]></category>
                            <category><![CDATA[Trials]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/november/uk-industry-clinical-trial-performance-shows-signs-of-improvement-says-abpi-report/</guid>
                    <description><![CDATA[The decline in the number of industry clinical trials initiated in the UK shows welcome early signs of recovery. However, progress is not yet enough to restore the UK&#x2019;s global ranking on trials.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/wauejrdp/scientist-microscope-930x930-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eed62530"/>
                </item>
                <item>
                    <title>The UK must harness the power of advanced manufacturing</title>
<link>https://www.abpi.org.uk/media/news/2023/november/the-uk-must-harness-the-power-of-advanced-manufacturing/</link>                    <pubDate>Tue, 14 Nov 2023 00:05:25 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Manufacturing]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/november/the-uk-must-harness-the-power-of-advanced-manufacturing/</guid>
                    <description><![CDATA[New report sets out the reforms necessary for the UK to close the gap with global competitors and unlock the potential for manufacturing to drive prosperity and pride across the UK.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/bpvorsy0/istock-1366733316.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1da16544310f660"/>
                </item>
                <item>
                    <title>UK antibiotic subscription model key to supporting antibiotic investment</title>
<link>https://www.abpi.org.uk/media/news/2023/november/uk-antibiotic-subscription-model-key-to-supporting-antibiotic-investment/</link>                    <pubDate>Thu, 02 Nov 2023 00:05:53 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[AMR]]></category>
                            <category><![CDATA[Antibiotic resistance]]></category>
                            <category><![CDATA[Anti Microbial Resistance]]></category>
                            <category><![CDATA[Antibiotics]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/november/uk-antibiotic-subscription-model-key-to-supporting-antibiotic-investment/</guid>
                    <description><![CDATA[Proposals for a Novel UK Antimicrobial Subscription Model: The Investor Perspective from the Office of Health Economics ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/brcd3tef/pexels-katarzyna-modrzejewska-6203349-small.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1da0cab8fd590d0"/>
                </item>
                <item>
                    <title>UK faces &#xA3;50bn economic hit due to spiralling medicines levy</title>
<link>https://www.abpi.org.uk/media/news/2023/october/uk-faces-50bn-economic-hit-due-to-spiralling-medicines-levy/</link>                    <pubDate>Thu, 12 Oct 2023 11:51:37 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Statutory Scheme]]></category>
                            <category><![CDATA[Economy and Industry]]></category>
                            <category><![CDATA[Medicines sales]]></category>
                            <category><![CDATA[Research and Development]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/october/uk-faces-50bn-economic-hit-due-to-spiralling-medicines-levy/</guid>
                    <description><![CDATA[A new report by WPI Economics, &#x2018;False Economy: How NHS medicine procurement threatens the UK&#x2019;s life sciences growth engine&#x2019; argues that unless the UK takes action to reduce the rebate rates levied on branded medicines sales, the UK stands to lose &#xA3;1.9bn investment in UK research and development spending (R&amp;D) in 2028, with a cumulative &#xA3;5.7bn of R&amp;D investment lost between 2024-28.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/arpoapgw/three-people-analysing-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef1291f0"/>
                </item>
                <item>
                    <title>EFPIA WAIT indicator survey 2022 launches</title>
<link>https://www.abpi.org.uk/media/news/2023/april/efpia-wait-indicator-survey-2022-launches/</link>                    <pubDate>Tue, 26 Sep 2023 17:55:56 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Health and Access to Medicines]]></category>
                            <category><![CDATA[UK-EU]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/april/efpia-wait-indicator-survey-2022-launches/</guid>
                    <description><![CDATA[EFPIA has published its 2022 WAIT Indicator Survey which records the time it takes to take a new medicine from regulatory licencing to reimbursement in different European countries.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/4ynexl2a/clinical-data-management-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f061ce40"/>
                </item>
                <item>
                    <title>New government consultation on medicine clawbacks will harm investment, says ABPI</title>
<link>https://www.abpi.org.uk/media/news/2023/july/new-government-consultation-on-medicine-clawbacks-will-harm-investment-says-abpi/</link>                    <pubDate>Tue, 26 Sep 2023 13:50:14 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                            <category><![CDATA[Statutory Scheme]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/july/new-government-consultation-on-medicine-clawbacks-will-harm-investment-says-abpi/</guid>
                    <description><![CDATA[In a move that will further damage UK life sciences investment, the government has launched a consultation into radically changing the Statutory Scheme for branded medicines (known as the Statutory Scheme). ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/xziohiwe/review-871-581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee51da00"/>
                </item>
                <item>
                    <title>ABPI response to Life Sciences Innovative Manufacturing Fund announcement</title>
<link>https://www.abpi.org.uk/media/news/2022/february/abpi-response-to-life-sciences-innovative-manufacturing-fund-announcement/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:13 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Manufacturing]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/february/abpi-response-to-life-sciences-innovative-manufacturing-fund-announcement/</guid>
                    <description><![CDATA[The Office for Life Sciences has today announced the Life Sciences Innovative Manufacturing Fund, designed to boost medical manufacturing in the UK.&#xA0;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/uk5fxrrt/manufacturing-aggregation-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52efa18b80"/>
                </item>
                <item>
                    <title>ABPI welcomes Health and Care Bill amendments on research</title>
<link>https://www.abpi.org.uk/media/news/2022/february/abpi-welcomes-health-and-care-bill-amendments-on-research/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:13 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Clinical research]]></category>
                            <category><![CDATA[Research and Development]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/february/abpi-welcomes-health-and-care-bill-amendments-on-research/</guid>
                    <description><![CDATA[The Government has made amendments to the Health and Care Bill to include a strengthened research mandate.&#xA0;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/a3ehmtfr/research-aggregation-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef9a5f90"/>
                </item>
                <item>
                    <title>MMIP chair responds to Life Sciences Innovative Manufacturing Fund grants announcement</title>
<link>https://www.abpi.org.uk/media/news/2023/march/mmip-chair-responds-to-life-sciences-innovative-manufacturing-fund-grants-announcement/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:13 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/march/mmip-chair-responds-to-life-sciences-innovative-manufacturing-fund-grants-announcement/</guid>
                    <description><![CDATA[The government has announced the winners of the first tranche of Life Sciences Innovative Manufacturing Fund (LSIMF) grants. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/nncpaw0e/pharmacist-medicines-shelves-580x405-1-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eec13da0"/>
                </item>
                <item>
                    <title>ABPI response to England Rare Diseases Action Plan</title>
<link>https://www.abpi.org.uk/media/news/2022/february/abpi-response-to-england-rare-diseases-action-plan/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:12 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Rare diseases]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/february/abpi-response-to-england-rare-diseases-action-plan/</guid>
                    <description><![CDATA[The ABPI has responded to publication of the England Rare Diseases Action plan today. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/mckn43oh/paul-catchpole-871x581-webp75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d8ab52a7e06a80"/>
                </item>
                <item>
                    <title>Call for urgency to deliver on global pledge for antibiotic incentives</title>
<link>https://www.abpi.org.uk/media/news/2023/march/call-for-urgency-to-deliver-on-global-pledge-for-antibiotic-incentives/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:12 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[AMR]]></category>
                            <category><![CDATA[Antibiotic resistance]]></category>
                            <category><![CDATA[Antibiotics]]></category>
                            <category><![CDATA[Anti Microbial Resistance]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/march/call-for-urgency-to-deliver-on-global-pledge-for-antibiotic-incentives/</guid>
                    <description><![CDATA[A new report, &#x2018;Incentivising new antibiotics&#x2019; by the Office of Health Economics (OHE)]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/whyoq4zl/petri-blue-glove-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c7fb4ab9390"/>
                </item>
                <item>
                    <title>ABPI welcome the appointment of Sir Hugh Taylor to key role in Voluntary Scheme negotiations</title>
<link>https://www.abpi.org.uk/media/news/2023/march/abpi-welcome-the-appointment-of-sir-hugh-taylor-to-key-role-in-voluntary-scheme-negotiations/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:12 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Statutory Scheme]]></category>
                            <category><![CDATA[Pricing]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/march/abpi-welcome-the-appointment-of-sir-hugh-taylor-to-key-role-in-voluntary-scheme-negotiations/</guid>
                    <description><![CDATA[Sir Hugh Taylor has been appointed as Chief Advisor to the government on the Voluntary Scheme Negotiations.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/3nypoi03/hugh-taylor-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d960d2ea217480"/>
                </item>
                <item>
                    <title>Spring Statement 2022</title>
<link>https://www.abpi.org.uk/media/news/2022/march/spring-statement-2022/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:12 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Budget]]></category>
                            <category><![CDATA[Apprentices]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/march/spring-statement-2022/</guid>
                    <description><![CDATA[Our reaction to the Chancellor of the Exchequer&#x27;s Spring Statement, delivered to Parliament on Wednesday 23 March 2022.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/1h5m3odm/medical-staff-blue-row-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef152a00"/>
                </item>
                <item>
                    <title>ABPI response to MHRA clinical trials framework</title>
<link>https://www.abpi.org.uk/media/news/2023/march/abpi-response-to-mhra-clinical-trials-framework/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:11 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/march/abpi-response-to-mhra-clinical-trials-framework/</guid>
                    <description><![CDATA[The Medicines and Healthcare products Regulatory Agency (MHRA), in partnership with the Health Research Authority (HRA), has announced a new regulatory framework for clinical trials in the UK.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/4ipl0jn0/lab-colleagues-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c803120ff00"/>
                </item>
                <item>
                    <title>Speech: Life sciences companies can be part of the cure for climate change</title>
<link>https://www.abpi.org.uk/media/news/2022/february/speech-life-sciences-companies-can-be-part-of-the-cure-for-climate-change/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:11 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Corporate Responsibility]]></category>
                            <category><![CDATA[Manufacturing]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/february/speech-life-sciences-companies-can-be-part-of-the-cure-for-climate-change/</guid>
                    <description><![CDATA[Speech from the ABPI&#x27;s Vice President Pinder Sahota to the Pharma Sustainability Integrates conference. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/l0ypsuv4/pinder-website.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d828d221897790"/>
                </item>
                <item>
                    <title>ABPI response to Clinical Research Implementation Plan publication</title>
<link>https://www.abpi.org.uk/media/news/2022/june/abpi-response-to-clinical-research-implementation-plan-publication/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:10 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Clinical research]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/june/abpi-response-to-clinical-research-implementation-plan-publication/</guid>
                    <description><![CDATA[The governments of the four nations of the UK have published a second joint implementation plan for improving clinical research in the UK. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/prhbezxo/event-930x930-man-with-vial-webp50.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee7603d0"/>
                </item>
                <item>
                    <title>ABPI response to NHS Long Term Workforce Plan</title>
<link>https://www.abpi.org.uk/media/news/2023/june/abpi-response-to-nhs-long-term-workforce-plan/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:10 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/june/abpi-response-to-nhs-long-term-workforce-plan/</guid>
                    <description><![CDATA[NHSE have published the first comprehensive workforce plan for the NHS]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/1h5m3odm/medical-staff-blue-row-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef152a00"/>
                </item>
                <item>
                    <title>Global research allies critical to UK science superpower ambitions</title>
<link>https://www.abpi.org.uk/media/news/2022/february/global-research-allies-critical-to-uk-science-superpower-ambitions/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:09 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[International]]></category>
                            <category><![CDATA[International research]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/february/global-research-allies-critical-to-uk-science-superpower-ambitions/</guid>
                    <description><![CDATA[Strategic alliances with advanced and emerging nations can put the UK at the heart of a new global economy for science and research says a new report.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ogojni0v/research-team-580x405.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eea6d7d0"/>
                </item>
                <item>
                    <title>ABPI response to Northern Ireland&#x27;s Rare Diseases Action Plan</title>
<link>https://www.abpi.org.uk/media/news/2022/march/abpi-response-to-northern-irelands-rare-diseases-action-plan/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:09 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Rare diseases]]></category>
                            <category><![CDATA[Northern Ireland]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/march/abpi-response-to-northern-irelands-rare-diseases-action-plan/</guid>
                    <description><![CDATA[Northern Ireland has published its Rare Diseases Action Plan, with 14 high-level actions that will be taken forward over the next year. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/wbsly1i1/disclosure-doctor-green-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef6ebbb0"/>
                </item>
                <item>
                    <title>ABPI welcomes new UK ambitions to accelerate genomic research</title>
<link>https://www.abpi.org.uk/media/news/2022/march/abpi-welcomes-new-uk-ambitions-to-accelerate-genomic-research/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:08 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Genomics]]></category>
                            <category><![CDATA[Research and Development]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/march/abpi-welcomes-new-uk-ambitions-to-accelerate-genomic-research/</guid>
                    <description><![CDATA[The Government has today announced new shared commitments and priority actions for genomics initiatives across the UK.&#xA0;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/prhbezxo/event-930x930-man-with-vial-webp50.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee7603d0"/>
                </item>
                <item>
                    <title>ABPI response to Board of Trade report on Life Sciences</title>
<link>https://www.abpi.org.uk/media/news/2022/november/abpi-response-to-board-of-trade-report-on-life-sciences/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:08 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Trade]]></category>
                            <category><![CDATA[Life Sciences]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/november/abpi-response-to-board-of-trade-report-on-life-sciences/</guid>
                    <description><![CDATA[ABPI response to the UK Board of Trade&#x2019;s latest report on the UK life sciences]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/jgrn2v23/data-woman-explain-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef712cb0"/>
                </item>
                <item>
                    <title>Innovative medicines can bring hope to people with rare diseases &#x2013; let&#x2019;s get them to patients</title>
<link>https://www.abpi.org.uk/media/blogs/2022/february/innovative-medicines-can-bring-hope-to-people-with-rare-diseases-let-s-get-them-to-patients/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:08 GMT</pubDate>
                            <dc:creator><![CDATA[Paul Catchpole]]></dc:creator>
                            <category><![CDATA[Rare diseases]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2022/february/innovative-medicines-can-bring-hope-to-people-with-rare-diseases-let-s-get-them-to-patients/</guid>
                    <description><![CDATA[England&#x2019;s Action Plan for Rare Diseases contains important commitments to ensure that people with rare diseases get faster diagnosis, better care and timelier access to the treatments they desperately need.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/a4unvq1q/paul-catchpole-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d82c85690afd30"/>
                </item>
                <item>
                    <title>ABPI response to the Autumn Statement</title>
<link>https://www.abpi.org.uk/media/news/2022/november/abpi-response-to-the-autumn-statement/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:08 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Research and Development]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/november/abpi-response-to-the-autumn-statement/</guid>
                    <description><![CDATA[The Association of the British Pharmaceutical Industry (ABPI) has welcomed Chancellor Jeremy Hunt&#x2019;s Autumn Statement for recognising the vital role UK life sciences will play in delivering innovation-led growth.&#xA0;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ogojni0v/research-team-580x405.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eea6d7d0"/>
                </item>
                <item>
                    <title>ABPI appoints new Director of PMCPA</title>
<link>https://www.abpi.org.uk/media/news/2022/february/abpi-appoints-new-director-of-pmcpa/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:08 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[ABPI news]]></category>
                            <category><![CDATA[PMCPA]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/february/abpi-appoints-new-director-of-pmcpa/</guid>
                    <description><![CDATA[Alex Fell, Vice-President and Head of Risk International at Amicus Therapeutics will take over the role from June 2022.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/g1heqncy/alex-fell.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d8289a094bd930"/>
                </item>
                <item>
                    <title>Act now to bring &#xA3;68bn economic boost to the UK through new research investment</title>
<link>https://www.abpi.org.uk/media/news/2022/june/act-now-to-bring-68bn-economic-boost-to-the-uk-through-new-research-investment/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:08 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Economy and Industry]]></category>
                            <category><![CDATA[Pricing]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/june/act-now-to-bring-68bn-economic-boost-to-the-uk-through-new-research-investment/</guid>
                    <description><![CDATA[The UK life science sector faces a &#x201C;moment of truth&#x201D; according to a new report produced by PwC for the ABPI.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/hmibbi0s/biochemical-research-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eea1a7b0"/>
                </item>
                <item>
                    <title>Novo Nordisk&#x2019;s Pinder Sahota appointed President of the ABPI</title>
<link>https://www.abpi.org.uk/media/news/2022/april/novo-nordisk-s-pinder-sahota-appointed-president-of-the-abpi/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:07 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Commercial]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/april/novo-nordisk-s-pinder-sahota-appointed-president-of-the-abpi/</guid>
                    <description><![CDATA[Pinder will lead on overseeing the ABPI, the ABPI Board, and the ABPI&#x2019;s Code of Practice, which is administered by the Prescription Medicines Code of Practice Authority (PMCPA). ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ahwbaz0j/pinder-sahota-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c8383b60500"/>
                </item>
                <item>
                    <title>ABPI response to the mini-Budget</title>
<link>https://www.abpi.org.uk/media/news/2022/september/abpi-response-to-the-mini-budget/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:07 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/september/abpi-response-to-the-mini-budget/</guid>
                    <description><![CDATA[The Chancellor has set out the Government&#x27;s plan for growth, aimed at releasing the huge potential in the British economy. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ogojni0v/research-team-580x405.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eea6d7d0"/>
                </item>
                <item>
                    <title>ABPI response to Life Sciences Competitiveness Indicators</title>
<link>https://www.abpi.org.uk/media/news/2022/july/abpi-response-to-life-sciences-competitiveness-indicators/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:07 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Manufacturing]]></category>
                            <category><![CDATA[Clinical research]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/july/abpi-response-to-life-sciences-competitiveness-indicators/</guid>
                    <description><![CDATA[The Government has today published Life Sciences Competitiveness Indicators, which provide data on the state of the life sciences sector in the UK.&#xA0;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ujfppdnf/dr_richard_torbett_abpi_dec_2019.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d82d91ae8095c0"/>
                </item>
                <item>
                    <title>ABPI response to DHSC antimicrobial resistance research funding</title>
<link>https://www.abpi.org.uk/media/news/2023/may/abpi-response-to-dhsc-antimicrobial-resistance-research-funding/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:06 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[AMR]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/may/abpi-response-to-dhsc-antimicrobial-resistance-research-funding/</guid>
                    <description><![CDATA[UK government announces &#xA3;39 million funding for antimicrobial resistance (AMR) research through the Global AMR Innovation Fund (GAMRIF).]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ktdjbjub/shinogi_global_web-460.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d98c8fdc2ba4c0"/>
                </item>
                <item>
                    <title>CSL Behring joins the ABPI</title>
<link>https://www.abpi.org.uk/media/news/2022/february/csl-behring-joins-the-abpi/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:06 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/february/csl-behring-joins-the-abpi/</guid>
                    <description><![CDATA[The ABPI is pleased to announce that CSL Behring has become a new full member from February 2022.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/jcsjc0qj/christian-wieszner-csl-bering-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d8224f7cdc4200"/>
                </item>
                <item>
                    <title>Developing new antibiotics key for the race against resistant infections, says ABPI</title>
<link>https://www.abpi.org.uk/media/news/2022/november/developing-new-antibiotics-key-for-the-race-against-resistant-infections-says-abpi/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:06 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[AMR]]></category>
                            <category><![CDATA[Anti Microbial Resistance]]></category>
                            <category><![CDATA[Antibiotics]]></category>
                            <category><![CDATA[Antibiotic resistance]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/november/developing-new-antibiotics-key-for-the-race-against-resistant-infections-says-abpi/</guid>
                    <description><![CDATA[World Antimicrobial Awareness Week aims to improve the awareness and understanding of antimicrobial resistance (AMR). ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ktdjbjub/shinogi_global_web-460.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d98c8fdc2ba4c0"/>
                </item>
                <item>
                    <title>ABPI welcomes new NHS research guidance</title>
<link>https://www.abpi.org.uk/media/news/2023/march/abpi-welcomes-new-nhs-research-guidance/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:06 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Clinical research]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/march/abpi-welcomes-new-nhs-research-guidance/</guid>
                    <description><![CDATA[NHS England has published new research guidance for the Integrated Care Systems, which have a legal duty to promote, facilitate, and report on research.&#xA0;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/vdhng3oq/asian-scientists-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eeccfd70"/>
                </item>
                <item>
                    <title>New report from The King&#x2019;s Fund shows the UK underperforming on treatable health conditions, says the ABPI</title>
<link>https://www.abpi.org.uk/media/news/2023/june/new-report-from-the-king-s-fund-shows-the-uk-underperforming-on-treatable-health-conditions-says-the-abpi/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:06 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/june/new-report-from-the-king-s-fund-shows-the-uk-underperforming-on-treatable-health-conditions-says-the-abpi/</guid>
                    <description><![CDATA[The King&#x2019;s Fund today published their independent report commissioned by the ABPI comparing the NHS to other international health systems. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/dsdjc5k2/nurses-corridor-white-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef7858a0"/>
                </item>
                <item>
                    <title>ABPI response to guidance on the value of new antibiotics</title>
<link>https://www.abpi.org.uk/media/news/2022/april/abpi-response-to-guidance-on-the-value-of-new-antibiotics/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:06 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[AMR]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/april/abpi-response-to-guidance-on-the-value-of-new-antibiotics/</guid>
                    <description><![CDATA[The ABPI has welcomed the NICE&#x27;s leadership in introducing a new approach to the evaluation of antibiotics.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/2geg0z5f/news-2-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d8b1a1ebd6bf00"/>
                </item>
                <item>
                    <title>ABPI response to MHRA European Commission Decision Reliance Procedure (ECDRP) announcement</title>
<link>https://www.abpi.org.uk/media/news/2023/january/abpi-response-to-mhra-european-commission-decision-reliance-procedure-ecdrp-announcement/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:06 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/january/abpi-response-to-mhra-european-commission-decision-reliance-procedure-ecdrp-announcement/</guid>
                    <description><![CDATA[Decision on The European Commission Decision Reliance Procedure (ECDRP) in GB.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ptvdrsdy/data-laptop-patient-580x405-1-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eed40250"/>
                </item>
                <item>
                    <title>ABPI response to TRIPS waiver proposals</title>
<link>https://www.abpi.org.uk/media/news/2022/march/abpi-response-to-trips-waiver-proposals/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:06 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Intellectual Property]]></category>
                            <category><![CDATA[COVID 19]]></category>
                            <category><![CDATA[TRIPS waiver]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/march/abpi-response-to-trips-waiver-proposals/</guid>
                    <description><![CDATA[The draft proposals from the WTO completely undermine the innovation system and seeks to resolve a problem that doesn&#x2019;t exist.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/1f0lkzvd/sterile-capsules-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eecef940"/>
                </item>
                <item>
                    <title>ABPI response to the Government&#x27;s Plan for Patients</title>
<link>https://www.abpi.org.uk/media/news/2022/september/abpi-response-to-the-governments-plan-for-patients/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:05 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/september/abpi-response-to-the-governments-plan-for-patients/</guid>
                    <description><![CDATA[The Government has today published its Plan for Patients, so that patients receive easier access to NHS and social care this winter and next.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/jihl0ma0/wheelchair-professional-871x581-webp75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eeebf720"/>
                </item>
                <item>
                    <title>Report: Pharmaceutical industry needs more digital talent</title>
<link>https://www.abpi.org.uk/media/news/2022/january/report-pharmaceutical-industry-needs-more-digital-talent/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:05 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Education]]></category>
                            <category><![CDATA[Skills]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/january/report-pharmaceutical-industry-needs-more-digital-talent/</guid>
                    <description><![CDATA[New research shows strong progress in addressing STEM skills gaps and shortages but digital skills deficits remain.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/z0jjjqqo/test-tubes-379x256-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d8b1a8251031b0"/>
                </item>
                <item>
                    <title>ABPI response to charity joint statement on the Voluntary Scheme</title>
<link>https://www.abpi.org.uk/media/news/2023/april/abpi-response-to-charity-joint-statement-on-the-voluntary-scheme/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:05 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[ABPI Patient Advisory Council]]></category>
                            <category><![CDATA[Patients]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Health and Access to Medicines]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/april/abpi-response-to-charity-joint-statement-on-the-voluntary-scheme/</guid>
                    <description><![CDATA[The ABPI welcomes this Joint Statement on the Voluntary Scheme and shares patient charities&#x2019; ambition for a new Voluntary Scheme that sees &#x2018;people and communities benefit from new treatments, the NHS able to make the best use of its budget, and the UK [as] an attractive location for global life sciences research investment&#x2019;.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/rszec1xe/compensation-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52efe74710"/>
                </item>
                <item>
                    <title>10-year Moderna deal underlines UK potential for global life science leadership</title>
<link>https://www.abpi.org.uk/media/news/2022/december/10-year-moderna-deal-underlines-uk-potential-for-global-life-science-leadership/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:04 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[#ValuingVaccines]]></category>
                            <category><![CDATA[Clinical research]]></category>
                            <category><![CDATA[Research and Development]]></category>
                            <category><![CDATA[Manufacturing]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/december/10-year-moderna-deal-underlines-uk-potential-for-global-life-science-leadership/</guid>
                    <description><![CDATA[The partnership with Moderna will see a new Innovation and Technology Centre in the UK, which will create more than 150 highly skilled jobs and have the capacity to produce up to 250 million vaccines per year in the event of a pandemic.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/0dunzkfz/vials-production-930x930-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eef08b00"/>
                </item>
                <item>
                    <title>ABPI response to research on the Innovative Medicines Fund</title>
<link>https://www.abpi.org.uk/media/news/2023/august/abpi-response-to-research-on-the-innovative-medicines-fund/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:03 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Innovative Medicines Fund (IMF)]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/august/abpi-response-to-research-on-the-innovative-medicines-fund/</guid>
                    <description><![CDATA[The ABPI has commented on research from the London School of Hygiene and Tropical Medicine (LSHTM) on the Innovative Medicines Fund. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/jihl0ma0/wheelchair-professional-871x581-webp75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eeebf720"/>
                </item>
                <item>
                    <title>Pharmaceutical industry sets out manifesto for the next Northern Ireland Assembly</title>
<link>https://www.abpi.org.uk/media/news/2022/january/pharmaceutical-industry-sets-out-manifesto-for-the-next-northern-ireland-assembly/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:03 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Northern Ireland]]></category>
                            <category><![CDATA[Devolved Nations - Northern Ireland]]></category>
                            <category><![CDATA[ABPI Manifesto]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/january/pharmaceutical-industry-sets-out-manifesto-for-the-next-northern-ireland-assembly/</guid>
                    <description><![CDATA[Five recommendations for the next Northern Ireland Assembly to deliver better health and care for patients, recover from the pandemic and deliver economic and jobs growth over the next term. &#xA0;&#xA0;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/vdhng3oq/asian-scientists-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eeccfd70"/>
                </item>
                <item>
                    <title>Pharmaceutical industry working to build public trust with new data principles</title>
<link>https://www.abpi.org.uk/media/news/2022/february/pharmaceutical-industry-working-to-build-public-trust-with-new-data-principles/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:03 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Health data]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/february/pharmaceutical-industry-working-to-build-public-trust-with-new-data-principles/</guid>
                    <description><![CDATA[Trust, transparency and public involvement are at the heart of new principles open for consultation that will shape how the pharmaceutical industry will use health data for research in the UK.&#xA0;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/xziohiwe/review-871-581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee51da00"/>
                </item>
                <item>
                    <title>ABPI response to Lord O&#x27;Shaughnessy Review</title>
<link>https://www.abpi.org.uk/media/news/2023/february/abpi-response-to-lord-oshaughnessy-review/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:03 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Clinical research]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/february/abpi-response-to-lord-oshaughnessy-review/</guid>
                    <description><![CDATA[Lord James O&#x2019;Shaughnessy will conduct a review of the UK&#x27;s commercial clinical trials landscape.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/1ncp0bwt/scientist-tablet-2-detail-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eedfc220"/>
                </item>
                <item>
                    <title>ABPI statement on CBI</title>
<link>https://www.abpi.org.uk/media/news/2023/april/abpi-statement-on-cbi/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:03 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[ABPI Statement]]></category>
                            <category><![CDATA[Corporate Responsibility]]></category>
                            <category><![CDATA[Trust]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/april/abpi-statement-on-cbi/</guid>
                    <description><![CDATA[&#x201C;The CBI has done the right thing to suspend its activities with members until its current crisis has been thoroughly investigated and until appropriate steps have been taken to ensure good governance and the highest possible standards of conduct are assured. The ABPI, like everyone else, is deeply disturbed by the reported allegations and we will keep our membership of the organisation under review until such time that we are confident that the right steps have been taken.&#x201D;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/e5pdepux/events-930x930-mug-laptop.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee893db0"/>
                </item>
                <item>
                    <title>ABPI welcomes Moderna investment</title>
<link>https://www.abpi.org.uk/media/news/2022/june/abpi-welcomes-moderna-investment/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:02 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Manufacturing]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/june/abpi-welcomes-moderna-investment/</guid>
                    <description><![CDATA[Moderna has signed an agreement with the UK Government to establish an mRNA Innovation and Technology Center in the UK.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/dkmh2k31/microscope-laptop-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eec7cd50"/>
                </item>
                <item>
                    <title>ABPI welcomes first women&#x27;s health strategy for England</title>
<link>https://www.abpi.org.uk/media/news/2022/july/abpi-welcomes-first-womens-health-strategy-for-england/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:02 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Clinical research]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/july/abpi-welcomes-first-womens-health-strategy-for-england/</guid>
                    <description><![CDATA[The Government has today published the first women&#x27;s health strategy for England, to tackle the gender health gap.&#xA0;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/jihl0ma0/wheelchair-professional-871x581-webp75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eeebf720"/>
                </item>
                <item>
                    <title>ABPI response to Applied Health Economics and Health Policy paper: &#x201C;Can the UK &#x2018;Netflix&#x2019; Payment Model Boost the Antibacterial Pipeline?&#x201D;</title>
<link>https://www.abpi.org.uk/media/news/2023/january/abpi-response-to-applied-health-economics-and-health-policy-paper-can-the-uk-netflix-payment-model-boost-the-antibacterial-pipeline/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:01 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[AMR]]></category>
                            <category><![CDATA[Antibiotics]]></category>
                            <category><![CDATA[Anti Microbial Resistance]]></category>
                            <category><![CDATA[Antibiotic resistance]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/january/abpi-response-to-applied-health-economics-and-health-policy-paper-can-the-uk-netflix-payment-model-boost-the-antibacterial-pipeline/</guid>
                    <description><![CDATA[An article published today in the Applied Health Economics and Health Policy journal describes the importance of the pioneering pilot scheme designed to incentivise and support the development of new antibiotic treatments. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ktdjbjub/shinogi_global_web-460.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d98c8fdc2ba4c0"/>
                </item>
                <item>
                    <title>ABPI response to health and social care committee report on vaccination</title>
<link>https://www.abpi.org.uk/media/news/2023/july/abpi-response-to-health-and-social-care-committee-report-on-vaccination/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:01 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Vaccines]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/july/abpi-response-to-health-and-social-care-committee-report-on-vaccination/</guid>
                    <description><![CDATA[The Health and Social Care Committee has published its report &#x2018;Prevention in health and social care: vaccination&#x2019;.&#xA0;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/r5gfhzmm/doctor-vaccine-arm-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eeb38200"/>
                </item>
                <item>
                    <title>Speech: ABPI Vice President Susan Rienow addresses Pharma Integrates conference</title>
<link>https://www.abpi.org.uk/media/news/2022/november/speech-abpi-vice-president-susan-rienow-addresses-pharma-integrates-conference/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:01 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Life Sciences]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/november/speech-abpi-vice-president-susan-rienow-addresses-pharma-integrates-conference/</guid>
                    <description><![CDATA[The ABPI&#x27;s Vice-President Susan Rienow opened the Pharma Integrates conference today.  ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/wauejrdp/scientist-microscope-930x930-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eed62530"/>
                </item>
                <item>
                    <title>ABPI response to the Goldacre Review</title>
<link>https://www.abpi.org.uk/media/news/2022/april/abpi-response-to-the-goldacre-review/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:01 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Health data]]></category>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Budget]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/april/abpi-response-to-the-goldacre-review/</guid>
                    <description><![CDATA[The Goldacre Review has been published, with recommendations for how to build efficient and safe use of health data for research and analysis.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/xeom40nk/event-930x930-hands-planning-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee7a97b0"/>
                </item>
                <item>
                    <title>ABPI comment on BGMA proposals for a new Voluntary Scheme</title>
<link>https://www.abpi.org.uk/media/news/2023/june/abpi-comment-on-bgma-proposals-for-a-new-voluntary-scheme/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:00 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Medicines sales]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/june/abpi-comment-on-bgma-proposals-for-a-new-voluntary-scheme/</guid>
                    <description><![CDATA[The ABPI shares the BGMA&#x2019;s frustration at the economic damage being done by the current Voluntary Scheme for Branded Medicines Pricing and Access (VPAS) and notes its new publication on these issues. &#xA;&#xA;The solution to these shared challenges must be a completely new approach, balanced across all segments of the branded medicines market, including branded generics and biosimilars, to benefit patients, the NHS and the economy.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/xziohiwe/review-871-581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee51da00"/>
                </item>
                <item>
                    <title>ABPI statement on the death of Aisling Burnand</title>
<link>https://www.abpi.org.uk/media/news/2022/september/abpi-statement-on-the-death-of-aisling-burnand/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:00 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/september/abpi-statement-on-the-death-of-aisling-burnand/</guid>
                    <description><![CDATA[The former CEO of the Association of Medical Research Charities, Aisling Burnand, has died from bowel cancer.&#xA0;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ddrip420/death-aisling-burnand-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d8ce97ee013630"/>
                </item>
                <item>
                    <title>ABPI response to Government&#x27;s future strategy for batch testing of medicinal products in Great Britain</title>
<link>https://www.abpi.org.uk/media/news/2022/december/abpi-response-to-governments-future-strategy-for-batch-testing-of-medicinal-products-in-great-britain/</link>                    <pubDate>Wed, 20 Sep 2023 09:53:00 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/december/abpi-response-to-governments-future-strategy-for-batch-testing-of-medicinal-products-in-great-britain/</guid>
                    <description><![CDATA[The Government has announced its future strategy for batch testing of medicinal products in Great Britain.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/prhbezxo/event-930x930-man-with-vial-webp50.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee7603d0"/>
                </item>
                <item>
                    <title>New approach to antibiotics good news for patients</title>
<link>https://www.abpi.org.uk/media/news/2022/june/new-approach-to-antibiotics-good-news-for-patients/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:59 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[AMR]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/june/new-approach-to-antibiotics-good-news-for-patients/</guid>
                    <description><![CDATA[The ABPI has responded to the NHS England and NHS Improvement announcement about a pioneering new approach for evaluating and reimbursing antimicrobials.&#xA0;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/umung4yl/amr-430x605.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d7e4af0ea086d0"/>
                </item>
                <item>
                    <title>Our commitment to CEPI and the 100-day mission</title>
<link>https://www.abpi.org.uk/media/news/2022/march/our-commitment-to-cepi-and-the-100-day-mission/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:59 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Global health threats]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/march/our-commitment-to-cepi-and-the-100-day-mission/</guid>
                    <description><![CDATA[The global pharmaceutical industry has jointly committed to support the 100 Day Mission to develop vaccines and treatments for future health threats. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/pq3fnuvz/scientist-pipetting-580x405-webp75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee960ef0"/>
                </item>
                <item>
                    <title>Pharmaceutical companies maintain reputation post-pandemic, new research finds</title>
<link>https://www.abpi.org.uk/media/news/2023/august/pharmaceutical-companies-maintain-reputation-post-pandemic-new-research-finds/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:58 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/august/pharmaceutical-companies-maintain-reputation-post-pandemic-new-research-finds/</guid>
                    <description><![CDATA[The latest research from the ABPI-Ipsos Attitudes towards pharmaceutical companies in the UK study.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/he2ijo33/people-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d891e9ea745690"/>
                </item>
                <item>
                    <title>Pinder Sahota to step down as ABPI President</title>
<link>https://www.abpi.org.uk/media/news/2023/february/pinder-sahota-to-step-down-as-abpi-president/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:58 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/february/pinder-sahota-to-step-down-as-abpi-president/</guid>
                    <description><![CDATA[Pinder Sahota has made the decision to resign as President of the ABPI.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/oaqilp01/pinder-sahota-vice-president-2022.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d8284dc1388810"/>
                </item>
                <item>
                    <title>Susan Rienow of Pfizer named Vice-President of the ABPI</title>
<link>https://www.abpi.org.uk/media/news/2022/september/susan-rienow-of-pfizer-named-vice-president-of-the-abpi/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:56 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Health and Access to Medicines]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/september/susan-rienow-of-pfizer-named-vice-president-of-the-abpi/</guid>
                    <description><![CDATA[The ABPI Board has confirmed that Susan Rienow, Country President of Pfizer, has been elected as Vice President.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/khwjpdqe/sr-aggregation.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d8c8ebafb67630"/>
                </item>
                <item>
                    <title>First of its kind coalition sees health industry, professional bodies and experts come together to holistically tackle &#x2018;hidden pandemic&#x2019; of antibiotic resistant infections</title>
<link>https://www.abpi.org.uk/media/news/2022/february/first-of-its-kind-coalition-sees-health-industry-professional-bodies-and-experts-come-together-to-holistically-tackle-hidden-pandemic-of-antibiotic-resistant-infections/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:56 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[AMR]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/february/first-of-its-kind-coalition-sees-health-industry-professional-bodies-and-experts-come-together-to-holistically-tackle-hidden-pandemic-of-antibiotic-resistant-infections/</guid>
                    <description><![CDATA[The ABPI announces membership of a new Infection Management Coalition.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ktdjbjub/shinogi_global_web-460.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d98c8fdc2ba4c0"/>
                </item>
                <item>
                    <title>ABPI response to Science and Technology Framework publication</title>
<link>https://www.abpi.org.uk/media/news/2023/march/abpi-response-to-science-and-technology-framework-publication/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:56 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Life Sciences]]></category>
                            <category><![CDATA[Research and Development]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/march/abpi-response-to-science-and-technology-framework-publication/</guid>
                    <description><![CDATA[The Department for Science, Innovation and Technology has published the Science and Technology Framework, with the aim of making the UK a science superpower.&#xA0;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/pq3fnuvz/scientist-pipetting-580x405-webp75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee960ef0"/>
                </item>
                <item>
                    <title>Medical research call to the Chancellor</title>
<link>https://www.abpi.org.uk/media/news/2022/november/medical-research-call-to-the-chancellor/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:56 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Clinical research]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/november/medical-research-call-to-the-chancellor/</guid>
                    <description><![CDATA[The ABPI alongside 10 other partners from across the life sciences sector, has called upon the Chancellor to use the Autumn Statement to send a strong message that the UK remains a premier destination to work on health research that improves lives.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/jcgofh1n/women-scientist-microscope-871x581-webp75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef19bde0"/>
                </item>
                <item>
                    <title>New EFPIA WAIT Indicators launched</title>
<link>https://www.abpi.org.uk/media/news/2022/april/new-efpia-wait-indicators-launched/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:56 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Access]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/april/new-efpia-wait-indicators-launched/</guid>
                    <description><![CDATA[The disparities in the time it takes for patients to access new medicines in different European countries have been revealed in a new piece of research.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ptvdrsdy/data-laptop-patient-580x405-1-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eed40250"/>
                </item>
                <item>
                    <title>Connecting Life Sciences and Education</title>
<link>https://www.abpi.org.uk/media/blogs/2023/september/connecting-life-sciences-and-education/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:56 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Skills]]></category>
                            <category><![CDATA[Education]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2023/september/connecting-life-sciences-and-education/</guid>
                    <description><![CDATA[A blog post from Andrew Croydon, ABPI Director of Education and Examination Policy and Partnerships]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/zf3l1z2v/schools-hero-fun-careers-lab.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d831fe617f0c40"/>
                </item>
                <item>
                    <title>ABPI response to Understanding Patient Data securing future funding</title>
<link>https://www.abpi.org.uk/media/news/2022/december/abpi-response-to-understanding-patient-data-securing-future-funding/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:55 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/december/abpi-response-to-understanding-patient-data-securing-future-funding/</guid>
                    <description><![CDATA[Understanding Patient Data (UPD has secured further funding, a move to the NHS Confederation and a new programme of work to support NHS data infrastructure, policy and legislation.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/5l2beqty/event-930x930-doctor-older-patient-webp75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee8ee300"/>
                </item>
                <item>
                    <title>Jessamy Baird of Sanofi named as new ABPI Vice-President Elect</title>
<link>https://www.abpi.org.uk/media/news/2023/may/jessamy-baird-of-sanofi-named-as-new-abpi-vice-president-elect/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:55 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/may/jessamy-baird-of-sanofi-named-as-new-abpi-vice-president-elect/</guid>
                    <description><![CDATA[New ABPI Vice-President Elect - Jessamy Baird]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/dwkfr4vf/jessamy-baird-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d989593ac73a10"/>
                </item>
                <item>
                    <title>ABPI conference panel session: Building on the UK&#x2019;s global strengths</title>
<link>https://www.abpi.org.uk/media/blogs/2023/april/abpi-conference-panel-session-building-on-the-uk-s-global-strengths/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:55 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Annual Conference]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2023/april/abpi-conference-panel-session-building-on-the-uk-s-global-strengths/</guid>
                    <description><![CDATA[The ABPI Annual Conference&#x27;s final session was on &#x27;Building on the UK&#x27;s global strengths&#x27;.&#xA0;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/lnbhgccw/global_strengths-2.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d97eafeae282b0"/>
                </item>
                <item>
                    <title>ABPI response to NICE review of how medicines and health technologies are evaluated</title>
<link>https://www.abpi.org.uk/media/news/2022/january/abpi-response-to-nice-review-of-how-medicines-and-health-technologies-are-evaluated/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:54 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Commercial]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[NICE Methods Review]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/january/abpi-response-to-nice-review-of-how-medicines-and-health-technologies-are-evaluated/</guid>
                    <description><![CDATA[The National Institute for Health and Care Excellence (NICE) looks set to approve changes to the way it evaluates new medicines and health technologies. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/prhbezxo/event-930x930-man-with-vial-webp50.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee7603d0"/>
                </item>
                <item>
                    <title>Pharmaceutical industry a key player in Scotland&#x2019;s life sciences sector</title>
<link>https://www.abpi.org.uk/media/news/2023/february/pharmaceutical-industry-a-key-player-in-scotland-s-life-sciences-sector/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:54 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/february/pharmaceutical-industry-a-key-player-in-scotland-s-life-sciences-sector/</guid>
                    <description><![CDATA[The pharmaceutical industry is a significant contributor to the Scottish economy and a key player in Scotland&#x2019;s life sciences sector, according to an independent report from the University of Strathclyde&#x2019;s Fraser of Allander Institute (FAI). &#xA;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/nncpaw0e/pharmacist-medicines-shelves-580x405-1-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eec13da0"/>
                </item>
                <item>
                    <title>Leading global pharma firms exit UK drug pricing agreement</title>
<link>https://www.abpi.org.uk/media/news/2023/january/leading-global-pharma-firms-exit-uk-drug-pricing-agreement/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:53 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Statutory Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/january/leading-global-pharma-firms-exit-uk-drug-pricing-agreement/</guid>
                    <description><![CDATA[AbbVie and Eli Lilly and Company, two of the world&#x2019;s largest pharmaceutical companies, have sent a warning signal to the UK government by leaving the voluntary medicines pricing agreement in protest over increasingly punitive revenue clawbacks.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/jmbn45nr/event-930x930-hands-laptop.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee7fa0c0"/>
                </item>
                <item>
                    <title>ABPI statement on BGMA legal action over Voluntary Scheme negotiation representation</title>
<link>https://www.abpi.org.uk/media/news/2023/april/abpi-statement-on-bgma-legal-action-over-voluntary-scheme-negotiation-representation/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:53 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/april/abpi-statement-on-bgma-legal-action-over-voluntary-scheme-negotiation-representation/</guid>
                    <description><![CDATA[The British Generic Manufacturers Association (BGMA) is seeking a judicial review of the Department of Health and Social Care&#x2019;s (DHSC) decision to negotiate a new Voluntary Scheme for branded medicines with the Association of the British Pharmaceutical Industry (ABPI). ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/d3gp0fba/capsules-clear-blister-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef5a4950"/>
                </item>
                <item>
                    <title>Moderna joins the Association of the British Pharmaceutical Industry</title>
<link>https://www.abpi.org.uk/media/news/2023/january/moderna-joins-the-association-of-the-british-pharmaceutical-industry/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:53 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/january/moderna-joins-the-association-of-the-british-pharmaceutical-industry/</guid>
                    <description><![CDATA[Moderna becomes the latest member of the Association of the British Pharmaceutical Industry (ABPI), deepening the company&#x2019;s UK connections.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/fgbfnfug/darius-hughes-aggregation.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d9271fe81303d0"/>
                </item>
                <item>
                    <title>ABPI response to MHRA future Medical Device Regulation implementation extension</title>
<link>https://www.abpi.org.uk/media/news/2022/october/abpi-response-to-mhra-future-medical-device-regulation-implementation-extension/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:53 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[MHRA]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/october/abpi-response-to-mhra-future-medical-device-regulation-implementation-extension/</guid>
                    <description><![CDATA[The extension will mean industry will have until July 2024 to ensure their medical devices meet the new regulations. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/xeom40nk/event-930x930-hands-planning-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee7a97b0"/>
                </item>
                <item>
                    <title>ABPI response to Data Strategy publication</title>
<link>https://www.abpi.org.uk/media/news/2022/june/abpi-response-to-data-strategy-publication/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:52 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Health data]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/june/abpi-response-to-data-strategy-publication/</guid>
                    <description><![CDATA[The Government&#x27;s new data strategy is published today. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/oxon3vgh/three-scientists-sitting-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef20e9d0"/>
                </item>
                <item>
                    <title>ABPI response to government Statutory Scheme rise</title>
<link>https://www.abpi.org.uk/media/news/2023/march/abpi-response-to-government-statutory-scheme-rise/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:52 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                            <category><![CDATA[Statutory Scheme]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Medicines sales]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/march/abpi-response-to-government-statutory-scheme-rise/</guid>
                    <description><![CDATA[The government has confirmed plans to raise the revenue clawback rate paid by pharmaceutical firms subject to the Statutory Scheme for branded medicines from 24.4% to 27.5%.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ujpcz05h/records-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f0369f90"/>
                </item>
                <item>
                    <title>ABPI response to the Hewitt Review recommendations</title>
<link>https://www.abpi.org.uk/media/news/2023/april/abpi-response-to-the-hewitt-review-recommendations/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:52 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/april/abpi-response-to-the-hewitt-review-recommendations/</guid>
                    <description><![CDATA[The ABPI has welcomed Patricia Hewitt&#x2019;s review of Integrated Care Systems ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/xziohiwe/review-871-581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee51da00"/>
                </item>
                <item>
                    <title>Eligible NHS patients missing out on new medicines that could extend lives and add &#xA3;billions to the UK economy</title>
<link>https://www.abpi.org.uk/media/news/2022/may/eligible-nhs-patients-missing-out-on-new-medicines-that-could-extend-lives-and-add-billions-to-the-uk-economy/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:52 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Health and Access to Medicines]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/may/eligible-nhs-patients-missing-out-on-new-medicines-that-could-extend-lives-and-add-billions-to-the-uk-economy/</guid>
                    <description><![CDATA[New research by PwC for the ABPI published today sets out the potential benefits of increased investment in clinically- and cost-effective new medicines to patients, society, and the economy.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/prhbezxo/event-930x930-man-with-vial-webp50.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee7603d0"/>
                </item>
                <item>
                    <title>New funding to support data access for health research - ABPI response</title>
<link>https://www.abpi.org.uk/media/news/2022/march/new-funding-to-support-data-access-for-health-research-abpi-response/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:51 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Health data]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/march/new-funding-to-support-data-access-for-health-research-abpi-response/</guid>
                    <description><![CDATA[The ABPI has welcomed Government&#x27;s announcement of &#xA3;200million to improve access to health data for research. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/5tyjzxue/female-pipette-bench-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef73c4c0"/>
                </item>
                <item>
                    <title>Ask your doctor about participating in a clinical trial, says Dr Catherine Bagot</title>
<link>https://www.abpi.org.uk/media/blogs/2023/february/ask-your-doctor-about-participating-in-a-clinical-trial-says-dr-catherine-bagot/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:51 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Rare diseases]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2023/february/ask-your-doctor-about-participating-in-a-clinical-trial-says-dr-catherine-bagot/</guid>
                    <description><![CDATA[Dr Catherine Bagot is a consultant haematologist who works in the West of Scotland Adult Haemophilia Comprehensive Care Centre.&#xA0; She talks about how treatments for haemophilia have evolved in recent years and why people with haemophilia should ask about participating in clinical trials.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/lyhdhub3/dr_catherine_bagot.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d94a1c736e04b0"/>
                </item>
                <item>
                    <title>CBI extraordinary general meeting outcome</title>
<link>https://www.abpi.org.uk/media/news/2023/june/cbi-extraordinary-general-meeting-outcome/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:51 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/june/cbi-extraordinary-general-meeting-outcome/</guid>
                    <description><![CDATA[In response to the confidence vote by CBI&#x2019;s members, trade bodies including the ABPI have released the following joint statement.&#xA0;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ilxj4h3y/glove-vial-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef087fd0"/>
                </item>
                <item>
                    <title>Global action needed to secure the era of green pharmaceuticals - new report</title>
<link>https://www.abpi.org.uk/media/news/2022/november/global-action-needed-to-secure-the-era-of-green-pharmaceuticals-new-report/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:50 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/november/global-action-needed-to-secure-the-era-of-green-pharmaceuticals-new-report/</guid>
                    <description><![CDATA[Immediate action must be taken by governments, health systems and companies to secure the era of green pharmaceuticals, according to a new report. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/44rbrqun/windfarm-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c80bb717950"/>
                </item>
                <item>
                    <title>ABPI response to launch of UK and Switzerland free trade agreement negotiations</title>
<link>https://www.abpi.org.uk/media/news/2023/may/abpi-response-to-launch-of-uk-and-switzerland-free-trade-agreement-negotiations/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:50 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/may/abpi-response-to-launch-of-uk-and-switzerland-free-trade-agreement-negotiations/</guid>
                    <description><![CDATA[ABPI response to launch of UK and Switzerland free trade agreement negotiations&#xA0;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ovihupfz/hr-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52efebdaf0"/>
                </item>
                <item>
                    <title>ABPI statement on the death of Her Majesty Queen Elizabeth II</title>
<link>https://www.abpi.org.uk/media/news/2022/september/abpi-statement-on-the-death-of-her-majesty-queen-elizabeth-ii/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:49 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/september/abpi-statement-on-the-death-of-her-majesty-queen-elizabeth-ii/</guid>
                    <description><![CDATA[ABPI statement on the death of Her Majesty Queen Elizabeth II.  ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/n12nkoyn/fcjld7qwiaa-cuu.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d8c3c7948545e0"/>
                </item>
                <item>
                    <title>ABPI conference panel session: improving the health and productivity of the whole of the UK</title>
<link>https://www.abpi.org.uk/media/blogs/2023/april/abpi-conference-panel-session-improving-the-health-and-productivity-of-the-whole-of-the-uk/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:49 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Annual Conference]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2023/april/abpi-conference-panel-session-improving-the-health-and-productivity-of-the-whole-of-the-uk/</guid>
                    <description><![CDATA[At the ABPI Conference 2023, the second panel session focussed on improving the health and productivity of the whole of the UK.&#xA0;&#xA0;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/1htbmj3g/improving_health_uk-2.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d97eafeac69640"/>
                </item>
                <item>
                    <title>Gilead Sciences joins the ABPI</title>
<link>https://www.abpi.org.uk/media/news/2022/january/gilead-sciences-joins-the-abpi/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:48 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Partnership]]></category>
                            <category><![CDATA[Reputation]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/january/gilead-sciences-joins-the-abpi/</guid>
                    <description><![CDATA[Gilead Sciences has joined the membership of the Association of the British Pharmaceutical Industry, effective from January 2022.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/1toj3kba/vw-photo.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d807d6a2b275f0"/>
                </item>
                <item>
                    <title>Open letter to Secretary of State for International Trade</title>
<link>https://www.abpi.org.uk/media/news/2022/august/open-letter-to-secretary-of-state-for-international-trade/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:48 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[International]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/august/open-letter-to-secretary-of-state-for-international-trade/</guid>
                    <description><![CDATA[The ABPI is one of 11 major cross-sector business groups that have written to Anne-Marie Trevelyan on talks between the UK and India]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ojzjxvni/events-930x930-zoom-mug.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee8b6090"/>
                </item>
                <item>
                    <title>New EFPIA WAIT indicator survey launches</title>
<link>https://www.abpi.org.uk/media/news/2022/april/new-efpia-wait-indicator-survey-launches/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:48 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Access]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/april/new-efpia-wait-indicator-survey-launches/</guid>
                    <description><![CDATA[Disparities in the access patients have to new medicines have been revealed in a new piece of research.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/pgwagn03/doctor-patient-bedside-871x581-web75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eefc4ad0"/>
                </item>
                <item>
                    <title>ABPI response to launch of International Science Partnerships Fund</title>
<link>https://www.abpi.org.uk/media/news/2022/december/abpi-response-to-launch-of-international-science-partnerships-fund/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:47 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[International research]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/december/abpi-response-to-launch-of-international-science-partnerships-fund/</guid>
                    <description><![CDATA[UK Science Minister George Freeman has announced a new global research fund. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/tw1pp1kj/pipette-purple-scientist-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef3fe380"/>
                </item>
                <item>
                    <title>ABPI response to &#xA3;210 million DHSC antimicrobial awareness funding</title>
<link>https://www.abpi.org.uk/media/news/2023/august/abpi-response-to-210-million-dhsc-antimicrobial-awareness-funding/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:47 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/august/abpi-response-to-210-million-dhsc-antimicrobial-awareness-funding/</guid>
                    <description><![CDATA[Funding will be used to partner with countries across Asia and Africa to tackle antimicrobial resistance.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ktdjbjub/shinogi_global_web-460.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d98c8fdc2ba4c0"/>
                </item>
                <item>
                    <title>Pharmaceutical industry response to national war on cancer</title>
<link>https://www.abpi.org.uk/media/news/2022/february/pharmaceutical-industry-response-to-national-war-on-cancer/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:47 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Cancer]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/february/pharmaceutical-industry-response-to-national-war-on-cancer/</guid>
                    <description><![CDATA[The government has launched an ambitious 10-Year Cancer Plan to make the country&#x2019;s cancer care system the &#x2018;best in Europe&#x2019;.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/y52kfl3z/people-line-smile-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef2a86c0"/>
                </item>
                <item>
                    <title>The Innovative Medicines Fund - Good news for patients but has an opportunity been missed to be more ambitious?</title>
<link>https://www.abpi.org.uk/media/blogs/2022/june/the-innovative-medicines-fund-good-news-for-patients-but-has-an-opportunity-been-missed-to-be-more-ambitious/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:47 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Innovation]]></category>
                            <category><![CDATA[Innovative Medicines Fund (IMF)]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2022/june/the-innovative-medicines-fund-good-news-for-patients-but-has-an-opportunity-been-missed-to-be-more-ambitious/</guid>
                    <description><![CDATA[NHS England and Improvement (NHSE/I) has announced the launch of the Innovative Medicines Fund. The ABPI&#x2019;s Director of Value and Access Policy, Paul Catchpole, provides further commentary on the announcement.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/5l2beqty/event-930x930-doctor-older-patient-webp75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee8ee300"/>
                </item>
                <item>
                    <title>Inspiring the next generation of STEM workers</title>
<link>https://www.abpi.org.uk/media/blogs/2022/december/inspiring-the-next-generation-of-stem-workers/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:46 GMT</pubDate>
                            <dc:creator><![CDATA[Andrew Croydon]]></dc:creator>
                            <category><![CDATA[Skills]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2022/december/inspiring-the-next-generation-of-stem-workers/</guid>
                    <description><![CDATA[Blog by Andrew Croydon, ABPI Director of Skills &amp; Education Policy and Examinations]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/dykjhy50/bsw-hero-square.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d8356ce6969d00"/>
                </item>
                <item>
                    <title>ABPI response to new MHRA fees announced for 1 April 2023</title>
<link>https://www.abpi.org.uk/media/news/2023/february/abpi-response-to-new-mhra-fees-announced-for-1-april-2023/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:46 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/february/abpi-response-to-new-mhra-fees-announced-for-1-april-2023/</guid>
                    <description><![CDATA[The MHRA have published their response to the consultation on proposals for changes to their statutory fees, which will come into effect on 1 April 2023.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/xziohiwe/review-871-581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee51da00"/>
                </item>
                <item>
                    <title>ABPI response to UKHSA Vaccine Development and Evaluation Centre (VDEC) announcement</title>
<link>https://www.abpi.org.uk/media/news/2023/august/abpi-response-to-ukhsa-vaccine-development-and-evaluation-centre-vdec-announcement/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:46 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/august/abpi-response-to-ukhsa-vaccine-development-and-evaluation-centre-vdec-announcement/</guid>
                    <description><![CDATA[Vaccine Development and Evaluation Centre (VDEC) will build on pandemic legacy and helping develop life-saving new vaccines for the UK and worldwide.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/z0jjjqqo/test-tubes-379x256-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d8b1a8251031b0"/>
                </item>
                <item>
                    <title>Collaboration with industry will help the NHS face the next 75 years, says ABPI</title>
<link>https://www.abpi.org.uk/media/blogs/2023/july/collaboration-with-industry-will-help-the-nhs-face-the-next-75-years-says-abpi/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:46 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Partnership]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2023/july/collaboration-with-industry-will-help-the-nhs-face-the-next-75-years-says-abpi/</guid>
                    <description><![CDATA[ABPI Partnerships Director Brian Duggan considers the role that partnerships with industry have played in the last 75 years of the NHS, and how those partnerships can help the NHS face the future.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/pnafsqgg/doctor-patient-detail-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eee25a30"/>
                </item>
                <item>
                    <title>ABPI response to &#x27;Healthy Mum, Healthy Baby, Healthy Future&#x27; report</title>
<link>https://www.abpi.org.uk/media/news/2022/may/abpi-response-to-healthy-mum-healthy-baby-healthy-future-report/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:46 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Clinical research]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/may/abpi-response-to-healthy-mum-healthy-baby-healthy-future-report/</guid>
                    <description><![CDATA[The &#x27;Healthy Mum, Healthy Baby, Healthy Future&#x27; report from the University of Birmingham sets out the case for developing more medicines for use in pregnancy.&#xA0;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/blwbgdmy/research-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f0150dd0"/>
                </item>
                <item>
                    <title>ABPI response to Innovative Medicines Fund announcement</title>
<link>https://www.abpi.org.uk/media/news/2022/june/abpi-response-to-innovative-medicines-fund-announcement/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:45 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Early Access to Medicines Scheme (EAMS)]]></category>
                            <category><![CDATA[Innovative Medicines Fund (IMF)]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/june/abpi-response-to-innovative-medicines-fund-announcement/</guid>
                    <description><![CDATA[The Government has launched the Innovative Medicines Fund, to fast track the most promising medicines in the NHS.&#xA0;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/a3ehmtfr/research-aggregation-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef9a5f90"/>
                </item>
                <item>
                    <title>ABPI response: UK joins Horizon Europe</title>
<link>https://www.abpi.org.uk/media/news/2023/september/abpi-response-uk-joins-horizon-europe/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:44 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/september/abpi-response-uk-joins-horizon-europe/</guid>
                    <description><![CDATA[UK to associate to Horizon Europe through a new agreement with the EU.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/hmibbi0s/biochemical-research-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eea1a7b0"/>
                </item>
                <item>
                    <title>ABPI response to NHS England Genomics Strategy</title>
<link>https://www.abpi.org.uk/media/news/2022/october/abpi-response-to-nhs-england-genomics-strategy/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:43 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Genomics]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/october/abpi-response-to-nhs-england-genomics-strategy/</guid>
                    <description><![CDATA[NHS England has today published its first Genomics Strategy. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/0ndln4ed/petri-look-scientist-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef470f70"/>
                </item>
                <item>
                    <title>ABPI response to BGMA Judicial Review dismissal</title>
<link>https://www.abpi.org.uk/media/news/2023/july/abpi-response-to-bgma-judicial-review-dismissal/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:43 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Legal]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/july/abpi-response-to-bgma-judicial-review-dismissal/</guid>
                    <description><![CDATA[The High Court has issued a judgment on the judicial review brought by the British Generic Manufacturers Association (BGMA), dismissing the claim that the organisation was improperly excluded from the ongoing negotiations between the government and industry to agree a new Voluntary Scheme for medicine pricing and access (VPAS).]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/zmelmbl3/royal_court_london.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d9b33e03fe9320"/>
                </item>
                <item>
                    <title>Negotiations begin for a new medicine pricing scheme</title>
<link>https://www.abpi.org.uk/media/news/2023/may/negotiations-begin-for-a-new-medicine-pricing-scheme/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:43 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/may/negotiations-begin-for-a-new-medicine-pricing-scheme/</guid>
                    <description><![CDATA[Negotiations for the successor to the voluntary scheme for branded medicines, pricing and access (VPAS) will begin today between the government, NHS England and the pharmaceutical industry.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/z4edx5vc/meeting-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c8c91abffd0"/>
                </item>
                <item>
                    <title>Five new patient organisation leaders to join ABPI Patient Advisory Council</title>
<link>https://www.abpi.org.uk/media/news/2023/april/five-new-patient-organisation-leaders-to-join-abpi-patient-advisory-council/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:43 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[ABPI Patient Advisory Council]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/april/five-new-patient-organisation-leaders-to-join-abpi-patient-advisory-council/</guid>
                    <description><![CDATA[New patient organisation leaders have been appointed to the ABPI&#x2019;s Patient Advisory Council]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/tm3bcmbm/pac-tile-2023-2.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d97e4ff5492cf0"/>
                </item>
                <item>
                    <title>Susan Rienow becomes President of the ABPI</title>
<link>https://www.abpi.org.uk/media/news/2023/may/susan-rienow-becomes-president-of-the-abpi/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:41 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/may/susan-rienow-becomes-president-of-the-abpi/</guid>
                    <description><![CDATA[Susan Rienow is taking up her role as President of the Association of the British Pharmaceutical Industry.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/khwjpdqe/sr-aggregation.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d8c8ebafb67630"/>
                </item>
                <item>
                    <title>ABPI statement on the death of Professor Sir Michael Rawlins GBE Kt</title>
<link>https://www.abpi.org.uk/media/news/2023/january/abpi-statement-on-the-death-of-professor-sir-michael-rawlins-gbe-kt/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:41 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/january/abpi-statement-on-the-death-of-professor-sir-michael-rawlins-gbe-kt/</guid>
                    <description><![CDATA[ABPI statement on the death of Professor Sir Michael Rawlins GBE Kt]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/owdlwpph/michael-rawlins-580x405.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d9250e5e6bc030"/>
                </item>
                <item>
                    <title>ABPI conference panel session: Research and Development as an Engine for Growth</title>
<link>https://www.abpi.org.uk/media/blogs/2023/april/abpi-conference-panel-session-research-and-development-as-an-engine-for-growth/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:40 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Annual Conference]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2023/april/abpi-conference-panel-session-research-and-development-as-an-engine-for-growth/</guid>
                    <description><![CDATA[At ABPI&#x2019;s Annual Conference 2023, the panel sessions kicked off with a debate on &#x2018;Research and Development as an engine for growth&#x2019;.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/sdljl1qz/randd_session-2.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d97eafea98cf80"/>
                </item>
                <item>
                    <title>ABPI response to new funding for UK medicines manufacturing</title>
<link>https://www.abpi.org.uk/media/news/2022/march/abpi-response-to-new-funding-for-uk-medicines-manufacturing/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:40 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Manufacturing]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/march/abpi-response-to-new-funding-for-uk-medicines-manufacturing/</guid>
                    <description><![CDATA[The ABPI has welcomed Government&#x27;s announcement of &#xA3;60million for UK medicines manufacturing ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/uk5fxrrt/manufacturing-aggregation-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52efa18b80"/>
                </item>
                <item>
                    <title>Industry response to Levelling Up White Paper</title>
<link>https://www.abpi.org.uk/media/news/2022/february/industry-response-to-levelling-up-white-paper/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:40 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Manufacturing]]></category>
                            <category><![CDATA[Research and Development]]></category>
                            <category><![CDATA[Science and innovation]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/february/industry-response-to-levelling-up-white-paper/</guid>
                    <description><![CDATA[By backing life sciences there is even greater potential for the life sciences to help level up the UK.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/fh4edk5k/events-930x930-production-worker-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee9376e0"/>
                </item>
                <item>
                    <title>UK pharmaceutical industry welcomes India trade talks</title>
<link>https://www.abpi.org.uk/media/news/2022/january/uk-pharmaceutical-industry-welcomes-india-trade-talks/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:40 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Politics]]></category>
                            <category><![CDATA[International]]></category>
                            <category><![CDATA[Trade]]></category>
                            <category><![CDATA[Free Trade Agreements]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/january/uk-pharmaceutical-industry-welcomes-india-trade-talks/</guid>
                    <description><![CDATA[The UK has published its negotiating objectives and announced the start of trade talks with India.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/wqxdl050/brown-bottle-fill-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef7af0b0"/>
                </item>
                <item>
                    <title>ABPI responds to Bioscience and health technology sector statistics 2021</title>
<link>https://www.abpi.org.uk/media/news/2022/december/abpi-responds-to-bioscience-and-health-technology-sector-statistics-2021/</link>                    <pubDate>Wed, 20 Sep 2023 09:52:38 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Life Sciences]]></category>
                            <category><![CDATA[ABPI Statement]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2022/december/abpi-responds-to-bioscience-and-health-technology-sector-statistics-2021/</guid>
                    <description><![CDATA[The Office for Life Sciences today published economic data on Bioscience and health technology sector statistics 2021, which show stable levels of sector employment, and sharp growth in sector turnover.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/qcmp1kqt/statistics-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f01275c0"/>
                </item>
    </channel>
</rss>

